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Nanoparticles have attracted considerable recent research interest for a variety of applica-
tions and can be used to visualize and characterise biological processes at the molecular
and cellular level. They can be exploited as contrast agents for imaging and function-
alised to incorporate luminescent moieties to a provide multi-modal imaging capability.
This thesis presents a detailed series of studies on a luminescently labelled gold and silica
nanoparticles, with the use of optical and electron microscopies to examine their applica-
tions.
Using surfactant and peptide pre-coatings gold nanoparticles were coated with an
organic dye developed bind to the nanoparticle surface. The imaging potential of these
novel nanoprobes is explored by examining uptake in vitro in cancer cells. Confocal
laser scanning and transmission electron microscopies indicate significant cellular uptake.
Nuclear uptake is also observed and possible methods of translocation to the nucleus
are discussed. Cell cycle dysregulation is also assessed with no statistically significant
perturbations observed.
The cellular uptake of 13 nm and 100 nm gold nanoparticles coated with a luminescent
ruthenium polypyridyl complex was also investigated. Microscopy studies demonstrated
the imaging potential of luminescent nanoprobes upon cellular uptake which was not
accompanied significant cytotoxicity.
Finally an investigation in to the interaction of luminescent silica particles with dentine
is presented. Confocal and scanning electron microscopies enable qualitative comparisons
of the dentinal tubule occluding ability of particles coated with surfactants. The data
indicate surfactant hydrophobicity is important factor in governing interactions with the
dentine and illustrate the potential of luminescence imaging in dentistry.
This thesis is dedicated
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Luminescence imaging can yield valuable morphological and functional information within
a variety of scientific disciplines. A great advantage of luminescence imaging is the ca-
pability of imaging with high contrast, sensitivity, temporal and spatial resolution. A
variety of measurements can be performed with luminescent sensing modes such as in-
tensity, lifetime and polarization detection. For imaging at the nanoscale transmission
electron microscopy (TEM) can provide nanometre imaging resolution of a range of speci-
mens, however the technique can involve extensive sample preparation making it relatively
time consuming in comparison to luminescence based experiments. The field of nanotech-
nology has undergone an exponential growth over the past two decades, providing great
potential for the design of nanoprobes for luminescence imaging.
1.1.1 Nanoparticles for Luminescence Imaging
Nanomaterials are defined as substances with at least one dimension below 100 nm and
often display novel physical and chemical properties.1 The unique physico-chemical prop-
erties can be attributed to their small size, chemical composition, surface structure, sol-
ubility, shape and aggregation characteristics.2 For the purposes of luminescent imaging
the inherent properties of the nanomaterial can be exploited or alternatively imaging moi-
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eties can be incorporated either in or on the nanomaterial.3–8 Luminescent nanoprobes
aim to offer an alternative to the use of molecular probes which can also be used as imag-
ing agents. Spatial specificity is improved with the use of nanoparticles, for example they
can be functionalised to target specific organelles or biological processes of interest via the
binding of targeting ligands such as peptides, proteins and antibodies. Greater temporal
control may also be demonstrated, for example the time taken to internalise different sizes
of nanoparticles by a cell may vary owing to differences in the kinetics of their uptake due
to their size. This can be exploited to deliver the particles at a desired rate, in contrast to
molecular probes which may be rapidly internalised by a cell without a trivial method of
controlling uptake rate. Detection platforms utilising nanoparticles thus overcome such
limitations offering improved sensitivity, stability and the potential for multiplexing with
the integration of multiple probes on a single platform.9–13
Integrating multiple lumiphores with nanoprobes can offer a higher brightness and
the potential for imaging via a range of imaging modalities depending on the nature of
the nanoprobe. Transmitted-light and reflected-light configurations on microscopes for
example can be used when the nanoprobe exhibits the appropriate light scattering or
absorption properties. In a biological context the nanoprobes can also be targeted to
specific cells and/or tissues by surface modification with targeting vectors, opening new
avenues for disease diagnosis and therapy.14–17
Nanoparticles engineered to simultaneously express therapeutic and diagnostic po-
tential and are said to possess a ‘theranostic’ capability.18,19 Research in the field of
‘nanotheranostics has the potential to eventually offer personalised treatment where ther-
apy is tailored to address a patient’s specific disease and genetic profile, of particular
importance in cancer therapy.20,21 Directing such treatment to specific cells or tissues can
also diminish the side-effects of off-target accumulation. In cancer treatment improved
biodistribution may also improve the therapy of the metastatic aspect of the disease with
the potential for eradication of cancer stem cells which are thought to be responsible for
primary and metastatic cancer growth.21
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A variety of nanoparticles have been engineered including those consisting of poly-
mers,22 dendrimers,23 silica,24,25 semiconductor quantum dots,26–28 carbon,29 magnetite,30,31
upconversion nanoparticles32 and noble metals such as gold33,34 and silver.35 The afore-
mentioned constructs each have their distinct advantages and disadvantages. Quantum
dots for example have several useful properties such as large Stokes shifts, high quantum
yields and broad excitation spectra making them useful luminescent nanoprobes.23,36–38
Their luminescence properties are however size dependant and surface functionalisation
can be non-trivial. Quantum dots also tend to be limited in size to the order of 5 nm
or less.39 Crucially with regard to biomedicinal applications quantum dots may be toxic
to cells. Cadmium, selenium or tellurium quantum dots may for example leach cytotoxic
heavy metal atoms in the intracellular environment and induce programmed cell death
(apoptosis).40,41
Upconversion nanoparticles, consisting of an inorganic lattice doped with lanthanide
ions, luminesce by the conversion of two or more low-energy photons into a higher-energy
photon.32 They offer a useful alternative to quantum dots as they do not suffer from
blinking and can be excited in the near infra-red region of the spectrum, ideal for biological
tissue.42 A large drawback however is the synthesis of such particles with reproducability,
yield and growth-control all proving non-trivial.43
Noble metal nanoparticles offer several distinct advantages for use as luminescent
probes.44–46 The relative ease of synthesis and surface functionalisation of gold nanopar-
ticles in particular has enabled their use as an inert scaffold for a myriad of purposes, and
has led to an exponential growth in gold nanotechnology based research over the last two
decades.47
1.2 Gold Nanoparticles for Imaging
The use of gold in human civilisation spans several thousand years with gold nanoparticles
in particular possessing a rich history. In Roman times they were used to stain glass
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Figure 1.1: Transmission electron microscopy images of (a) 15 nm colloidal AuNPs, (b) 15-by-50
nm gold nanorods, (c) core/shell silica/gold nanoshells, (d) 250 nm gold nanobowls containing
55 nm gold seeds, (e) silver cubes and gold nanocages, (f) gold nanostars, (g) gold bipyramids
and (h) gold octahedrals . Image adapted from Khlebtsov and Lev.48
for decorative purposes and over the centuries have even been recommended as cures
for numerous diseases.11 The first scientific report on gold nanoparticles was in 1857
when Faraday reported their red appearance as an attribute of their colloidal nature
and observed that colloidal gold solutions have differing properties to bulk gold.17,49 In
1908 Mie went on to characterise their visible absorption using the electromagnetic wave
equations of Maxwell.50
Gold nanoparticles are relatively easily synthesised with numerous synthetic routes
available. Most methods use the commercially available HAuCl4 for citrate reduction of
AuIII to Au0 in water using a technique first introduced by Turkevitch et al. in 1951.51,52
Gold nanoparticles can be manufactured in a variety of shapes including nanospheres,
nanorods, nanobelts, nanocages and nanostars53 (Figure 1.1). Their relative ease of syn-
thesis coupled with their unique physico-chemical properties make them ideally suited for
translation from the laboratory to the clinic. The large surface to volume ratio of spher-
ical nanoparticle allows for a high loading of functionalising ligands and water solubility
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also affords biocompatibilty.48
Strategies for conjugation of ligands to gold nanoparticles can be broadly categorised
as covalent and non-covalent, with the former often yielding a more stable conjugate. This
is particularly relevant for imaging purposes where it is important to have a strong link
between the luminescent moiety and the nanoparticle. An example of a popular covalent
conjugation strategy is the direct attachment of a thiolated moeity to the gold surface via
an Au-S bond.54 Conjugation to gold via such functional groups on luminescent probes,
oligonucleotides, proteins and antibodies can be used to impart a huge array of function-
ality to gold nanoparticles, allowing for numerous applications in biomedicine.11,17,55
An important physical property of gold nanoparticles is the surface plasmon resonance
(SPR) and the size related absorption peak from 500 to 550 nm exhibited by particles
ranging 1 to 100 nm in size. The SPR can be determined using UV-Vis (Ultraviolet-
Visible) Absorption Spectroscopy which can be used to monitor changes in the SPR of
the gold nanoparticles as they undergo surface functionalisation. A schematic showing
a typical UV-Vis Spectrophotometer is shown in Figure 1.2. In brief this spectroscopic
analysis involves passing light of a known wavelength through a simple and measuring
how much light is absorbed as a function of wavelength. Molecules absorb radiation of
different wavelengths depending on their structural composition. The absorption of UV
or visible radiation for organic molecules for example correspond to electronic transitions,
where outer electrons are promoted to excited states such as the π to π? transition.
With regards to gold nanoparticles an important feature of the UV-Vis spectrum is
the aforementioned SPR. According to Mie theory the SPR arises from the absorption
of electromagnetic radiation resulting in the collective oscillation of conduction electrons
on the nanoparticles surface, providing the wavelength of the incident radiation is small
with respect to size of the nanoparticle.50 The SPR absorption wavelength is in the visible
region for gold nanoparticles 520 nm in diameter, and is furthermore also dependent on the
gold nanoparticle shape, solvent/environment (dielectric properties), surface ligands and




Figure 1.2: (a) Schematic diagram of a double-beam UV-Vis spectrophotometers. UV-Vis spec-
trophotometers consist of a (tungsten) filament lamp employed as the light source. The polychro-
matic light from the lamp light passes through an entrance slit and is directed through a dispersion
device (prism/grating) by a collimating lens (not shown). A focusing lens (not shown) directs
monochromatic light through an exit slit, through the sample and on to a detector, usually a
photo-multiplier tube. By moving the dispersing device or the exit slit, radiation of a particular
wavelength can be selected to leave through the exit slit. (b) Schematic diagram of the surface
plasmon resonance effect on a gold nanoparticle. The interaction of light of a specific wavelength
with electrons on the surface of the gold nanoparticle causes their collective oscillation, resulting
in an effect called the surface plasmon resonance. This causes the strong absorption/scattering
of light at that wavelength that is evident by a broad band in the UV-Vis spectrum. The SPR
peak is strongly dependant on the gold nanoparticle size, shape, surface and agglomeration state,
and thus an important parameter for their characterisation.
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Figure 1.3: Theoretical spectra of the efficiency of absorption (red dashed line), scattering (black
dotted line) and extinction (green solid line) observed for spherical gold nanoparticles as a func-
tion of the wavelength of incident light. Diameter (a) = 20 nm, (b) = 40 nm and (c) = 80 nm.
(Figure adapted from Jain et al.59).
significant redshift upon nanoparticle aggregation and is accompanied by a broadening of
the SPR band and a colour change of colloid from red to blue.58 The high sensitivity of
the SPR to the physico-chemical properties of gold nanoparticles make it an important
diagnostic in their surface functionalisation.59
Total light extinction, defined as the energy loss of an electromagnetic wave after
passing through matter, comprises of scattering as well as the aforementioned absorption.
Light absorption occurs due to inelastic scattering of incident photons resulting in a
dissipation of energy. Scattering occurs in the form of Rayleigh scattering, where scattered
light is emitted at the same frequency as the incident light, or in the form of Raman
scattering where it is emitted at a different frequency. The SPR, scattering and total
extinction of nanoparticles are characterised by Mie theory and for nanoparticles larger
than 20 nm in diameter, high order electron oscillations become significant and must be
accounted for when characterising light absorption.50
Using Mie theory it was shown by El-Sayed et al. that optical absorption and scatter-
ing is highly dependent on nanoparticle size.59 It was found that for 20 nm gold nanopar-
ticles the total extinction is contributed to nearly entirely by absorption. Scattering then
becomes an increasing contributor to light extinction for 40 nm nanoparticles, whilst at
80 nm size scattering and absorption contribute to the total extinction to a similar degree
(Figure 1.3). This is particularly relevant for biomedical theranostic applications. Larger
7
Figure 1.4: Schematic of the hypothetical fluctuations in scattering intensity observed from large
and small particles. The rate of change of intensity fluctuations depends on particle velocity, that
is in turn related to particle size (smaller particles in Brownian motion diffuse faster and vice-
versa). Thus the size distribution of particles in a solution can be acquired through measurement
of scattered light. (Image adapted from M. Jones63).
gold nanoparticles are often preferred for their greater scattering efficiency, a property that
has been readily exploited for the imaging of cancer cells by with dark field microscopy
and confocal microscopy.60 Contrastingly due to their greater absorption smaller nanopar-
ticles are preferred for photothermal therapy due to their greater efficiency at converting
incident light to heat.61,62
Nanoparticle size is an important property that must be measured once they are syn-
thesised and furthermore to monitor changes upon their functionalisation. Dynamic Light
Scattering (DLS) is a technique often employed to measure the size of sub-micron particles.
DLS determines the size of particles by measuring their Brownian motion; the random
movement of particles due to collisions with the surrounding solvent molecules. The ve-
locity of the Brownian motion is characterised by a parameter known as the translational
diffusion coefficient (D). The size of the particle is calculated using the Stokes-Einstein
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equation which also relates temperature (T ) and viscosity η to the translational diffusion
coefficient. The particle size is referred to the particle’s hydrodynamic diameter d(H),
and with the Boltzmann constant defined as k the Stokes-Einstein equation is thus:
d(H) = kT
3πηD
Particle size is defined as the so-called hydrodynamic diameter because it refers to the
diameter of a sphere that has the same translational diffusion as the sample particle. This
is dependant on the surface structure/morphology of the particle and any surrounding
ionic layers, not just on the size of the core, thus the concentration of particles and the
ionic nature of the medium can affect diffusion speed and perceived particle size.
In practice the DLS machine measures the extent to which intensity of scattered light
fluctuates using a signal correlator that measures the degree of similarity between two
signals or indeed the same signal over time. The amount of correlation measured over
time is a signature of particle size with large particles exhibiting slowly changing cor-
relation and vice-versa. Computational algorithms are then applied to determine the
translational diffusion coefficient. Particle size can therefore be calculated in addition to
the polydispersity index (PDI); a measure of a sample’s polydispersity. Nanoparticle size
and monodispersity are useful parameters to measure upon their synthesis and function-
alisation, providing an indication as to whether successful ligand conjugation has been
achieved and colloidal stability maintained.
Another important phyiscal property of nanoparticles that requires characterisation
is the zeta potential ζ. This refers to the electrokinetic potential in a colloidal disper-
sion and is essentially the potential difference between the dispersion medium and the
stationary layer of fluid surrounding the dispersed particle. To examine this in greater
detail, one must consider the dispersed particle being surrounded by a layer of ions. A net
charge on the particle surface will affect the distribution of ions in the surrounding region
resulting in an increased concentration of counter ions close to the surface. This liquid
layer surrounding the particle comprises of an electrical double layer, consisting of an
inner region (Stern layer) where ions are strongly bound, and a diffuse outer region where
9
Figure 1.5: Schematic illustrating a negatively charged particle in solution surrounding by ions.
Ionic concentration is depicted and electric potential as a function of distance from the charged
particle surface is depicted graphically. Also shown are the boundaries comprising the electrical
double layer namely the inner (Stern) layer and diffuse outer layer. The zeta potential is defined
at the slipping plane interface, as depicted in the diagram.
they are loosely bound. Within the diffuse outer layer there exists a notional boundary
where if the particle moves, ions within the boundary move with it but ions beyond it do
not. This boundary is referred to as the slipping plane and the potential that exists at
this boundary defines the zeta potential.
The stability of a colloid can be assessed by measuring the magnitude of the zeta
potential. If the particles have a large negative or positive potential they will electrostati-
cally repel each other. If not the particles may exhibit a tendency to flocculate as the lack
of an electrostatic repulsion allows them to come in closer proximity to each other and
flocculate. Generally colloids with zeta potentials more positive than +30 mV or less neg-
ative than -30 mV are considered stable. In practice the zeta potential is measured using
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electrophoresis where an electric field is applied across a sample causing charged samples
to move toward the electrode of opposite charge. Particle velocity is determined using the
intensity of the scattered light as particles move through a laser beam directed through the
sample64,65 (Figure 1.4). Exploiting the proportional relationship between the frequency
of the intensity fluctuations and particle speed, a property known as the Electrophoretic
mobility (UE) can be determined using the Henry equation. The electrophoretic mobility
is related to the zeta potential by the dielectric constant (ε), viscosity (η) and Henry’s




Nanoparticle conjugation can alter the zeta potential of the particles due the dis-
placement of ions on the nanoparticle surface and/or through the addition of species to
the nanoparticle surface. This affects particle diffusion and thus zeta potential, allowing
nanoparticle functionalisation and colloidal stability to be characterised.
Although gold nanoparticles exhibit intrinsic luminescence the emission mechanism is
not fully understood.66 The emission properties are also very sensitive to particle size,
surface roughness and surface functionalisation.67,68 The design and synthesis of gold
nanoprobes to exploit these luminescence characteristics can therefore be problematic
due low quantum yields and variable luminescence properties. Imaging has however been
achieved using gold nanostars and plasmon-enhanced two-photon luminescence in vitro
in BT549 breast cancer cells and in vivo in laboratory mouse studies.69
An alternative to the use of the inherent gold nanoparticle luminescence is the func-
tionalisation of the nanoparticle surface with luminescent moieties. A wide variety of
functional molecular linkers are currently being employed to enable conjugation of such
probes to gold nanoparticles including thiolate,70,71 dithiolate,72 carboxylate73 and phos-
phine74 moieties. A schematic showing use of a gold nanoparticle as a scaffold for multiple
luminescent groups is shown in Figure 1.6. Functionalising gold nanoparticles with lu-
minescent probes in this manner can enable construction of a nanoprobe that bears the
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Figure 1.6: Schematic illustrating the functionalisation of gold nanoparticles with surface-active
lumiphores.
distinct optical signature of the luminescent agent, independent of the particle proper-
ties.75–77 Such probes can also exploit the high electron density of gold to offer multimodal
imaging and do not suffer from blinking as observed in quantum dots.
For biomedicinal applications gold nanoparticles may encounter complex environments
such as those of cells and tissues and many such studies on uptake have been conducted
both in vivo78,79 and in vitro.80,81 Some of the commonly used methods of imaging or
assessing gold nanoparticle uptake are transmission electron microscopy (TEM), exploit-
ing the high atomic mass of gold, and inductively coupled plasma mass spectrometry
(ICPMS). These techniques are however destructive in nature and therefore provide im-
petus to use luminescent based imaging modalities. Furthermore gold nanoparticles of
the order of tens of nanometres in diameter can be imaged by phase contrast or differ-
ential interference contrast microscopy with an optical microscope. The aforementioned
gold scattering can also be exploited by reflection and dark field microscopies,59,77,82–85
thus a number of complementary techniques to luminescence based imaging are possible
allowing for a broad spectrum of biomedical applications.86–89
The majority of nanoparticle uptake studies in cells presented in this thesis are per-
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Figure 1.7: Schematic of a Confocal Microscope
formed with confocal microscopy. Confocal microscopy has the distinct ability to perform
optical sectioning by means of a pinhole at the detector that works to eliminate out-of-
focus light and enable the reconstruction three-dimensional structures from the recorded
images. These reconstructions, referred to as “z-stacks” allow specimens to be visualised
through their vertical planes by creating a coronal (“yz”) and transverse (“xz”) projection
image through the data set. Confocal image data presented using these “side” views are
referred to as “orthogonal views” for the remainder of the thesis.
In brief a confocal microscope operates with the use of a laser as an excitation source
which is raster scanned across the sample by motorised mirrors. The emitted light is
directed by the (dichroic) mirrors and focused on to a detector (photomultiplier tube)
through a pinhole which eliminates out-of-focus light. The confocal microscope is ex-
tremely useful for looking at stained cells that have been stained to indicate particular
organelles of interest via fluorescence. Nanoparticles can also be imaged by a confocal
microscope by exploiting their aforementioned light absorption/scattering properties in
addition to their luminescence or conjugated luminescent moieties.
An important issue to consider when examining nanoparticle uptake in cells is the
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Figure 1.8: Schematic of a Transmission Electron Microscope
potential for artefacts from the fixation processes required for preparing cells microscopy.
Ideally all confocal and indeed all microscopy studies on biological samples would be
performed on living specimens, such that the biological specimen is imaged in its most
native physiological state and any processes/featured imaged cannot be attributed to
fixation artefacts. Furthermore many light microscopy fixation techniques were developed
for two-dimensional imaging, thus retaining the three-dimensional structure of a sample is
often not possible. In practice however live specimen imaging is not always trivial with cell
movement and keeping cells in a physiologically “happy” state important considerations.
Imaging cells in liquid media and staining the cells can also be non-trivial, as such many
imaging studies are performed on fixed samples.
Fixatives are used to essentially “fix” biological specimens and render any macro-
molecular processes inert by causing the cessation of metabolic reactions, thus preserving
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microstructures for an extended period of time. Three general categories of fixation pro-
tocols exist for biological specimens, namely chemical fixation that works by coagulating
proteins or chemically cross-linking them, freeze substitution and microwave fixation.90
An example of a popular chemical fixative is formaldehye and is was the method adopted
by the author to fix cells for confocal microscopy. Ideally a fixative should penetrate
the specimen quickly and act rapidly to preserve the physical structure however chemical
fixation of this type can cause permeabilisation of some cellular structures such as the
cell membrane. It can also damage lipids and in the case of formaldehyde damage DNA
structure.91 It is thus of great importance that fixed-cell imaging be complemented with
live-cell imaging, particularly when scrutinising the spatial localisation of features of in-
terest such as nanoparticles in cells. As such the author adopts both fixed and live-cell
confocal imaging in this thesis. A complementary modality that allows for imaging of
cells and nanoparticles is the aforementioned transmission electron microscopy (TEM)
imaging modality. TEM utilises a beam of electrons that is focused and transmitted
through an ultra-thin sample of the specimen, as depicted schematically in Figure 1.8.
An image is formed by the interaction of electrons with the sample with the absorption
of electrons according to the thickness and composition of the specimen providing image
contrast. Electron microscopes are capable of achieving a much higher resolution than
light microscopes due to the small de Broglie wavelength of electrons, thus intracellular
and single nanoparticle imaging can be performed with relative ease.
1.2.1 Cellular Uptake of Gold Nanoparticles
Numerous developments in biomedical science involve studying the interaction of artifi-
cially produced nanoparticles with living organisms not only as imaging agents but also
as therapeutic agents on the cellular level.6,92 Colloidal nanoparticles are naturally “in-
gested” by cells, thus functionalised luminescent gold nanoparticles have the potential to
probe the intracellular environment and a wide array of biomolecular interactions that
occur therein.77,93 Of particular interest is the ability to functionalise particles for prefer-
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Figure 1.9: Schematic of the known pathways for intracellular uptake of nanoparticles. Adapted
from Zhao et al.7
ential accumulation in cancer cells through the use of targeting ligands. These ligands may
be specific to receptors which are overexpressed on the surface of cancer cells, providing
a method of cancer diagnosis and therapy.83,94
For in vitro applications nanoparticles are required to achieve cellular uptake which
involves the traversal of the dynamic structure of lipid bilayers and membrane proteins
comprising the cell membrane. A range of experimental findings have indicated that en-
gineered nanoparticle such as metal clusters, carbon nanotubes and quantum dots can
achieve membrane penetration in a variety of cell lines such as endothelial cells,95,96
pulmonary epithelial cells,97,98 intestinal epithelial cells,99 alveolar macrophages100 and
neuronal cells101 A host of uptake mechanisms have been suggested broadly categorised
as active102 or passive103 forms of nanoparticle transport, with the latter referring to ATP
independant mechanisms and not requiring cellular machinery for uptake (Figure 1.9).
A common form of active transport is endocytosis in which the cell internalises objects
by enclosing them in vesicles which pinch off the cell membrane (Figure 1.9). The endocy-
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totic energy-dependant mechanisms are phagoytosis, pinocytosis and caveolae-dependant
or clathrin-mediated endocytosis.104–108 Phagocytosis is a process usually utilised by
specialised mammalian cells such as macrophages and neutrophils to ingest large solid
particles larger than approximately 750 nm in diameter, leading to the formation of an
internal phagosome.7 The processes of pinocytosis or macropinocytosis occurs in nearly
all cell types and is a method used by cells to internalise particles ranging from a few to
several hundred nanometres in size.
Clathrin-mediated endocytosis is the mechanism believed to be responsible for most
of the cellular uptake of nanoparticles.109–113 Also referred to as receptor-mediated endo-
cytosis, this mechanism involves binding of the nanoparticles to receptors which span the
cell membrane. The formation of a membrane invagination then internalizes the particles
in clathrin-coated vesicles which go on to fuse with early-stage endosomes.114 Caveolae-
mediated endocytosis in the context of nanoparticle uptake is of particular importance
in endothelial cells,.115,116 This pathway involves uptake via invaginations in the cell
membrane 50-80 nm in size consisting of cholesterol, sphingolipids and caveolins.117
Despite the vast number of investigations on the interaction of nanoparticles with
cells, relating their physico-chemical properties with the uptake is still a largely unresolved
problem. It is likely that the effect of size, surface chemistry, cell line and colloidal stability
are all contributory factors to the method of uptake. Generally each type of nanoparticle
has a preferred mechanism for cellular uptake, for example gold nanoparticles are usually
internalised by cells by clathrin-mediated endocytosis. Once internalised by endocytosis
it is believed that the nanoparticles remain trapped in the endosomes created by the
endocytotic pathway118
A study demonstrating some of the hitherto discussed uptake mechanisms is the in-
vestigation by Nativo et al. which involved a TEM study of the uptake of 16 nm surface-
modified gold nanoparticles by HeLa cells119 It was found that citrate-stabilised gold
nanoparticles were readily internalised by cells in to endosomes which eventually became




Figure 1.10: (a) Typical TEM images of citrate-stabilized gold nanoparticles confined to the
endosome after cellular uptake in HeLa cells. (b-f) Uptake of PEG-modified gold nanoparticles
in the presence of liposomes. Uptake mechanisms observed without apparent direct involvement
of the liposomes include (b) caveolae and (c) clathrin-mediated endocytosis. (c) Nanoparticle
delivery by liposomes. PEG-modified gold nanoparticles are found in the endosome (d) or free
in the cytosol (e). Arrows indicate nanoparticles in the endosome that are surrounded by an
additional membrane, indicating that they have been taken up by the endosome from the cytosol.
(Scale bars - 200 nm). Figure adapted from Nativo et al.119
were found freely dispersed in the cytoplasm of the HeLa cells, commercially available
neutral liposomes that could deliver nanoparticles directly to the cell cytoplasm by fusion
with the cell membrane were used. In the presence of these liposomes it was found that
Poly(ethylene glycol) (PEG) modified gold nanoparticles were internalised by the cells by
a number of different pathways, surprisingly not all of which were directly mediated by the
liposomes.120 For example caveolae-mediated uptake was observed which was particularly
surprising considering that in the absence of the liposomes the PEG-modified nanparti-
cles were not internalised at all (Figure 1.10b). The caveolae mechanism is the major
non-clathrin dependant route of uptake from the cell surface into the endosomal pathway
(Figure 1.10c),121 however uptake via clathrin-coated vesicles was also observed in the
presence of the liposomes (Figure 1.10d). It was therefore concluded that the presence
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of the liposomes induces employment of both the major routes of endocytosis (caveolae
and clathrin) for particle internalisation. The majority of nanoparticles internalised in
the HeLa cells were thus found in endosomes (Figure 1.10e). As a result of direct delivery
by the liposomes to the cytoplasm however, some particles were also found free in the
cytoplasm (Figure 1.10f).
A further point of discussion in this study regarded the introduction of nanoparti-
cles to a biological cell culture medium and the diverse range of biomolecules, including
proteins, carbohydrates and lipids, they subsequently encounter. When introduced into
a serum containing media with such molecules a so-called “protein corona” will form
on the nanoparticle surface. The protein corona can have important consequences on
the stability of the nanoparticles.122–126 In the study by Nativo et al. it was observed
that citrate-coated gold nanoparticles remained stable after their addition to cell culture
medium.119 This was indicated by retention of the characteristic red colour of the gold
colloid and confirmed by UV-Vis absorption spectroscopy, which indicated no signifcant
red-shift or SPR broadening. It was concluded that proteins secreted by the cells and
the presence of fetal bovine serum (FBS) in the cell culture medium were responsible for
the observed nanoparticle stability.120 Another consequence of the protein corona is that
the cell surface may potentially encounter a nanoparticle much different to the original
engineered nanoparticle. This is of great relevance for the design and manufacture of
nanoparticles with targeted uptake.
In addition to the active uptake processes discussed nanoparticles may also enter
cells by passive penetration of the cell membrane,127–129 as indicated by the uptake of
nanoparticles into cells that lack endocytotic machinery such as erythrocytes.130 Uptake
may occur through diffusion across the cell membrane or via protein channels in the cell
membrane.131 This method of uptake may often go unnoticed because of the dominance
of endocytotic uptake.
A typical mammalian cell membrane is negatively charged and cationic gold nanopar-
ticles have been shown to exhibit greater adhesion to neutral or negative regions of the
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membrane and subsequently achieve uptake.132 It has however also been reported that
anionic gold nanoparticles can bypass endocytotic uptake with direct entry into the cy-
toplasm particles into the cytosol by passing directly through the cell membrane in an
example of passive uptake.133 Simulations of gold nanoparticle interactions with cell mem-
branes reported by Lin et al. also indicated that electrostatic interactions with the surface
ligands on the nanoparticle can affect membrane interaction and uptake.132
Overall there are numerous factors to consider when assessing nanoparticle internalisa-
tion in cells, particularly passive uptake which is much less characterised than active up-
take. Passive uptake may indeed even be the main contributor to uptake in the long-term
exposure to low concentrations of nanoparticles, where the threshold for active uptake of
nanoparticles across the cell membrane is not achieved.134
Nanoparticles can also be internalised by cells by methods categorised as facilitated
delivery mechanisms. These involve the use of cell penetrating peptides (CPPs) and
localisation signals on the particles to direct the nanoparticles to organelles of interest.
Peptide sequences can also be used to stabilise aqueous gold nanoparticles. The CALNN
peptide created in 2004 by Levy et al. is a short sequence incorporating a cysteine residue
to promote binding to gold nanoparticles via the functional thiol group.135 The uptake of
gold nanoparticles stabilised with the CALNN peptide has been demonstrated by Nativo
et al.119 and Sun et al.136 in HeLa cells.
Peptide functionalised gold nanoparticles can also demonstrate active cellular target-
ing in biological applications. Cancer cells for example can suffer from oxygen deprivation
when their blood supply is insufficient. As a result they often adapt to this hypoxic envi-
ronment by developing alternative metabolic pathways which result in acidic extracellular
environments. The resulting reduction in pH can be used as biomarker for cancer and
also as a strategy for the delivery of nanoparticles via the use of peptides activated in
an acidic environment.137 One such example is the pH low insertion peptide (pHLIP)
developed by Engelman et al.138,139 At neutral pH the peptide is hydrophilic and hence
water soluble, enabling weak association with the cell membrane. At slightly acidic pH
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Figure 1.11: Schematic representation of gold nanoparticles coated with the pHLIP peptide and
luminescent europium complex. At neutral pH, the nanoparticles are loosely associated with the
lipid membrane. Upon a decrease in pH to 6.5, pHLIP peptide molecules form alpha-helical struc-
tures and insert across the lipid membrane, allowing translocation of the luminescent nanopar-
ticles across the lipid membrane into the cytoplasm. Image adapted from Davies et al.82
(<7) the peptide becomes hydrophobic (due to protonation of the carboxylic side chains
on the aspartic acid residues), causing insertion into the cell membrane through formation
of an alpha-helix structure.140,141
Delivery of 13 nm gold nanoparticles into platelets using the pHLIP peptide has been
reported by Davies et al.82 The peptide was attached to the gold nanoparticles through
the thiol group of the cysteine residue. A luminescent europium(III) probe was also
attached to the nanoparticles to enable optical imaging of the nanoprobes. A schematic
of the insertion mechanism showing the translocation mechanism of the gold nanoparticle-
pHLIP-europium construct is shown in Figure 1.11.
The uptake of pHLIP coated gold nanoparticles 1 nm in diameter were also investigated
in HeLa cells by Yao et al.142 Gold nanoparticles modified with pHLIP peptide showed
higher uptake relative to unmodified particles at both the neutral and acidic conditions
tested. A pH dependence was observed with a 3-fold greater uptake at pH 7.4 and a 6.4-
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Figure 1.12: TEM image of nanoconstructs composed of nucleolin-specific aptamers and gold
nanostars (left) were actively transported to the nucleus as indicated by confocal luminescence
microscopy (middle) [nucleus - blue, Cy5 labelled nanoparticles - red]. TEM images indicated
nanoparticles induced major changes to the nuclear phenotype in the form of nuclear envelope
invaginations near the site of the nanoparticle localisation (right). Adapted from Dam et al.148
fold greater uptake at pH 6.5. The pH dependence is perhaps expected but it is interesting
to note that the pHLIP coated particles show greater uptake than the uncoated particles
even at neutral pH. This may be because at neutral pH the pHLIP peptide exists in an
equilibrium between it’s water soluble and membrane-bound unstructured forms.143,144
The pHLIP peptide has demonstrated further versatility with silica nanoparticles.
Mesoporous silica nanoparticles 140 nm in diameter were loaded with a chemotherapy
drug (doxorubucin) and delivered to tumorous tissue through pHLIP mediation, again
exploiting the characteristics of the pHLIP peptide in the acidic tumour microenviron-
ment.145
Functionalising nanoparticles with localisation signals as well as peptides can also
provide a targeting capability to nanoparticles as mentioned previously. Of particular
interest is the cell nucleus where the majority of the genetic material in cells is located,
thus making the nucleus most important organelle in the cell. Responsible for control-
ling cellular growth, proliferation and apoptosis it is a particularly desirable target for
nanoparticles used for drug delivery and gene therapy.146 Nanoparticles present a viable
alternative to the use of viral vectors, the conventional method of nuclear drug delivery,
which often illicit an immunogenic response.147
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Nuclear uptake is inherently non-trivial as it requires that a nanoprobe first gain cellu-
lar entry via a mechanism that avoids endosomal restriction. Furthermore the nanoprobe
may also require a nuclear localisation signal (NLS) to achieve translocation to the nu-
cleus via traversal of the nuclear envelope, which like the cell membrane consists of a
phospholipid bilayer.149 Nuclear uptake of gold nanoparticles coated with PEG and con-
jugated with an arginine-glycine-aspartic acid peptide and a nuclear localization signal
was demonstrated in human oral squamous cancer cells.150 In this study by Kang et al.
cytokinetic arrest was also observed, referring to the ability of the nanoparticles to dis-
turb the cell cycle of the cancer cells. This was indicated by binucleate cell formation in
the late stages of mitosis which resulted in the failure of complete cell division. Confocal
microscopy and a flow cytometry based investigations into the cell cycle also indicated
DNA damage and apoptosis accompanying the cytokinetic arrest.
Active nuclear targeting has also been achieved with gold nanoparticles modified with
CPPs and an adenovirus nuclear localization signal in the HeLa and HepG2 cell lines.147
Video-enhanced colour differential interference contrast microscopy and TEM indicated
the transport of nanoparticles into the cytoplasm and nucleus. Another study aimed at
direct visualization of interaction between drug loaded nanoparticles and the nuclei of
HeLa cells was conducted by Dam et al.,148 whose approach consisted of the construction
of gold nanostars functionalised with nucleolin-specific aptamers and a Cy5 red fluorescent
marker (Figure 1.12). Nuclear uptake was achieved by taking advantage of the nuclear
trafficking ability of the nucleolin phosphoprotein which is over expressed in the cyto-
plasm and cell membrane in metastatic and rapidly dividing cells.151 A striking result
from this study were major changes to the shape of the nuclear envelope in areas where
the nanoconstructs localised after uptake. Cells displaying these foldings in the nuclear
envelope showed increased apoptosis and decreased cell viability, thus revealing a new
correlation between changes in nuclear phenotype and potential therapeutic efficacy in
potential anti-cancer therapies using gold nanoparticles.
The preceding discussion illustrates the wide range of biological effects gold nanoparti-
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cles can elicit in cells, however the detailed mechanisms by which such interactions occur
are only just being understood.152 Gold nanoparticles can be targeted to specific or-
ganelles such as the nucleus with the aforementioned nuclear localisation signals, however
non-targeted gold nanoparticles can also illicit cell damage in the form of photothermal
ablation,153 mechanical injury152 or be utilised for localised drug delivery.154,155 The devel-
opment of gold nanoparticle based therapeutics in cancer cell eradication is of particular
importance as rapidly metastasising cancers often lack effective treatment.156 Imaging
of gold nanoparticle uptake in cancer cells and examining the intracellular fate of the
nanoparticles is thus of great importance.
Optimal therapeutic outcome is based on organelle targeting in cells such that accu-
mulation in specific compartments affects important intrinsic cell functioning. Targeted
treatment methods also have the benefit of reduced side-effects. As mentioned the cell
nucleus is a particularly desirable target for nanoparticles, responsible for growth, pro-
liferation and apoptosis; all of which anti-cancer treatments would hope to disrupt.146
Nuclear phenotypes are usually altered in cancer cells relative to normal healthy cells
with changes in nuclear size, shape, envelope and genetic organisation.157–159 Crucially
nucleo-cytoplasmic trafficking may be enhanced in cancer cells with nuclear translocation
of gold nanoparticles resultantly more efficient.160–162
The permeability characteristics of the nuclear envelope have also been demonstrated
to vary during different phases of cellular activity. Diffusion rates across the nuclear enve-
lope of gold nanoparticles stabilised with bovine serum albumin (BSA) for example have
been shown to correlate directly with known rates of nuclear pore formation, suggesting
greater nuclear permeability during or just after nuclear envelope reformation in cell di-
vision.160 In this study by Feldherr et al. it was also found that the nuclei of dividing
cells could incorporate larger nanoparticles (23 nm) compared to non-dividing cells (19
nm).160
It is of great interest that non-targeted i.e. nanoparticles lacking functionalisation
with a specific targeting signal have demonstrated nuclear uptake accompanied by varying
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Figure 1.13: Small gold nanospheres and gold nanoflowers inhibit RNA synthesis (green) in the
nucleolus of MCF7 breast cancer cells, co-stained with DAPI (blue nuclear stain). (Scale bar 3
µm). Adapted from Kodiha et al.163
degrees of toxicity. Gold nanoparticles 3.7 nm in diameter have been shown to accumulate
in HeLa cell nuclei with cell viability measured at 85 % after 24 hours and 70 % after 72
hours suggesting a low cytotoxic effect.164 Gold nanoclusters (Au55) 1.4 nm in size have
demonstrated nuclear uptake accompanied with significant toxic effects attributed to the
ability of the gold clusters to interact with nuclear DNA. A particularly interesting study
performed by Kodiha et al. illustrates the complexities of the nuclear uptake mechanisms
of nanoparticles.163 Although Pante et al. state that the nuclear pore complex is able to
transport macromolecules no greater than 39 nm in size,165 the study by Kodiha et al.
observed large gold nanoflowers 40 - 120 nm in size entering the nuclei of breast cancer
cells. Nuclear uptake was observed to disrupt nuclear homeostasis via inhibition of RNA
synthesis (Figure 1.13).
In summary cellular uptake of gold nanoparticles is achieved through a variety of
mechanisms. Whilst nuclear targeting of gold particles is achieved predominantly through
the hitherto discussed nuclear localisation signals, non-targeted gold nanoparticles have
also demonstrated nuclear uptake. The major restriction on gold nanoparticles in cells is
compartmentalisation to endosomal/lysosomal compartments. As nanoparticles are inter-
nalised in cells through a variety of mechanisms, including those which are non-endocytotic
e.g. passive diffusion, nanoparticles may still find free dispersion in the cytoplasm. Fur-
thermore compartmental release may be promoted by endosomal swelling, possibly as a
result of pH dependant aggregation or lipid membrane rupture.166 Several studies have
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Figure 1.14: Schematic illustrating iridium complexes covalently incorporated at the surface of
a preformed 500 nm silica nanoparticle using a fluorinated polymer (left), and encapsulation of
the iridium complex within the silica nanoparticle (right). Adapted from Lewis et al.169
demonstrated nuclear uptake of nanoparticles much larger than those originally believed
to be able to traverse nuclear pore complexes, thus illustrating the complexities of uptake
mechanics but also the diverse potential of the therapeutic and imaging applications of
gold nanoparticles in cells.
1.3 Silica Nanoparticles for Imaging
The gold nanoparticles discussed hitherto are surface functionalised however nanomate-
rials can also be engineered to encapsulate lumiphores for imaging applications. One
such example are silica nanoparticles which can be synthesised to encapsulate lumines-
cent probes. Wang et al. incorporated quantum dots in a silica based nanosphere which
was able to measure local pH in a ratiometric fashion.167 Sung et al. also incorporated
quantum dots in to porous silica nanoparticles which were able to sense for Cu2+ ions.168
Zhang et al. demonstrated surface functionalisation of silica nanoparticles with pairs
of DNA strands that “uncap” in the presence of Hg2+ ions, releasing a fluorescent dye
resulting in a measurable increase in fluorescence signal.
Encapsulation of multiple lumiphores enables a much higher signal intensity compared
to single lumiphores. Lewis et al. demonstrated this with the caging of luminescent ruthe-
nium(II) tris-bipyridyl in 500 nm diameter colloidal silica nanoparticles.170 The particles
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were used for the analysis of fluid flow in microchannels by exploiting the luminescence
from the encapsulated ruthenium. A subsequent study established a method of immo-
bilizing a cyclometalated iridium(III) complex on to the surface of silica nanoparticles
using a fluorinated polymer.169 These particles exhibited better stability than those pre-
pared without the polymer in addition to a seven-fold increase in the luminescence inten-
sity and luminescence lifetime. The surfactant prepared particles were also successfully
used in fluid flows for microparticle imaging velocimetry, exploiting the enhanced particle
brightness and demonstrating the potential for using the nanoparticles as nanotracers
in microchannels. Many such studies have been conducted where the silica nanoparticles
have been used as sensors however silica nanoparticles also have great potential in biologi-
cal applications due to their robustness, mechanical stability, transparency and protection
they offer to the encapsulated lumiphore.
One such example in which silica based nanoparticles have found a biological appli-
cation is in cancer research. Their relatively simple synthesis, uniform and controllable
morphology, size and pore volume as well as their easy functionalisation make them well
suited as imaging and drug delivery agents.171–174 The two main types of silica nanoparti-
cles developed for cancer imaging and therapy are the hitherto discussed mesoporous silica
nanoparticles174 and core/shell silica nanoparticles.173 The unique ability of mesoporous
nanoparticles to release encapsulated payloads, not only of fluorescent dyes as discussed
in the example above, but also drugs through the surface pores with easily controllable
release are of particular relevance in tumour therapy. Core/shell nanoparticles are par-
ticularly useful as imaging agents as they are easily doped with flurophores, quantum
dots and gold nanoparticles which are protected by the shell structure, thus the imaging
signal obtained yields the precise location of the nanoparticle. These properties in addi-
tion to the biocompatibility both types of nanoparticles exhibit make them ideally suited
theranostic agents.175,176
The robust nature of silica nanoparticles has also seen their application in the field
of dentistry. Most studies involving silica nanoparticles have involved their development
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in resin-based composite technology177–179 or for caries (tooth decay) prevention as they
can be used to polish tooth surfaces to prevent bacterial adhesion.180 Silica nanoparticles
can also be used to address the issue of dentin hypersensitivy, a common dental problem
caused by the exposure dentinal tubules.181,182 It is theorised that external irritation
can induce movement of fluid in and out of dentinal tubules, which can stimulate the
sensory nerve endings within and lead to hypersensitivity.183 The stability and ability of
the silica nanoparticle to adhere, as a result of surface hydroxyl groups interacting with
the dentine surface,184 has led to their application for the attempted occlusion of dentinal
tubules.185 Their water solubility allows them to be easily deposited into the irregular
spaces composing the dentine surface186 and their large surface area allows for further
functionalisation to enhance tubule occlusion.169,187
Successful tubule occlusion has been demonstrated by Besinis et al. who evaluated
the size dependence of the nanoparticles in relation to their tubule occluding ability
using electron microscopy.188 Tian et al. also investigated dentinal tubule occlusion with
mesoporous silica nanoparticles using electron microscopy, demonstrating almost complete
occlusion over 100 µm deep in to the tubule.189 These results illustrate the great potential
for silica based nanomaterials for applications in clinical dentistry.
1.4 Thesis Outline
In the last few decades nanoparticles have attracted considerable research interest. Their
variable composition, structure and surface characteristics yield physico-chemical proper-
ties that can be finely-tuned for a variety of applications. Functionalised nanomaterials
have been afforded use as drug delivery agents, diagnostic sensors, labelling and imaging
agents. This thesis details the use of gold and silica particles for applications in imaging,
exploring additional capabilities as a result of their specific functionalisation.
Chapter Two details the labelling strategy utilised to attach a luminescent organic
dye to gold nanoparticles. This involved development of the Hoechst DNA binding dye to
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incorporate a surface-active thiol group for attachment to gold, with the subsequent ad-
dition to gold nanoparticles achieved via surfactant and peptide mediation. The resulting
luminescent nanoparticles are characterised and explored in cellular imaging applications.
Confocal microscopy and transmission electron microscopy in particular enable the uptake
and intracellular fate of the nanoparticles to be examined and with evidence of nuclear
uptake observed cell cycle dysregulation is also evaluated.
Chapter Three details the cellular imaging of 13 nm and 100 nm gold nanoparticles
coated with a luminescent ruthenium complex. The luminescent nanoparticles were pro-
duced and characterised by Dr. Nicola Rogers.77,190 Confocal microscopy of the nanoparti-
cles in cells was performed in collaboration with Dr. Robert Harris (School of Biosciences,
University of Birmingham). Transmission electron microscopy and toxicity studies further
characterised the cellular interactions of these nanoparticles. The work performed in this
chapter contributes to the first appended publication.
Chapter Four examines the use of silica particles for application in dentistry to ad-
dress the problem of dental hypersensitivity. Specifically the interaction of sub-micron
silica particles with dentine is evaluated in the context of their ability to occlude denti-
nal tubules. Silica particles bearing an encapsulated ruthenium luminescent complex
are coated with surfactants and assessed for achieving tubule occlusion via confocal mi-
croscopy and scanning electron microscopy. Imaging was performed with Sophie Glinton,
Hayley Floyd (EPSRC Doctoral Training Centre for the Physical Sciences of Imaging in
the Biomedical Sciences, School of Chemistry, University of Birmingham) in collaboration
with Prof. Damien Walmsley (School of Dentistry, University of Birmingham). The work
performed in this chapter contributes to the second appended publication.
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2
Labelling of Gold Nanoparticles with Thiol
Functionalised Hoechst
2.1 Introduction
Nanoparticles possess numerous characteristics that make them ideal imaging agents.
Targeting capability can be incorporated in to nanoparticles to offer specificity, many
lumiphores can be conjugated to a single nanoparticle producing bright luminescence,
lumiphore stability can be enhanced upon nanoparticle conjugation, and the potential
for drug delivery mean nanoparticles offer a great theranostic potential.9–13 Luminescent
nanoprobes can be imaging with multiple modalities depending on their composition and
can be functionalised to target specific cells and/or tissues, exhibit a sensing ability or
to interrogate a range of biomolecular processes.14–17,77 Gold nanoparticles and quantum
dots in particular have been used for a wide range of biochemical and therapeutic ap-
plications.13,17,47,119 Functionalising gold nanoparticles with luminescent probes enables
construction of nanoprobes that bear the distinct optical signature of the luminescent
agent, independent of the particle properties.75 Such probes can also exploit the high
electron density of gold to offer multimodal imaging and do not suffer from blinking as
observed in quantum dots.
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2.1.1 Functionalisation of Gold Nanoparticles
A variety of nanomaterials have been developed for imaging applications. For the purposes
of luminescent imaging the inherent properties of the nanomaterial can be exploited or
imaging moieties incorporated within or on the surface of the nanomaterial.3–8 Lumines-
cent imaging of gold nanoparticles functionalised with neutral lanthanide lumophores and
co-coated with a pH sensitive peptide have demonstrated this concept with selective cell
uptake and luminescent imaging of the probe in the intracellular environment.82 Associat-
ing luminescent ruthenium complexes with gold nanoparticles has previously been studied
using electrostatic interactions,191 thiol exchange methods using Brust-type nanoparti-
cles,192 or by direct reduction of Au3+ by NaBH4.
193–195 All of these methods however
have their limitations as nanoparticles are restricted to sizes smaller than 10 nm, are
relatively polydisperse and offer limited control over the coating of the ruthenium probe.
An alternative coating method has been developed with gold nanoparticles 13 and
100 nm in diameter. The large Au cores of these nanoparticles enable extensive labelling
with a ruthenium(II) polypyridyl complex producing a luminescent water soluble gold col-
loid.77 Addition of the ruthenium complex was achieved by pre-coating the nanoparticle
with Zonyl 7950, a non-ionic fluorinated surfactant, prior to addition of the surface-active
ruthenium complex.77,196 Uptake of the luminescent nanoparticles was investigated in
A549 human lung cancer cells and revealed uptake of nanoparticles undergoing inter-
esting biomolecular interactions including nuclear uptake. Such nanoparticles may thus
offer significant improvements in sensitivity, selectivity and practicality over conventional
diagnostic methods in biological assays for DNA and protein markers.197 Furthermore
exploiting nanoparticle binding with DNA has seen their use in molecular diagnosis, gene
therapy and sensing.198
Functionalisation of nanoparticles is a crucial step in their design to achieve optimal
biological and physico-chemical properties.199 In addition to luminescence capabilities
nanoparticles may also be designed to undergo specific biomolecular interactions. The
binding of nanoparticles with DNA in particular must be characterised in the context
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of their biocompatibility, as it is of particular relevance in a cellular environment where
binding to DNA can have a number of important implications.200 It is therefore necessary
to study such nanoprobes in a cellular environment and to examine their uptake and inter-
actions with cell membranes, organelles and indeed the cell nucleus. The nucleus contains
the cells’ genetic material, responsible for controlling cellular growth, proliferation and
apoptosis and is a particularly desirable target for nanoparticles.146 After passing through
the cellular membrane nanoparticles may achieve nuclear uptake which may be instigated
by attaching targeting ligands to the particles, for example with a ligand that exhibits
a response to nuclear localisation. This furthermore requires endosomal release of the
nanoparticles if internalisation occurs through an endocytotic uptake mechanism.147
Gold nanoparticles are particularly suited for cellular uptake and imaging as they can
be easily functionalised to aid uptake, for example with peptides, aptamers or antibodies
which help in their internalisation and specificity. Their large surface-to-volume ratio
also means multiple such ligands can be attached to a single particle. Nanoparticles
functionalised with multiple lumiphores can thus exhibit a greater luminescence that
single lumiphores alone. Gold nanoparticles are furthermore relatively easily synthesised
with good monodispersity.
Functionalisation can be classified as covalent or non-covalent. Covalent methods in-
clude the use of -SS, -SH, -OH, -NH2 or -COOH derivatised moieties. Gold nanoparticles
for example can be functionalized with thiolated oligonucleotides to achieve specific DNA
hybridization through recognition of complementary sequences of interest.198 A study by
Cima et al. found that the -SH thiol link, most frequently used in biomedical applica-
tions for attachment to gold nanoparticles, remains stably adsorbed for up to 35 days
in physiological conditions. It is therefore the most commonly used functional group for
attachment of biomolecules to gold surface binding for biomedical applications.201
The non-specific binding between DNA and nanoparticles can be also achieved by sim-
ple adsorption via non-covalent interactions. Gold nanoparticles may be used to achieve
DNA binding however it is believed that the electrostatic repulsion between the negatively
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charged DNA and the negatively charged surface of citrate-stabilised gold nanoparticles
would not be favourable. This is particularly an issue with double-stranded DNA which
has a higher surface charge density, and therefore more electrostatic repulsion, than single-
stranded-DNA.202 An obvious and widely used strategy for promoting DNA interaction
is functionalising nanoparticles with positively charged organic moieties, exploiting their
electrostatic affinity for the negatively charged phosphate backbone of DNA.197
2.1.2 Hoechst Organic Dye
Figure 2.1: Structure of Hoechst 33258
The approach discussed in this chapter to produce luminescent gold nanoparticles
which can achieve cellular uptake, involves functionalisation of the Hoechst 33258 or-
ganic dye to achieve surface binding to gold nanoparticles. The Hoechst 33258 (2-
(4-hydroxyphenyl)-5-[5-(4-methylpiperazine-1-yl) benzimidazo-2-yl]-benzimidazole) stain
is part of a family of three bis-benzamide dyes developed by Hoechst AG (Figure 2.1).
Stains and dyes are frequently used in biomedicine to highlight structures of interest in
cells for microscopy. The Hoechst dyes can bind to all nucleic acids but have a prefer-
ence for sequences rich in adenine and thymine bases and binding to DNA blueshifts and
enhances the fluorescence considerably, as shown in Section 2.3.2.
A result of the Hoechst dyes’ DNA binding ability in living cells is the suppression
of protein synthesis and cell division as binding can interfere with DNA transcription
and translation,203 thus the bis-benzamide family of dye molecules may exhibit further
potential as anticancer drugs.204,205
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2.1.3 Uptake and Imaging of Nanoparticles in Cells
As discussed gold nanoparticles are well-suited to surface functionalisation and courtesy of
their water-solubility are biocompatible. They also exhibit a relative lack of toxicity and
as such find uses in many biomedical applications11,13,206 including imaging,206,207 chemi-
cal sensing208 and nanotheranostics.19 Numerous studies on gold nanoparticle interaction
with cells have also explored their uptake, fate and toxicity.13,17,78,79,81 The investiga-
tions indicate that nanoparticle uptake is affected by several physico-chemical properties,
including particle size and surface functionality.13,15,119,209,210 A host of uptake mecha-
nisms have been suggested and can be broadly categorised as active102 or passive103 forms
of transport, the latter referring to ATP independant mechanisms not requiring cellular
machinery.
The majority of uptake studies have suggested that nanoparticle internalisation is
achieved primarily through endocytotic processes.211–213 Nanoparticles are often found
in vesicular structures along various trafficking pathways associated with endocytosis. A
schematic illustrating the cellular uptake of nanoparticles and the subsequent intracellular
trafficking is shown in Figure 2.2a. A study by Mobius et al. examined the morphological
characteristics and uptake kinetics of bovine serum albumen (BSA) coated gold nanopar-
ticles in the endocytic pathway of B lymphocytes and further classified the organelles of
endocytotic pathway in to several sub-divisions, as depicted schematically in Figure 2.2c,
with six different endocytotic organelles identified. Figure 2.2d shows a schematic repre-
sentation of the endocytic compartments and their internal pH,comprising initial entry→
uptake in a trafficking vesicle → transfer in to an early endosome → multivesicular body
→ late-stage endosome/ lysosome with the associated timescale for each stage.214,215
Nanoparticle excretion from cells is also an important aspect in their cellular interac-
tion, particularly in the context of drug-delivery or therapeutic applications where cellular
tissue and organ clearance is an important consideration. Nanoparticles may be ejected
from cells through three possible pathways namely lysosomal secretion, vesicle and non-




Figure 2.2: (a) Cellular uptake mechanisms of nanoparticles and related intracellular traffick-
ing. A: Phagocytosis - leading to phagosomes (AI) and phago-lysosomes (L). B: Macropinocy-
tosis - leading to macropinosomes (BI) which might be exocytosed or fused with lysosomes (L).
C: Clathrin-mediated endocytosis - leading to primary endosomes (CI) and late endosomes
(CII)including multivesicular bodies (CIII). D: Clathrin- and caveolae-independent endocytotic
pathways. E : Caveolae-mediated endocytosis - leading to caveosomes (EI) which fuse with the
endoplasmic reticulum (EII) or translocate through the cell (EIII). F: Particle diffusion/trans-
port through the apical plasma membrane, resulting in particles located freely in the cytosol.
Adapted from Brandenberger et al.217 (b) Schematic of endocytosis and exocytosis mechanisms
for nanoparticles. Nanoparticles exit via lysosome secretion, vesicle-related secretion and non-
vesicle-related secretion. Adapted from Oh et al.216 (c) Morphological designations of intracel-
lular compartments in the endocytic pathway. Type 1 - clathrin-coated pits and vesicles, type
2 - vesicular and tubular structures (including primary endocytic vacuoles), type 3 - irregularly
shaped MVB with a few internal vesicles, type 4 - globular MVB with abundant internal vesi-
cles, type 5 - an intermediate between the multivesicular (type 4) and the multi-laminar (type 6)
vesicles (considered lysosomal in nature), type 6 - multi-laminar vesicle (considered lysosomal
in nature). Adapted from Mobius et al.118 (d) Schematic representation of the endocytic com-
partments comprising initial entry → uptake in a trafficking vesicle → transfer in to an early
endosome → multivesicular body → late-stage endosome/ lysosome with the associated timescale
for each stage.,214 as well as the internal pH of each compartment. Adapted from Canton et
al.131
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It is important to note that many studies can reveal contrasting findings when studying
nanoparticle uptake in cells perhaps indicative of the intricate relationship between the
physico-chemical properties of the nanoparticle and the internalisation mechanisms. Ray-
nal et al. for example showed that iron oxide nanoparticle uptake in macrophages occurred
via receptor-mediated endocytosis.218 Anionic nanoscale micelles were also found to be
internalised by the same mechanism in macrophages by Chnari et al.219,220 Gold nanopar-
ticle uptake in macrophages however was shown to occur through pinocytosis,221 whilst
polystyrene nanoparticles uptake were shown to internalise via an actin-independant
mechanism by Geiser et al.222 The actin cytoskeleton is crucial to endocytosis as it is
responsible for the membrane protrusions which encompass extracellular entities,223 hence
endocytotic uptake of the polystyrene nanoparticles could be excluded. In the study by
Geiser et al the polystyrene nanoparticles were found in the macrophage cytoplasm and
were thus proposed to have acheived uptake through direct particle diffusion through the
cell membrane. Carbon nanotubes were also observed to achieve uptake in HeLa cells in
a study by Pantarotto et al. in what was referred to as the “needle-effect” where uptake
was attributed to the shape and hydrophobic nature of the nanotubes allowing direct
physical penetration of the cell membrane.224
Surface topology has also been demonstrated to be important factor in uptake. Verma
et al. studied the uptake of gold nanoparticles coated with self-assembled organic ligand
monolayers. It was found that nanoparticles on which there were alternating anionic
and hydrophobic groups entered cells via membrane pores, whilst nanoparticles coated
with a random distribution of the same surface ligands entered by endocytosis.105 The
consequences of such uptake were nanoparticles free of vesicle restriction with potential
access to intracellular proteins, organelles and DNA.212
2.1.4 Nanoparticle Uptake and the Cell Cycle
Although nanoparticle related investigations comprise a large field of research many of
biological properties of the nanoparticles remain relatively less well understood, one of
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Figure 2.3: Cell cycle in eukaryotes: G1 phase - Cell prepares for division, once it reaches the
“restriction point” the cell is committed to division. S phase - genetic material is duplicated. G2
phase - cytoplasmic materials are prepared for division and cytokinesis (the physical process of
division). M phase - Nuclear division (mitosis) followed by a cell division (cytokinesis) starting
with constriction of the cytoplasm. Interphase - The time period between mitotic divisions (G1,
S and G2). (Figure adapted from Clinical Tools Inc.226)
the most important of which is the effect of nanoparticles on the cell cycle. Nanoparticles
can induce a wide range of cellular responses including cell death which is closely linked
to the cell cycle.225 Multiple check points in the cell cycle control the division process
and if any of these criteria aren’t achieved the cell can undergo necrosis and/or apoptosis
with arrest in more or more of the division stages.200 The method by which nanoparticles
induce toxicity is also important in this context in regards to both targeted toxicity in
therapy and inadvertent toxicity in diagnostics.
The cell cycle of a cell refers to a chain of events resulting in its duplication and
division.227–229 The cell cycle in eukaryotic cells can be divided in to two periods namely
interphase - comprising cell growth and preparation for DNA replication, and mitosis (M
phase) - when the cell divides in to two daughter cells (Figure 2.3). Interphase is further
split in to three stages; G1 phase when the cell grows and produces the enzymes require
for cell division, S phase when DNA undergoes replication and G2 phase when the cell
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continues growth and prepares for mitosis. The division process can vary in length from
12 hours to several days depending on the cell type.
Nanoparticles can exhibit many effects on cells following cellular uptake including
interaction with chemical signalling pathways and induction of stress, cell cycle dysregu-
lation and apoptosis or necrosis.230 Examining the cell cycle for changes is of particular
importance where nanoparticles are used for delivering anti-proliferative drugs.231,232 One
of the most popular methods for analysing the cell cycle is fluorescent activated cell sort-
ing (FACS). Also known as flow cytometry this technique examines cells in flow thereby
allowing fast examination of the properties of large cell populations.233 For the purposes
of cell cycle analysis this technique uses the fact that the DNA content of a cell is closely
related to the various stages of the cell cycle. In G0/G1 phase cells will have half the
DNA content of cells in G2/M phase, referred to as 2N and 4N amounts of chromasomal
DNA. In S-phase, the stage between these two phases, the DNA content is between 2N
and 4N (Figure 2.4a). Cells with lower than 2N amounts of chromasomal DNA are cell
debris or apoptotic cells which have suffered loss or damage to their chromosomal DNA.
The cells can be stained with a fluorescent dye, the most popular of which is propidium
iodide (PI) which binds to the double-stranded nuclear DNA, thus fluorescent signal
intensity is directly correlated to the amount of DNA and therefore the stage of the
cell cycle (Figure 2.4a).234 The resulting fluorescence intensity data can be analysed
using computer software which applies mathematical models to determine the number
of cells in each stage of the cell cycle (Figure 2.4a). The problem of nonspecific binding
to double-stranded RNA is avoided by the addition of RNaseA to the propidium iodide
staining solution.234,235 Cell doublets and debris artefacts are also excluded using scatter
and fluorescence intensity plots (Figure 2.4b).236,237
The effect of nanoparticles on the cell cycle can be ascertained on non-synchronised
cells using the FACS protocol. However dysregulation of the cell cycle may potentially
be masked by cells’ natural distribution in different phases. An alternative approach is




Figure 2.4: (a) Cell cycle schematic showing amount of DNA in a cell at each stage (left) and
the theoretical intensity profile that would be obtained (right). Figure adapted from FCS Express
Flow Webinar.238 (b) Analysis of a typical HeLa cell culture. Cell debris and apoptotic cells
(left) and doublets (right) are excluded. The fluorescence intensity histogram is then fitted - the
first prominent peak corresponds to G0/G1 phase, followed by the S phase continuum leading up
to the second prominent peak corresponding to G2/M phase.
by removing growth factors from the cell medium to arrest the cells at the desired cell
cycle stage. This is followed by reintroduction of the depriving factor to allow the cells
to continue through the cycle in a synchronised manner.239
Several investigations have indicated that gold nanoparticles can affect the cell cycle.
An investigation by Kang et al. demonstrated nuclear targeted gold nanoparticles caused
cytokinetic arrest in cancer cells inducing apoptosis through failure of complete cell divi-
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sion.150 Although an exact mechanism was not established the study demonstrated that
nuclear localised nanoparticles can have specific and significant effects on cellular func-
tioning. It was furthermore proposed that these results demonstrated a novel method
by which gold nanoparticles could be used as an anticancer therapy if conjugated to a
nuclear-targeting ligand. Furthermore the cytokinetic arrest observed was proposed as
being a general consequence of nuclear uptake of the nanoparticles.150 This is of partic-
ular relevance to this chapter which discusses conjugation of the Hoechst DNA binding
dye to gold nanoparticles and evaluates uptake of the nanoparticle construct in cells.
In a further study by Kang et al it was demonstrated that pre-treating cells with
nuclear targeted gold nanoparticles caused an increase in the efficacy of the 5-Fluorouracil
chemotherapy drug, with cell arrest observed as an accumulation of cells in the S-phase
and depletion of the cells in the G2/M phase.240 This illustrates how nuclear localised
nanoparticles may effect drug efficacy. A further point of interest is the effect of the cell
cycle stage on the uptake of nanoparticles.
2.2 Chapter Outline
Luminescent gold nanoparticle constructs for the purposes of imaging are desirable for
uptake in cultured cells. The synthesis of a surface-active lumiphore based on the Hoechst
33258 organic dye thiol functionalised to achieve binding to citrate-stabilised gold nanopar-
ticles is initially discussed. Coating of gold nanoparticles with the dye is subsequently
explored through surfactant and peptide mediated methods. The colloidal preparations
are characterised and their uptake and intracellular interactions explored in two human
cancer cell lines. Cells are also evaluated for cell cycle dysregulation in the context of the
striking nuclear uptake observed.
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2.3 Results and Discussion
2.3.1 Synthesis and Characterisation of HoechstSS
Figure 2.5: Synthesis of the surface-binding HoechstSS (HSS) complex.
The first derivatisation of Hoechst 33258 incorporates a disulphide group attached
to the OH terminal of the Hoechst 33258 for binding to the gold surface (Figure 2.1).
Referred to as HoechstSS (HSS) this derivative was synthesised by the ester coupling
reaction of Hoechst 33258 with alpha-lipoic acid (Figure 2.5). Production of the
HoechstSS was confirmed by 1H and 13C(1H) NMR spectroscopy and mass spectrometry
(Appendix B). Synthesis of HoechstSS was performed by the author, with assistance on
NMR characterisation provided by Dr. Samuel Adams, School of Chemistry, University
of Birmingham.
The HoechstSS was however subject to decomposition after purification on a silica
column with the product fraction indicating the presence of the Hoechst 33258 starting
material after a few hours as confirmed by NMR and mass spectrometry (Appendix B).
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This is possibly due to pH sensitivity and hydrolysis of the ester bond and although column
purification was attempted on a neutral alumina column the issue was not rectified. An
alternative derivative (HoechstSH) was therefore synthesised.
2.3.2 Synthesis and Characterisation of HoechstSH
HoechstSH incorporates a surface-binding thioacetyl group to the OH terminal of the
Hoechst 33258 for binding to the gold surface. The ancillary ligand was synthesised by
the Williamson reaction of 6-bromohexene with thioacetic acid (bromoSAc) complexed
to Hoechst 33258 by refluxing in DMF (Figure 2.6). Successful production of Hoech-
stSAc and HoechstSH was confirmed by 1H and 13C pendant NMR spectroscopy and
mass spectrometry (Appendix C). Synthesis of HoechstSH was performed by the au-
thor, with assistance on NMR characterisation provided by Dr. Samuel Adams, School
of Chemistry, University of Birmingham.
Solution-based photophysical properties of Hoechst 33258 have been thoroughly
characterised in the literature.203–205,241 UV-Vis absorption, steady-state luminescence
emission and excitation spectra and characterisation of Hoechst 33258 are provided in
Appendix A (Figures A1-6) for convenience. When attached to citrate-stabilised gold
nanoparticles the HoechstSS and HoechstSAc complexes are exposed to an aqueous
environment, hence the photophysical properties of both are measured in water. Table
2.1 summarises the UV-Vis absorbance, excitation and emission maxima of the Hoechst
33258 and the two surface-binding derivatives HoechstSS and HoechstSH. Further
photophysical data is provided in Appendix D (Figure D1).
2.3.3 Surfactant Modification of Gold Nanoparticles
Synthesis of 13 nm Gold Nanoparticles
There are a number of ways of synthesizing both spherical and non-spherical metal
nanoparticles consisting of top-down66 and bottom-up approaches.242 An example of
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Figure 2.6: Synthesis of the surface-binding HoechstSH complex.
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λabs/ nm λexc/ nm λemm/ nm
Hoechst 33258 263, 342 263, 345 505
HoechstSS 258, 338 264, 345 509
HoechstSAc 258, 340 264, 345 486
Table 2.1: Summary of the photophysical properties of Hoechst 33258, HoechstSS and
HoechstSH in water (1 µM). (λexc = 350 nm, λem = 500 nm) (Errors are approximated
as ±1 nm
a bottom-up approach is to produce metal nanoparticles by the reduction of the metal
ion from its salt in the presence of a suitable stabilising agent. The commonly used ap-
proach for the production of aqueous gold nanoparticles involves the citrate reduction of
HAu3+Cl4, in which the Au
3+ is reduced to Au0.209 In this method the gold nanoparti-
cles are surrounded by a layer of citrate ions, chloride ions and cations. The Coulombic
repulsion between these capping layers stabilises the nanoparticles from coalescing due
to van der Waals attractions between metal centres.243 Gold nanoparticles (AuNP) were
produced according to Grabar et al.244 using a method originally developed by Turkevitch
in 1951.52 This preparation is highly reproducible and gives a narrow size distribution,
13±1.7 nm as measured by Transmission Electron Microscopy (TEM) analysis of 100
nanoparticles.244 Due to it’s facile nature and reproducibility, this method of nanopar-
ticle synthesis has been employed by the Pikramenou research group several times for a
range of applications.76,77,82,196,245
13 nm citrate-stabilised gold nanoparticles were thus synthesised by the reduction of
the Au3+ salt (HAuCl4).
244 After dissolving the gold salt in water, the trisodium citrate
is added whilst the solution is rapidly stirred, reducing the Au3+ ions to form neutral gold
atoms. As their concentration rises and the solution exceeds saturation, sub-nanometer
particles begin to precipitate and the nanoparticles form via a nucleation process with the
remaining gold atoms. Providing the solution is stirred vigorously the particles formed
will be uniform in size and electrostatically stabilised by citrate ions, thus the trisodium
citrate acts as a capping and reducing agent (Figure 2.7).
Using the concentration of the Au3+ used and assuming all ions form nanoparticles,
44
Figure 2.7: Synthesis of 13 nm citrate-stabilised gold nanoparticles.
the concentration of the aqueous colloid produced is estimated at 9 nM (Appendix E.1).
The nanoparticles were characterised by UV-Vis absorption spectroscopy, TEM, dynamic
light scattering (DLS), and electrophoretic light scatting (zeta potential) measurements.
Data are presented in Appendix E.
The UV-Vis absorption of the 9 nM citrate-coated gold nanoparticles exhibit the char-
acteristic SPR peak at 520 nm. DLS sizing of the nanoparticles gives an average intensity
distribution of 28±14 nm and an average number distribution of 12 ±4 nm. An interest-
ing observation is the scattering intensity contribution from aggregates several hundred
nanometers in size. They contribute 10 % of the intensity distribution but are not evident
in the number distribution. This can be explained using Rayleigh’s approximation which
states that the scattering intensity from a particle is proportional to the sixth power of its
diameter, thus larger particles scatter much more than smaller particles.246,247 When the
intensity distribution is converted in to a number distribution this factor is accounted for
and it is apparent that these aggregates, although contributing an appreciable scattering
intensity, are negligible in quantity.
The nanoparticles possess a zeta potential of -34±2 measured in water at a 1 nM con-
centration. The zeta potential is measured by performing electrophoresis on the sample
and measuring the velocity of the particles using Laser Doppler Velocimetry. Thus the
electrophoretic mobility of the sample can be determined by applying the Henry equa-
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(a)
Figure 2.8: UV-Vis absorption spectra of citrate gold nanoparticles (3 ml, 4.5 nM) (bold) with
the addition of 1-25 µl HoechstSH [0.6 mM, MeOH] (dashed lines). (HoechstSH achieves a
final concentration of 5 µM.)
tion.248 The greater the magnitude of this potential, either positive or negative, in a
colloid gives an indication of its stability, where we define a colloid as a system in which
one of the three states of matter is finely dispersed in another. In this case the solid
nanoparticles are finely dispersed in liquid water. A large negative or positive zeta poten-
tial means that colloidal particles will repel each other. The gold colloid possesses a zeta
potential of -34±2 mV which is significant enough to stabilise the nanoparticles against
aggregation.
Direct Addition of HoechstSH to Gold Nanoparticles
Direct addition of the HoechstSH to 13 nm citrate-stabilised gold nanoparticles was
initially attempted and monitored by UV-Vis absorption spectroscopy (Figure 2.8). An
addition of the HoechstSH up to a final concentration of 5 µM was however unsuccessful
with the prompt formation of a new SPR band in the UV-Vis spectrum between 600 -
800 nm.
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The emergence of the new SPR band occurs upon the first 1 µl addition of the Hoech-
stSH, suggesting plasmon coupling between agglomerating nanoparticles and particle
flocculation.57 This corresponds to a gold nanoparticle concentration of 4.5 nM and a
dye concentration of 0.2 µM. The new SPR band eventually convolves with the SPR of
the 13 nm gold nanoparticles, resulting in a red-shift and a broadening of the convoluted
SPR.57,249
Previous work in the group includes the successful addition of neutral lanthanide
complexes to citrate-stabilised gold nanoparticles without the problem of particle floc-
culation.75,82 This is possible because the citrate-stabilised nanoparticles are stable due
to the negative electrostatic repulsion between the citrate coating, and the addition of a
neutral complex to the nanoparticles causes no electrostatic peturbation. Upon addition
and binding of the HoechstSH to the surface of a nanoparticle however, its positive
charge attracts neighbouring negatively charged partially-coated nanoparticles, leading
to their flocculation. Coupled with the displacement of the electrostatically stabilising
citrate anions from the gold surface this eventually causes the aggregation of the particles.
This is confirmed by visual inspection of the colloid with a colour change from red to blue
accompanied by sedimentation of gold aggregates.
Surfactant-mediated Labelling of Gold Nanoparticles with HoechstSH
An alternative strategy to attach the HoechstSH complex to citrate-stabilised gold
nanoparticles was thus required to circumvent the issue of aggregation. One method
of achieving this is through surface modification where the surfactant is added to displace
the negative citrate layer on the nanoparticle surface, thus sterically/electrostatically sta-
bilising the particles prior to addition of a cationic complex. Such a method was previously
employed by Aslan et al. to coat citrate-stabilised gold nanoparticles with peptide nucleic
acid.249
A study evaluating two commercially available surfactants, Tween 20 and Zonyl 7950,
as pre-coating moieties to enable subsequent attachment of a cationic complex to citrate-
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Figure 2.9: Structures of (a) Tween 20 and (b) Zonyl 7950
stabilised gold nanoparticles was performed by Dr. N. J. Rogers.190 The nonionic sur-
factant polyoxyethylene (20) sorbitan monolaurate (Tween 20) has four hydrophilic
polyethylene oxide chains and a single aliphatic chain (Figure 2.9).
The Zonyl 7950 is a fluorosurfactant with a hydrophilic methyl-methacrylate head-
group an a hydrophobic perfluorinate alkyl chain (Figure 2.9). Both surfactants were
titrated into the gold colloid which was monitored by UV-Vis absorption spectroscopy
with each addition of the surfactant to the gold nanoparticles accompanied by an SPR
shift.
For the purposes of attaching the HoechstSH to gold nanoparticles a similar method
was employed and monitored by UV-Vis absorption spectroscopy to ensure the surfactant-
mediated approach was possible across multiple nanoparticle preparations. A schematic
of the surfactant-coated nanoparticle constructs is shown in Figure 2.10. UV-Vis spectra
monitoring the addition of 1.5 ml Tween 20 [1.2 mM] to 1.5 ml (9 nM) 13 nm citrate-
stabilised gold nanoparticles (Au13-T20), and the addition of 1.5 µl (1 mg ml−1) Zonyl
7950 to 3 ml (4.5 nM) 13 nm citrate gold nanoparticles (Au13-Z) are shown in Figure
2.11. Addition of the Tween 20 and the Zonyl 7950 produced a 5 nm and 1 nm
bathochromic shift to the SPR of the gold nanoparticles respectively. This is due to
the absorption of the surfactant to the gold nanoparticles which modifies their surface
dielectric constant.68,75
Further characterisation on the surfactant-coated nanoparticles was performed with
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(a) (b)
Figure 2.10: Schematics of 13 nm gold nanoparticles coated with (a) Tween 20 and (b) Zonyl
7950.
(a) Addition of Tween 20 (b) Addition of Zonyl 7950
Figure 2.11: UV-Vis absorption spectra of the addition of (a) 1.5 ml (1.2 mM) Tween 20 and
(b) 1.5 µl (1 mg ml−1) Zonyl 7950 (dashed line) to 9.0 nM and 4.5 nM 13 nm citrate-stabilised
gold nanoparticles respectively (solid line).
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Particle Coating Citrate Tween 20 Zonyl 7950
DLS Intensity Distribution/ nm 28±14 43±22 34±13
DLS Number Distribution/ nm 12±4 17±5 18±5
Zeta Potential/ mV -34±2 -16±5 -69±3
PDI 0.153 0.243 0.157
Table 2.2: Summary of the DLS intensity, DLS number and zeta potential measurements of
13 nm gold nanoparticles coated with Tween 20 (Au13-T20) and Zonyl 7950 (Au13-Z). All
errors are quoted as ±1 SD.
DLS and zeta potential measurements to afford the hydrodynamic radii and the magnitude
of the electrostatic charge between particle (Figure 2.12). Prior to uniform dilution to 1
nM for DLS and zeta potential measurements, Au13-T20 and Au13-Z were isolated to
remove excess/unbound surfactant by size-exclusion chromatography.
The addition of the Tween 20 and Zonyl increased the hydroynamic radii with
respect to the citrate-stabilised gold nanoparticles, indicative of the surfactant coating
adding steric bulk to the nanoparticles and slowing down their diffusion in solution (Figure
2.12). Data are summarised in Table 2.2.
The citrate-stabilised gold nanoparticles exhibited a zeta potential of -34±2 mV which
changed to -16±5 mV upon addition of the neutral Tween 20 surfactant, indicating the
negatively charged citrate ions on the nanoparticle surface are being displaced by the
Tween 20 surfactant. Interestingly immediate aggregation is not induced by the reduc-
tion in surface charge, as illustrated by the DLS data which exhibits intensity and number
distribution peaks of 43±22 and 17±5 nm respectively. The addition of the Zonyl 7950
caused a decrease in the zeta potential to -69±3 mV. Although the Zonyl 7950 is it-
self neutral, the decrease in the zeta potential was attributed to the perfluorinated alkyl
chain of the molecule (Figure 2.9). These chains consist of multiple polarised C-F bonds
are assumed to present negative charges on the outer surface of the hydrodynamic radii
of the particles.169 Following the production of stable surfactant-coated nanoparticles,
Au13-T20 and Au13-Z were investigated as scaffolds for the addition of the thiolated




Figure 2.12: DLS intensity (a, b) and number distributions (c, d) of citrate-stabilised gold
nanoparticles (solid line) coated with (a, c) Tween 20 and (b, d) with Zonyl 7950 (dashed lines).
Gold nanoparticles were diluted to 1 nM for DLS measurements following purification by size-
exclusion chromatography and centrifugation respectively.
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Figure 2.13: Schematic of Au13-T20-HSH nanoparticle construct.
factant coated gold nanoparticles with HoechstSS. The resulting colloid was relatively
unstable with aggregates of gold nanoparticles visible within a few hours of the addition
of the HoechstSS. This is most likely a result of the impurities remaining from the syn-
thesis. As such the HoechstSH was utilised as the sole thiolated Hoechst derivative for
addition to gold nanoparticles.
Synthesis and Characterisation of Au13-T20-HSH
The Tween 20 coated gold nanoparticles were investigated as a scaffold for the addition
of the HoechstSH complex. Titration of the HoechstSH into the Tween 20 coated
gold nanoparticles was monitored by UV-Vis absorption spectroscopy and caused a 1
nm redshift in the SPR λmax of the gold nanoparticles, as determined computationally
by the UV-Vis SPR Analyser (Appendix J.1). The redshift was also accompanied by
the emergence of the Hoechst absorption band at 350 nm (Figure 2.14). The redshift is
observed in Figure 2.14b which exhibits a plot of the SPR λmax as a function of the molar
concentration of the HoechstSH added.




Figure 2.14: (a) UV-Vis absorption spectra of 13 nm Tween 20 coated gold nanoparticles (3
ml, 4.5 nM) (black) and the addition of 0.04-8 µM (1-200 µl) HoechstSH (dashed line). (b)
Corresponding plot monitoring the change in SPR λmax during the titration as a function of
the concentration of HoechstSH added. (Error bars are applied according to variations in the
computational fitting method used to determine SPR maxima (Appendix J.1).)
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Figure 2.15: UV-Vis absorption spectra of 13 nm HoechstSH coated Tween 20 coated gold
nanoparticles (Au13-T20-HSH) before (solid line) and after (dashed line) purification by size-
exclusion chromatography.
below 527 nm following the addition of 4.3 µM HoechstSH with a shift from 526.1 nm
to 526.5 nm. A rather more abrupt shift is then observed following the next titration
point, corresponding to a further 150 µl addition of the HoechstSH (to achieve a dye
concentration of 7.63 µM) with the SPR shifting to 527.3 nm. This is suggestive of a
secondary binding event and that a 4.3 µM addition of HoechstSH is enough to achieve
maximal surface coverage on the nanoparticles by displacing some of the adsorbed neutral
Tween 20. Further addition of the HoechstSH complex beyond this point may then be
in excess. A further important observation is the lack of SPR broadening or emergence
of a new SPR band other than the gold nanoparticle band (520 - 527 nm), indicating the
nanoparticles are not flocculating and/or aggregating and the colloid is stable.
Purification of the HoechstSH coated Au13-T20 to remove unbound HoechstSH
was attempted by centrifugation. Following resuspension of the nanoparticle pellet the
particles immediately aggregated and sedimented out of solution. Size-exclusion chro-




Figure 2.16: (a) DLS intensity distributions and (b) DLS number distributions of Au13-T20
(solid line) and Au13-T20-HSH (dashed line). (c) Zeta potential distribution of Au13-T20
(green) and Au13-T20-HSH (red). (Nanoparticles are diluted to 1 nM for DLS and zeta
measurements).
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T20-HSH (Figure 2.15). A schematic of isolated Au13-T20-HSH is shown in Figure
2.13.
To estimate the amount of HoechstSH remaining on the nanoparticles following col-
umn purification, the UV-Vis spectrum of the Au13-T20 was subtracted from UV-Vis
spectrum of the Au13-T20-HSH before and after column purification. By integrating
the area under the resulting curves and taking the ratio of the quantity of the resultant
area, the amount of HoechstSH remaining can be estimated. This is possible as a known
quantity is added prior to purification. Performing these calculations on the UV-Vis spec-
tra between 300 - 450 nm, corresponding to the HoechstSH absorption, indicates a 6.7
µM concentration of HoechstSH remaining in the nanoparticle colloid, a reduction from
a 7.63 µM concentration prior to purification. With a gold nanoparticle concentration of
4.5 nM this corresponds to approximately 1400 HoechstSH complexes per nanoparticle.
The zeta potential of the Au13-T20 changes to -34±1 mV following addition of the
HoechstSH and isolation following size-exclusion chromatography (Figure 2.16c). This is
a decrease from the zeta potential of Au13-T20 (-16±5). The DLS intensity distribution
increases from 43±22 (97%), 4506±877, (3%) for the Au13-T20 to 207 ±127 (70%),
36±13 (30%) for the Au13-T20-HSH, indicating the presence of flocculates (Figure
2.16a). The number distribution of the Au13-T20-HSH gives a single peak of 19±6 nm,
an increase from the 17±5 nm of the Au13-T20 (Figure 2.16b)indicating that the large
flocculates observed in the intensity distribution are negligible in quantity.
Synthesis and Characterisation of Au13-Z-HSH
The Zonyl 7950 coated gold nanoparticles were also investigated as a scaffold for the
addition of the HoechstSH complex. Citrate-coated 13 nm gold nanoparticles were
synthesised and coated with Zonyl 7950 as previously described, with the addition of
1.5 µl (1 mg ml−1) Zonyl 7950 to 3 ml (4.5 nM) of the nanoparticles. The nanoparticles
exhibited a 1 nm redshift in the λmax from 518 nm to 519 nm following centrifugation
(Figure 2.18a). The HoechstSH complex was then titrated in to the Zonyl 7950 coated
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Figure 2.17: Schematic of Au13-Z-HSH nanoparticle construct.
nanoparticles up to a final HoechstSH concentration of 38 µM in the gold colloid (Figure
2.18c).
Addition of HoechstSH induces a redshift in the SPR accompanied by an increase
in the absorption peak of the HoechstSH at 350 nm. The SPR can also be observed to
broaden during the titration however there is no emergence of a secondary peak in the
absorption profile in the 600 nm region to suggest nanoparticle flocculation/aggregation.
To further analyse the addition of the HoechstSH with respect to the SPR shift and
SPR broadening, the SPR λmax was again determined using the computational SPR
analyser. SPR broadening was quantified by fitting the SPR with a Gaussian curve and
determining its full-width at half-maximum (FWHM) (Appendix J.1). Results of the
analysis are exhibited in Figure 2.18c.
Figure 2.18c shows that the FWHM does not go under any significant change up to
an addition of 10 µM HoechstSH whilst the SPR increases by approximately 1.5 nm.
After this point in the titration the FWHM increases at a constant rate from 90 to 97




Figure 2.18: UV-Vis absorption spectra (a) of the addition of Zonyl 7950 to (dashed) coated 13
nm citrate-stabilised gold nanoparticles (solid line) (Au13-Z). (b) UV-Vis spectra monitoring
the addition of HoechstSH up to 38 µM HoechstSH to AuNP13-Z. (c) Plot of the SPR λmax
and full-width at half-maximum (FWHM) as a function of the molar amount of HoechstSH
added. (d) Normalised UV-Vis spectra monitoring the addition of 8 µM HoechstSH to Au13-Z
and isolated Au13-Z-HSH. Also exhibited are the supernatants following centrifugation.
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emergence of a secondary band in the absorption profile on the gold nanoparticles was
observed, there is the possibility that this relatively abrupt increase in the FWHM could
be indicative of the start of nanoparticle flocculation. To ensure optimal nanoparticle
stability in terms of avoiding possible flocculation, an 8 µM addition of HoechstSH was
thus adopted.
Isolation of the nanoparticles to remove excess/unbound HoechstSH was achieved by
centrifugation as described in the Section 2.6.2. The supernatant was discarded and the
nanoparticle pellet resuspended in deionised water affording Au13-Z-HSH. Figure 2.18d
shows UV-Vis absorption spectra following the addition of the HoechstSH and isolation,
including spectra of the supernatant following each centrifugation step. The supernatant
from the second centrifugation step does not exhibit a HoechstSH absorption peak so
it can be concluded that two centrifugation steps are sufficient to render isolated Au13-
Z-HSH. From the normalised spectra it is also apparent that the centrifuged Au13-Z-
HSH possess the HoechstSH absorption peak at 350 nm, indicating the nanoparticles
are successfully coated with the HoechstSH complex (Figure 2.18d).
To estimate the amount of HoechstSH remaining on the nanoparticles following
centrifugation the UV-Vis spectrum of the Au13-Z was subtracted from spectrum of the
Au13-Z-HSH before and after centrifugation. By integrating the area under the resulting
curves and taking the ratio of the quantity of the result, as a known quantity is added prior
to centrifugation the amount of HoechstSH remaining can be estimated. Performing
these calculations on the UV-Vis spectra between 300 - 450 nm corresponding to the
HoechstSH absorption indicates a 7.1 µM concentration of HoechstSH remaining in
the nanoparticle colloid. With a colloidal concentration of 4.5 nM this corresponds to
approximately 1500 HoechstSH complexes per nanoparticle.
DLS and zeta potential measurements were performed on the 13 nm citrate-stabilised
gold nanoparticles, isolated Au13-Z and isolated Au13-Z-HSH (Figure 2.19c). The
citrate-stabilised nanoparticles exhibit a peak in the intensity distribution diameter of




Figure 2.19: (a) DLS intensity distributions, (b) DLS number distribution of 1 nM citrate gold
nanoparticles (solid line), isolated 1 nM Au13-Z (dashed line) and isolated 1 nm Au13-Z-HSH
coated Zonyl 7950 coated nanoparticles (bold dashed line) (Au13-Z-HSH). (c) of 1 nM citrate
gold nanoparticles (blue), isolated 1 nM Au13-Z (green) and isolated 1 nm Au13-Z-HSH
coated Zonyl 7950 coated nanoparticles (red) (Au13-Z-HSH).
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of 41 ±18 nm. The corresponding number distributions yield values of 12±4 nm, 18±5
nm and 20±6 nm respectively.
The 20% increase in the intensity distribution and change in the number distribution
from 18±5 to 20±6 nm following addition of HoechstSH to the Au13-Z, indicates an
increase in the hydrodynamic radius of the particle, attributed to the binding of the
HoechstSH to the nanoparticle surface. Although a small number of flocculates are
present in the intensity distribution of the isolated Au13-Z-HSH, as indicated by the
broad peak at approximately 900 nm in Figure 2.19a, these are negligible in quantity as
indicated by the single peak in the number distribution for the Au13-Z-HSH.
These results suggest a stable colloid with no evidence of nanoparticle aggregation.
This is confirmed by the zeta potential measurements (Figure 2.19c). The citrate-stabilised
gold nanoparticles possess a zeta potential of -34±2 mV which increases in magnitude to
-69±3 mV for the isolated Au13-Z. Following addition of the HoechstSH complex the
zeta potential reduces in magnitude to -45±12 mV which indicates that the HoechstSH
complex displaces some of the electronegative surfactant. With the zeta potential of
the Au13-Z-HSH greater in magnitude than the citrate-stabilised gold nanoparticles it
suggests that the Au13-Z-HSH colloid remains electrostatically stable with significant
amounts of surfactant remaining with the HoechstSH on the nanoparticle surface. A
summary of the DLS and zeta potential measurements of Au13-T20-HSH, Au13-Z-
HSH and all precursors are presented in Appendix E, Figure E.1.
Photophysical Characterisation of Au13-T20-HSH and Au13-Z-HSH
Photophysical properties of Au13-T20-HSH and Au13-Z-HSH were characterised as
isolated dispersions and following the addition of calf-thymus DNA (CT-DNA) to examine
the DNA binding capability of the HoechstSH complex when bound to nanoparticles.
The free HoechstSH complex was thus similarly characterised following the addition of
CT-DNA in the presence of the Tween20 and Zonyl 7950 surfactants.
Figure 2.20 exhibits the steady-state excitation and emission spectra of the isolated
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(a) HoechstSH (b) HoechstSH-T20
(c) HoechstSH-Zonyl
Figure 2.20: Steady-state luminescence excitation (bold line) and emission spectra of Hoech-
stSH [0.1 mM] (solid line) and HoechstSH following the addition of CT-DNA to achieve a
final concentration of 180 mM (dashed lined) with prior addition of: (a) Tween20 [0.5 mM] and
(b) 0.5µl (1 mg ml−1) Zonyl 7950. (λexc = 350 nm, λem = 500 nm. Measurements were per-
formed in Tris-HCl [10 mM], NaCl [100 mM] buffer (pH 7.4). Spectra corrected for instrument
response, as described in General Experimental).
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HoechstSH complex following addition of CT-DNA and the same addition in the pres-
ence of the Tween 20 and Zonyl 7950 surfactants. The free HoechstSH possesses an
excitation maximum of λexmax = 340 nm which is red-shifted by 5 nm following the
addition of the Tween20 and blue-shifted by 5 nm following the addition of the Zonyl
7950. These shifts are attributed to the change in the polarity of the environment of the
HoechstSH complex due to the surfactants.241
The emission spectra of the HoechstSH and HoechstSH in the presence of the
surfactants exhibit the characteristic blueshifts and increase in emission intensity after
the addition of the CT-DNA.241 The HoechstSH exhibits an emission maximum of 484
nm and the addition of 10 molar equivalents of the CT-DNA produces a 20 nm blueshift
to 464 nm. Presence of the Tween 20 redshifts the emission maximum to 490 nm and
addition of the CT-DNA causes a 30 nm blueshift to 460 nm.
The presence the Zonyl 7950 causes the HoechstSH to exhibit an emission maximum
of 499 nm which blueshifts to 493 nm following the addition of CT-DNA. Notably both
surfactants cause a redshift in the emission maximum of the HoechstSH. A previous
investigation of the effect of the Tween 20 and indeed a number of other nonionic sur-
factants on the fluorescent sulfonephthalein dye attributed the redshift in the emission
maxima of the organic dye to the interaction with Tween 20 micelles.250
Excitation and emission spectra were also recorded of the gold nanoparticles stabilised
with the surfactants and coated with the HoechstSH complex. The Au13-T20-HSH
and Au13-Z-HSH exhibit excitation maxima of 350 nm and emission maxima of 445 nm
and 480 nm respectively (Figure 2.21). The UV-Vis absorption spectra of the Au13-T20-
HSH and Au13-Z-HSH exhibit the SPR of the gold colloid and an absorption peak at
350 nm matching the excitation profile of the HoechstSH. The emission maximum of the
Au13-T20-HSH (λmax = 445 nm) is blue-shifted considerably with respect to the free
HoechstSH (λmax = 487 nm), and also with respect to the HoechstSH in the presence
of the Tween 20 (λmax = 490 nm). This could be due to the hydrophobic polyoxyethylene
side chains of the Tween 20 which are in close proximity to the HoechstSH complex on
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(a) Au13-T20-HSH (b) Au13-Z-HSH
Figure 2.21: UV-Vis absorption spectrum (dashed line), excitation spectrum (λem = 500 nm,
dashed line) and steady-state emission spectrum (λexc = 350 nm, bold solid line) of (a) Au13-
T20-HSH (1 nM) and (b) Au13-Z-HSH (1 nM). Measurements were performed in Tris-HCl
[10mM], NaCl [100mM] buffer (pH 7.4). (All spectra corrected for instrument response).
the surface of the gold nanoparticle where it is packed between molecules of the adsorbed
surfactant.251 Free in solution howeverHoechstSH complex is not in such close proximity
and may furthermore not be exposed to the side chains due to the micelle formation of
Tween 20.252,253 A similar effect is perhaps occurring with the Zonyl 7950 with its
hydrophobic perfluorinated alkyl chain. The Au13-Z-HSH exhibits a λmax = 480 nm
which is blueshifted by 7 nm and 16 nm respectively from the isolated HoechstSH
complex (λmax = 487 nm) and the HoechstSH with Zonyl 7950 (λmax = 496 nm).
Addition of calf-thymus DNA (CT-DNA) to HoechstSH, HoechstSH-Tween20
and HoechstSH- Zonyl7950 solutions causes a blueshift in the emission maxima of
the HoechstSH as discussed previously (Figure 2.20). This characteristic shift is again
observed following the addition of CT-DNA to Au13-T20-HSH and Au13-Z-HSH
which exhibited 3 and 12 nm blueshifts to the HoechstSH emission maxima relative
to the respective colloids in isolation (Figure 2.22). These shifts as well as the increase
in emission intensity upon addition of CT-DNA to the gold colloids suggest that the
HoechstSH complex is still able to interact with DNA when bound to the nanoparticle
surface. Data are summarised in Table 2.3.
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(a) (b)
Figure 2.22: Steady-state luminescence emission spectra of (a) Au13-T20-HSH (1ml, 1 nM,
solid line) and (b) Au13-Z-HSH (1ml, 1 nM, solid) with the addition of CT-DNA (50 µl, 3
mM, dashed line). (λexc = 350 nm. Measurements were performed in Tris-HCl [10mM], NaCl
[100mM] buffer (pH 7.4). All spectra corrected for instrument response).
λex/ nm λmax/nm
HoechstSH 340 484
HoechstSH + CT-DNA - 464
HoechstSH + T20 345 490
HoechstSH + T20 + CT-DNA - 460
Au13-T20-HSH 350 445
Au13-T20-HSH + CT-DNA - 440
HoechstSH + Zonyl 335 500
HoechstSH + Zonyl + CT-DNA - 493
Au13-Z-HSH 350 480
Au13-Z-HSH + CT-DNA 468
Table 2.3: Summary of the photophysical properties of aqueous free HoechstSH, Au13-T20-
HSH and Au13-Z-HSH, with the addition of Tween 20, Zonyl 7950 and CT-DNA. Hoech-
stSH [1 mM, MeOH] added to Milli-Q H2O to achieve a concentration of 1µM. Addition of
Tween 20 [1.2 mM, Milli-Q H2O] to HoechstSH to achieve a final concentration of 0.5 mM.
Addition of Zonyl 7950 [1 mg ml−1] to HoechstSH to achieve a final concentration of 0.5 mM.
Au13-T20-HSH and Au13-Z-HSH at 1 nM with the addition of CT-DNA [3 mM, Milli-Q
H2O] to achieve a final concentration of 150 µM. (Estimated error = ±1 nm).
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Synthesis and Characterisation of Au100-Z-HSH
There are several methods for producing gold nanoparticles above 20 nm in diameter,
including one-pot reactions254 and seed-mediated processes.255–258 One-pot reactions gen-
erally produce particles with a low concentration, high polydispersity and limited shape
control. Post-synthetic clean up steps are possible in such synthesis, for example cetyl
trimethylammonium bromide (CTAB)-stabilised nanoparticles can be grown via a seed-
mediated process and subsequently purified to leave only spherical particles.255 An al-
ternative synthesis by Perrault et al. uses hydroquinone as a reducing agent however
the oxidation product is toxic and particle polydispersity relatively high.256 The method
therefore adopted in this study is an adapted synthesis by Ziegler and Eychmüller which
does not require a post-synthetic clean up and uses a biocompatible reducing agent, pro-
ducing nanoparticles of a nominal 100 nm diameter.259
The nanoparticles are produced in a three step process which starts with 13 nm citrate-
stabilised gold nanoparticles (Section 2.3.3). The 13 nm nanoparticles act as seeds to
which HAuCl4 is added with a mixture of sodium citrate and ascorbic acid to reduce the
gold3+ ions to gold0. Nucleation of the gold0 on the nanoparticle seeds then produces
larger nanoparticles as illustrated in Figure 2.23.
An approximate doubling in size is achieved in the each of the three growth steps due
to the ratio of seed (gold nanoparticles) to gold salt added, the 13 nm seeds thus grow
to 25 nm, then to 50 nm and finally to a nominal 100 nm. An increase in nanoparticle
diameter causes a decrease in the resonant frequency of the electron oscillations in the
conduction band of the gold, thus a 566 nm SPR λmax is observed for the 100 nm gold
nanoparticles.50 The resulting 40 pM aqueous gold colloid were subsequently studied
as scaffolds for attachment of the thiolated HoechstSH complex using the Zonyl 7950
surfactant. (Concentration calculation provided in Appendix E.1).
As described in Section 2.3.3 direct addition of HoechstSH to 13 nm citrate-stabilised
gold nanoparticles gives rise to their immediate aggregation. This was again observed
upon addition of the HoechstSH to the 100 nm gold nanoparticles as evident by a colour
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Figure 2.23: Schematic of the seeded-growth synthesis method to produce 100 nm gold nanopar-
ticles.
(a) (b)
Figure 2.24: (a) UV-Vis absorption spectra of 100 nm citrate-stabilised gold nanoparticles (solid
line) and isolated Au100-Z (dashed line). (b) UV-Vis spectra monitoring the addition of 50µl
(10µM) HoechstSH to Au100-Z.
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change from purple to grey accompanied by sedimentation of the gold. To circumvent
this the Zonyl 7950 was again employed in a method analogous to that used for the 13
nm gold nanoparticles.
Coating of the nanoparticles was monitored by UV-Vis absorption spectrscopy. The
addition of 1.5 µl (1 mg ml−1) Zonyl 7950 to 1 ml (40 pM) 100 nm gold nanoparticles
caused a 1 nm red-shift in the SPR from 542.5 nm to 543.5 nm (Figure 2.24a). This is
similarly observed with the 13 nm gold nanoparticles where addition of the Zonyl 7950
causes a 1 nm redshift (Figure 2.18a). The UV-Vis spectrum also shows the absorption
band at 295 nm due to the ascorbic acid remaining from the nanoparticle synthesis. Ascor-
bic acid and excess/unbound Zonyl 7950 is removed following isolation by centrifugation
affording Au100-Z.
Following isolation of Au100-Z, 50 µl HoechstSH (0.6 mM MeOH) was titrated in
to 1 ml (40 pM) Au100-Z. This induced a 1.5 nm red-shift in the SPR from 543.5 nm
to 545 nm in the UV-Vis absorption spectrum, indicated by the arrow in Figure 2.24b.
Also evident is the absorption band at 350 nm of the HoechstSH convoluted with the
absorption profile of the particles. This is similar to the addition of HoechstSH to
Au13-Z particles where a red-shift is also observed (Figure 2.18).
The gold colloid was twice centrifuged with removal of the supernatant and resuspen-
sion of the nanoparticle pellet in deionised water on each occasion to remove excess/un-
bound HoechstSH complex. Figure 2.25 shows the UV-Vis absorption spectra before
and after centrifugation. The spectra show no change in the SPR band (λmax = 545 nm)
of the particles and indeed no widening of the band. This indicates that the colloid is
stable and the particles are not subject to flocculation and/or aggregation, the indica-
tions of which would be widening of the SPR and the emergence of an absorption band
beyond 600 nm (Figure 2.8).57,249 A further noticeable feature is the absorption band of
the HoechstSH at 350nm following centrifugation steps. With unbound/excess Hoech-
stSH removed by the centrifugation this feature originates from HoechstSH bound to
the gold nanoparticles.
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Figure 2.25: UV-Vis absorption spectra of Au100-Z-HSH before (solid line) and after (dashed
line) isolation by centrifugation.
To estimate the amount of HoechstSH remaining on the nanoparticles following cen-
trifugation, the UV-Vis spectrum of the Au100-Z was subtracted from the spectrum of
the Au100-Z-HSH before and after centrifugation. By integrating the area under the
resulting curves and taking the ratio of the quantity of the resultant, as a known amount
is added prior to centrifugation the amount of HoechstSH remaining on the particles
can be estimated. Performing these calculations on the UV-Vis spectra between 300 -
450 nm, corresponding to the HoechstSH absorption, indicates a 2.4 µM concentration
of HoechstSH remaining in the nanoparticle colloid. With a gold nanoparticle concen-
tration of 29 pM this corresponds to approximately 8x104 HoechstSH complexes per
nanoparticle. The 100 nm gold nanoparticles have a greater surface area by a factor of
sixty compared to the 13 nm particles, thus it would be expected that there are a greater
number of HoechstSH complexes on the surface by this same factor. An analogous cal-
culation as performed above for Au13-Z-HSH (Section 2.3.3) indicates approximately
1500HoechstSH complexes per nanoparticle; a factor of fifty less than what is calculated
for the Au100-Z-HSH. Both calculations are thus consistent with each other taking in
to account the difference in surface area. Furthermore it would indicate that this method
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of using the UV-Vis spectra to determine the number of HoechstSH complexes per
nanoparticle provides a valid estimate.
Isolated 100 nm gold particles were further characterised by DLS following addition of
the Zonyl 7950 and subsequently the HoechstSH complex (Figure 2.26). DLS measure-
ments of the 100 nm gold nanoparticles and isolated Zonyl 7950 coated nanoaparticles
show a single peak in the intensity and number distributions. The 100 nm gold nanopar-
ticles possess a single peak at 93±37 nm in the intensity distribution which increases
to 98±37 nm following addition of the Zonyl 7950 (Figure 2.26a). A single peak is
also observed in the number distribution at 72±17 nm which also increases to 80±19 nm
(Figure 2.26b) following addition of the Zonyl 7950. Both distributions demonstrate an
absence of aggregates in all cases. Following coating with the HoechstSH complex and
purification by centrifugation, a single peak in the intensity and number distributions is
again observed. A peak in the intensity distribution of 100±37 nm is observed for the
isolated Au100-Z-HSH (Figure 2.26c), and the number distribution exhibits a peak at
83±19 nm (Figure 2.26d). The incremental increases in the nanoparticle diameter follow-
ing addition of the Zonyl 7950 and the HoechstSH in addition to the increase in the
SPR observed (Figure 2.24), indicate successful surface binding of the HoechstSH on
the 100 nm gold nanoparticles.
DLS measurements of the 100 nm nanoparticles and particles coated with the Zonyl
7950 and the HoechstSH were conducted at 10 pM concentrations (Figure 2.26e). Ad-
dition of the Zonyl 7950 fluorosurfactant increases the magnitude of the zeta potential
from -30±15 mV to -50±11 mV, followed by a decrease in magnitude to -40±12 mV upon
addition of the HoechstSH complex. This is similar to the preparation of Au13-Z-HSH
where the citrate-stabilised gold nanoparticles possess a zeta potential of -34±2 mV which
increases in magnitude to -69±3 mV for the isolated Au13-Z. Following addition of the
HoechstSH complex to Au13-Z the zeta potential then reduces in magnitude to -45±12
mV. The increase in magnitude of the zeta potential after the addition of the Zonyl 7950





Figure 2.26: (a) DLS intensity and (b) DLS number distributions of Au100-Z. (c) DLS intensity
and (d) DLS number distributions of Au100-Z-HSH. (e) zeta potential distributions of Au100




Figure 2.27: (a) UV-Vis absorption spectra of isolated (Au13-Z (blue)), the addition of 22 µM
(17 µl) Hoechst 33258 to Au13-Z (red) and subsequent centrifugation (black). (b) Magnifi-
cations of the SPR peak.
posed to the outer region of the hydrodynamic radii of the particles. The HoechstSH
complex then decreases the magnitude of the zeta potential when it displaces of some of
the electronegative fluorosurfactant on the nanoparticle surface.
Addition of Hoechst 33258 to Gold Nanoparticles
A control study was performed to determine whether the SPR shift observed in the UV-
Vis absorption spectrum of the Zonyl 7950 coated gold nanoparticles following addition of
the HoechstSH (Figure 2.18b) was indeed due to the sulphur-gold bonding between the
HoechstSH complex and the nanoparticle surface. A solution of Hoechst 33258, the
starting material for the synthesis of the HoechstSH which possesses a hydroxyl group
in place of the thiolated ligand on the HoechstSH, was thus titrated in to isolated Zonyl
7950 coated 13 nm gold nanoparticles.
UV-Vis spectra monitoring the addition of the Hoechst 33258 Au13-Z are shown in
Figure 2.27. As expected a large absorption band centred at 350 nm is observed following
addition of the Hoechst 33258 and importantly the SPR band of the nanoparticles does
not shift, remaining at 520 nm (Figure 2.27b). The SPR of the gold nanoparticles is
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Figure 2.28: Structure of the pHLIP peptide (cysteine group indicated by the red arrow)
dependant on the dielectric constant of the local surrounding medium and any changes
due to binding at the nanoparticle surface,249 hence the absence of an observed SPR shift
indicated a lack of binding of Hoechst 33258 to the nanoparticle. Following centrifuga-
tion to isolate the nanoparticles from the unbound Hoechst 33258 the UV-Vis spectrum
exhibits a complete absence of the Hoechst absorption band at 350 nm. This supports the
conclusion that the SPR observed upon the addition of the HoechstSH to the Zonyl
7950 gold nanoparticles is due to the sulphur-gold bond.
2.3.4 Peptide Modification of Gold Nanoparticles
Synthesis and Characterisation of Au13-P-HSH
Citrate-stabilised 13 nm gold nanoparticles were synthesised as reported in Section 2.3.3.
The pHLIP peptide (purchased from Alta Biosciences) is insoluble in water and therefore
dissolved in a 10% DMSO phosphate buffer saline solution, analogous to the preparation
by Davies et al.82 The pHLIP peptide sequence contains a single cysteine amino acid with
a free thiol group for binding to gold (Figure 2.28) and was investigated to mediate the
attachment of the HoechstSH to gold nanoparticles (Figure 2.29).
Coating of the 13 nm citrate-stabilised gold nanoparticles with the pHLIP peptide
sequence was monitored by UV-Vis absorption spectroscopy (Figure 2.30a). Addition of
the pHLIP peptide resulted in a redshift of 1 nm from (519 - 520 nm) in the SPR λmax of
the gold nanoparticles, affording (Au13-P). Such a shift indicates a change in the surface
dielectric constant and therefore binding of the pHLIP peptide to the nanoparticles.68,75,82
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Figure 2.29: Schematic of Au13-P-HSH nanoparticle construction starting with the gold
nanoparticle, followed by addition of the pHLIP peptide and HoechstSH.
The magnitude of the shift is less than that reported in the study by Davies et al. in
which a 5 nm red shift in the SPR λmax is observed.
82 This is not however unexpected as
the 5 nm shift was attributed to the 80 µM addition of the pHLIP peptide whereas here
8 µM of the peptide is added.
The HoechstSH complex was subsequently added to gold nanoparticles pre-coated
with the pHLIP peptide Au13-P. The SPR λmax was again monitored by UV-Vis absorp-
tion spectroscopy (Figure 2.30b). The HoechstSH was titrated in to the gold nanoparti-
cles up to a final concentration of 45 µM. The HoechstSH was induced a further redshift
in the SPR λmax of the nanoparticles with a shift from 520 nm to 522 nm. Significantly
no indication of particle flocculation or aggregation was observed with the FWHM of the
SPR showing no increase in magnitude and no new formation of an SPR band at 600 nm
or beyond (Figure 2.8).57,249
Nanoparticles were isolated from excess free HoechstSH complex and pHLIP peptide
by size-exclusion chromatography on superfine Sephadex G-25 (GE Healthcare HiTrap
Column) affording Au13-P-HSH. UV-Vis absorption spectra of the particles before and
after size-exclusion chromatography are presented in Figure 2.31a. Following isolation
the spectra also exhibit a further redshift in the SPR λmax of the particles to 524 nm,
indicating a change in the surface environment of the particles. This may be due to excess
peptide and/orHoechstSH which was adsorbed to the particles in the outer region of the
hydrodynamic radius, but was removed upon size-exclusion chromatography. A further
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(a) (b)
Figure 2.30: UV-Vis absorption spectra (a) of the addition of 8 µM (20 µl) pHLIP peptide
(dashed) to 13 nm citrate-stabilised gold nanoparticles - Au13-P (solid line). (b) UV-Vis spectra
monitoring the addition of λmax to Au13-P up to a final concentration of 45 µM (200 µl).
point of note is the dilution factor of 1.5 and again an absence of any signs of particle
flocculation and/or aggregation.
In analagous fashion to the surfactant coated nanoparticles, to estimate the amount of
HoechstSH remaining on the nanoparticles following centrifugation, the UV-Vis spec-
trum of the Au13-P was subtracted from UV-Vis spectrum of the Au13-P-HSH before
and after centrifugation. By integrating the area under the resulting curves and taking
the ratio of the quantity of the resultant, the amount of HoechstSH remaining can be
estimated. This is possible as a known quantity is added prior to centrifugation. Perform-
ing these calculations on the UV-Vis spectra between 300 - 450 nm, corresponding to the
HoechstSH absorption, indicates a 4 µM concentration of HoechstSH remaining in the
nanoparticle colloid. With a gold nanoparticle concentration of 9 nM this corresponds
to approximately 400 HoechstSH complexes per nanoparticle. This compares to 1400 -
1500 complexes for the surfactant coated 13 nm nanoparticles. This would perhaps not
be unexpected as the pHLIP peptide is larger than the surfactants and may occlude more
of the nanoparticle surface, thus fewer HoechstSH are able to bind.
DLS and zeta potential measurements were performed (Figure 2.31). The citrate-
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Figure 2.31: (a) UV-Vis spectra of Au13-P (solid line) and Au13-P-HSH before (bold line)
and after (dashed line) centrifugation. (b) zeta potential distributions of 13 nm citrate-stabilised
gold nanoparticles (red), Au13-P (green) and isolated Au13-P-HSH (blue). DLS intensity
(c) and number (d) distributions of 13 nm citrate-stabilised gold nanoparticles (solid line) and
Au13-P-HSH (dashed line).
stabilised nanoparticles exhibit an intensity distribution diameter of 28±13 nm and the
Au13-P-HSH a diameter of 36±19 nm. The number distributions yield diameters of
13±4 for the citrate-stabilised gold nanoparticles and 14±4 for Au13-P-HSH respec-
tively. The increase in hydrodynamic radius observed upon addition of the pHLIP pep-
tide and the HoechstSH complex indicates binding to the nanoparticles. Furthermore
no evidence of flocculates/aggregates are apparent with single distributions observed in
the DLS number distributions.
Zeta potential measurements of the 13 nm citrate-stabilised gold nanoparticles yield
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Figure 2.32: UV-Vis absorption spectrum (dashed line), excitation spectrum (λem = 500 nm,
solid line) and steady-state emission spectrum (λexc = 350 nm, bold solid line) of Au13-P-
HSH.
a zeta potential of -38±3 mV which increases in magnitude to -44±3 mV upon addition
of the pHLIP peptide (Figure 2.31b). With the peptide possessing an overall negative
charge this would be expected.260 Following addition of the HoechstSH complex the
zeta potential again increases in magnitude to -53±12 mV. This is surprising considering
the HoechstSH is cationic, thus a decrease in magnitude would be expected as it binds
on the pHLIP coated gold nanoparticle. The increase in magnitude may be due to the
HoechstSH complex binding to the nanoparticle in such a way the negatively charged
pHLIP peptide rearranges on the nanoparticle surface to become more exposed, thus
yielding a more negative zeta potential.
Photophysical Characterisation of Au13-P-HSH
The photophysical properties of Au13-P-HSH were characterised as isolated dispersions
and following the addition of calf-thymus DNA (CT-DNA) due to the DNA binding
property of the HoechstSH complex. For comparison the HoechstSH complex was
similarly characterised in isolation and following addition of the pHLIP peptide.
Upon excitation at 350 nm theAu13-P-HSH exhibits blue (cyan) emission with λmax
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(a) (b)
Figure 2.33: (a) Steady-state excitation (bold line) and emission spectra of HoechstSH [0.1
mM, Milli-Q H2O] and pHLIP peptide before (solid line) and after the addition of 10 molar
equivalents of CT-DNA (dashed line). (b) emission spectra of Au13-P-HSH (1 nM) before
(solid line) and after (dashed line) the addition of CT-DNA to achieve a final concentration of
17 µM. (All spectra corrected for instrument response).
= 478 nm (Figure 2.32. The UV-Vis absorption spectra of the Au13-P-HSH although
dominated by the SPR of the gold colloid exhibits a peak at 350 nm corresponding to the
excitation peak of the HoechstSH. The emission maximum of the Au13-P-HSH (λmax
= 478 nm) is blue-shifted with respect to the isolated HoechstSH (λmax = 487 nm) and
the HoechstSH with pHLIP (λmax = 493 nm) (Figure 2.332.33a). This could be due
to the close proximity of the HoechstSH complex with the negatively charged pHLIP
peptide on the surface of the gold nanoparticle.
Figure 2.33a shows the excitation and emission spectra of the isolated HoechstSH
andHoechstSH-pHLIP solution before and after the addition of CT-DNA. TheHoech-
stSH possesses an excitation maximum of λex = 340 nm which is unchanged following
the addition of the pHLIP. The emission spectrum of the HoechstSH with the pHLIP
following the addition 10 molar equivalents CT-DNA exhibits the characteristic blueshift
and increase in emission intensity, with a shift from 493 nm to 463 nm. The addition
of CT-DNA to Au13-P-HSH also causes an increase in the emission intensity and a
blueshift of approximately 30 nm from 478 nm to 461 nm (Figure 2.33b).
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Synthesis and Characterisation of Au100-P-HSH
Coating of 100 nm gold nanoparticles with the pHLIP peptide was performed analo-
gously to the preparation for the 13 nm gold nanoparticles. Coating of the 100 nm
citrate-stabilised gold nanoparticles (40 pM, 2.5 ml) with the pHLIP peptide sequence
was monitored by UV-Vis absorption spectroscopy (Figure 2.34a). An addition of 2 µM
(5 µl) pHLIP peptide resulted in a redshift of 1 nm in the SPR λmax of the gold nanopar-
ticles with a shift from 595 nm to 596 nm. Addition of 50 µl (10 µM) HoechstSH
followed by isolation by centrifugation induces a blueshift of 8 nm to 588 nm, affording
Au100-P-HSH.
Isolated Au100-P-HSH were further characterised by DLS (Figure 2.34). DLS mea-
surements of the 100 nm gold nanoparticles and isolated Au100-P-HSH show a single
peak in the intensity and number distributions. The 100 nm gold nanoparticles possess a
single peak at 93±37 nm in the intensity distribution which increases to 154±50 nm for the
Au100-P-HSH (Figure 2.34c). A single peak in the number distribution is also observed
at 72±17 nm which increases to 113±41 nm for the Au100-P-HSH, demonstrating an
absence of aggregates in all cases.
To estimate the amount of HoechstSH remaining on the nanoparticles following cen-
trifugation, the UV-Vis spectrum of the Au100-P was subtracted from UV-Vis spectrum
of the Au100-P-HSH before and after centrifugation. By integrating the area under the
resulting curves and taking the ratio of the quantity of the resultant, the amount of
HoechstSH remaining can be estimated. This is possible as a known quantity is added
prior to centrifugation. Performing these calculations on the UV-Vis spectra between
300 - 450 nm, corresponding to the HoechstSH absorption, indicates a 2 µM concen-
tration of HoechstSH remaining in the nanoparticle colloid. With a gold nanoparticle
concentration of 40 pM this corresponds to approximately 5x105 HoechstSH complexes
per nanoparticle. Taking in to account the increase in surface area of the 100 nm par-
ticles compared to the 13 nm particles, and the result of the same calculation above for




Figure 2.34: (a) UV-Vis spectra of 100 nm gold nanoparticles (solid line), Au100-P (dashed
line) and Au100-P-HSH (bold line). (b) zeta potential distributions of 100 nm gold nanoparti-
cles (red) and Au100-P-HSH (green). DLS intensity (c) and number (d) distributions of 100
nm gold nanoparticles (dashed line) and Au100-P-HSH (solid line). (PDI = 0.088 for both
distributions)
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plexes per nanoparticle. This variation could be attributed to variations in size (particle
sizes quoted are nominal values), or perhaps due to a different surface orientation of the
pHLIP peptide on the larger particles that allows a great number of HoechstSH to bind
compared to the 13 nm particles.
Following coating with the HoechstSH complex and purification by centrifugation,
the single peak in the intensity and number distributions is again observed. A peak in the
intensity distribution of 99±37 nm is observed for Au100-P-HSH (Figure 2.34c). The
number distribution shows a peak at 83±19 nm for Au100-P-HSH. The incremental
increases in the diameters following addition of the Zonyl 7950 and subsequently the
HoechstSH in addition to the increase in the SPR, indicate surface functionalisation of
the gold nanoparticles with the HoechstSH complex.
Electrophoretic light scattering measurements of the 100 nm nanoparticles and Au100-
P-HSH were conducted at 10 pM concentrations (Figure 2.34). Addition of the pHLIP
and HoechstSH followed by isolation by centrifugation yields an increases in the zeta
potential. The magnitude of the zeta potential increases from -30±15 mV for the 100 nm
gold nanoparticles to -39±12 mV for the Au100-P, followed by a decrease in magnitude
to -40±12 mV upon addition of the HoechstSH complex Au100-P-HSH.
2.3.5 Preliminary Study: Circular Dichroism of Au13-Z-HSH
and Au13-P-HSH
Preliminary circular dichroism (CD) spectroscopy studies monitoring the conformational
changes of calf-thymus (CT-DNA) upon addition of the Au13-Z-HSH and Au13-P-
HSH were performed. Circular dichroism refers to the differential absorption of left and
right-handed circularly polarised light by a molecule that contains one of more chiral
molecules. CD is used to assess the conformation of a range of macromolecules such as
proteins and DNA as their structures are sensitive to their environment (pH, temperature)
and interaction with other molecules. The Hoechst dye possesses the ability to bind to
DNA, thus the Au13-Z-HSH and Au13-P-HSH were similarly examined to assess their
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Figure 2.35: Circular dichroism (a) and UV-Vis absorption (b) spectra of 100 µM CT-DNA plus
the addition of Au13-Z-HSH as per the figure legend. Addition of the Au13-Z-HSH induces
changes in the circular dichroism spectra as indicated by the dashed red-arrows. Changes in
the DNA structure may be due to conformational changes and/or stiffening upon binding with
the HoechstSH complex on the gold nanoparticles. (CT-DNA was added upon each titration to
keep DNA concentration consistent. Measurements were performed in Tris-HCl [10mM], NaCl
[100mM] buffer (pH 7.4). CT-DNA was dissolved in milli-Q water, and all solutions were
sonicated and vortexed before measurement).
interaction with DNA. Spectra of CT-DNA addition of the Au13-Z-HSH and Au13-P-
HSHare presented in Figure 2.35 and 2.36. In both spectra the increases in magnitude and
shifts in wavelength of the CD spectra between 200 and 300 nm indicate stiffening of the
three-dimensional structure of the DNA.261 This is perhaps due to interaction/binding
with the nanoparticle bound Hoechst-SH, indicating that the both the nanoparticle
HoechstSH conjugates still possess the ability to bind to DNA. This is of great relevance
considering that cellular and nuclear uptake in cells will be examined, as the nanoparticles
may possess the potential to interact with nuclear DNA in cells.
2.3.6 Cellular Uptake of Au13-T20-HSH, Au13-Z-HSH and Au100-
Z-HSH
One of the major areas of interest in nanotechnology is the interaction of nanoparticles
with cells, specifically their ability to achieve uptake and the fate of the nanoparticles
once intracellular localisation is achieved. Visualisation of populations of cells exposed
to nanoparticles is thus required. A widely used technique in the life sciences for cellular
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Figure 2.36: Circular dichroism (a) and UV-Vis absorption (b) spectra of 100 µM CT-DNA plus
the addition of Au13-P-HSH as per the figure legend. Addition of the Au13-P-HSH induces
changes in the circular dichroism spectra as indicated by the dashed red-arrows. Changes in
the DNA structure may be due to conformational changes and/or stiffening upon binding with
the HoechstSH complex on the gold nanoparticles. A reverse titration comprising the addition of
CT-DNA to Au13-P-HSH (as denoted by the Figure legend) is shown in (c) with magnification
of the inset in (d). Changes in the circular dichroism spectra indicated by the dashed red-arrows
again indicated changes in DNA structure/stiffening. (CT-DNA was added upon each titration
to keep DNA concentration consistent. Measurements were performed in Tris-HCl [10mM],
NaCl [100mM] buffer (pH 7.4). CT-DNA was dissolved in milli-Q water, and all solutions were
sonicated and vortexed before measurement).
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imaging is light microscopy which allows the interrogation of living or fixed cells with
relatively minimal sample preparation time. Light microscopes can use a range of contrast
methods including label free techniques such as brightfield microscopy. The most widely
used form of light microscopy is however fluorescence based. The diffraction-limit places
a fundamental limit on the resolution achievable in light microscopy (approximately half
of the incident wavelength used), thus individual nanoparticles may not be completely
resolved depending on their size.262 Although this limit can be reduced or overcome using
specialised “super-resolution” techniques, light microscopy can still be used to image
nanoparticles which would instead appear as blurred point sources.
Gold nanoparticles are particularly suited to bright-field and reflection microscopy,
exploiting the absorption and scattering properties of gold nanoparticles.263 Nanoparti-
cles functionalised with luminescent moieties are widely employed due to their potentially
higher luminescence when multiple lumiphores can be conjugated to a nanoparticle rel-
ative to single lumiphores alone. Also possible are an array of excitation and emission
wavelength/bands, thus multiple “channels” of luminescence/fluorescence can be moni-
tored. The most common form of fluorescence microscopy is epifluorescence in which an
arc lamp is used to illuminate the field-of-view (FOV) with filters selecting the required
excitation and emission wavelengths. The contrast and resolution achieved via this tech-
nique is however not ideal as the wide field of illumination allows for out-of-focus planes
to be superimposed on the objects of interest in the desired focal plane. In confocal laser
scanning microscopy excitation is achieved via a laser that is rastered across the FOV with
both the incident laser and emitted light passing through a pinhole in the focal plane of the
objective. Out-of-focus fluorescence is thus removed providing improved contrast and res-
olution relative to epifluorescence microscopy. A great advantage of confocal microscopy
is the ability to create three-dimensional reconstructions and to record emission spectra
by examining pixel/image intensity in a discrete series of wavelength bands.
To investigate their potential as cellular imaging agents and to evaluate the biological
consequences of functionalising the nanoparticles with the Hoechst DNA binding dye,
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A549 human adenocarcinomic alveolar basal epithelial cells and HeLa human adenocar-
cinomic cervical epithelial cells were incubated with Au-T20-HSH, Au-Z-HSH and
Au-P-HSH. Cells were incubated for a range of time periods and imaged using confo-
cal microscopy to image HoechstSH. Confocal reflectance and transmission brightfield
microscopy was used to image the nanoparticles and cellular features.
Images of untreated cells and the appropriate controls for the counterstains used are
shown in Appendix H. Confocal microscopy instrument settings and parameters are pro-
vided in Section 6.0.8. UV-Vis absorption spectra of Au13-T20-HSH, Au13-Z-HSH
and Au13-P-HSH in complete cell media at the same concentration used for the imaging
studies were measured. Spectra were void of any indications of particle aggregation/floccu-
lation, demonstrating the stability of the nanoparticles in cell culture medium (Appendix
F).
Confocal Microscopy of Au13-T20-HSH in Cells
Initial cell work was performed with the A549 human lung adenocarcinoma epithelial cell
line (Appendix G.2). Confocal luminescence and reflection microscopy images of Au13-
T20-HSH in A549 cells following a 20 minute incubation are exhibited in (Figure 2.37).
In brief, widefield and magnifications of representative cells show Au13-T20-HSH in
the outer regions of the cells as would be expected following a relatively short exposure
time. Co-localisation analysis (described in Figure 2.37) on the nanoparticles confirms
HoechstSH luminescence from bright pixels in the reflectance channel corresponding to
scatter gold nanoparticles. This demonstrates the stability of the HoechstSH complex
on gold nanoparticles upon exposure to a cellular environment/medium (Figure 2.37).
Furthermore nanoparticles are relatively disperse in their distribution in the cell and are
not localised to one area in particular. This is again what would be expected with such
a relatively short exposure time as the cells would most likely not have had enough time
to “process” the nanoparticles and either expel them or compartmentalise them in to
lysosomal/endosomal vesicles, assuming this would be their eventual fate. The dark spots
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Figure 2.37: Images of Au13-T20-HSH nanoparticles in A549 cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au13-T20-HSH at a concen-
tration of 0.25 nm in complete cell media for 20 minutes before fixing. (a) and (b) white light
transmission and blue HoechstSH luminescence channel image. Magnifications of yellow inset
boxes are shown in (c) and (d) respectively, designated (a*) and (b*). (e), (f) and (g) - magnifi-
cations of another cell with white light transmission, blue HoechstSH luminescence and reflection
images respectively. Nanoparticles are observed as dark spots, cyan (from the HoechstSH sur-
face coating) spots and white spots respectively in these images. Co-localised pixels in the blue
HoechstSH luminescence and reflection images indicate HoechstSH emission from spatial loca-
tions corresponding to white spots i.e. nanoparticles in the reflection image. Co-localisation was
performed using the ImageJ Colocalisation Analyser plugin. NB. Not all pixels “cross-correlate”
because of differences in intensity, namely scattering of some of the reflection signal by the cel-
lular material in the reflectance channel image. Cell-membrane and nuclear (N) envelope are
manually drawn as indicated by the green and red dashed lines respectively. Reflection image
λexc = 633 nm, λem = 623-643 nm, HoechstSH luminescence, blue channel, λexc = 405 nm,
λem = 405-550 nm. (Scale bar (a, b) = 20 µm, (c - h) = 10 µm).
evident in the transmission image are also notably very similar to observations made in
a study on lipid-coated gold nanoparticle uptake in A549 cells by Wang et al.264 Such
features were attributed as lamellar bodies which were concluded to help internalise the
gold nanoparticles in the cells (Figure 3.2).
Subsequent imaging studies were performed with the HeLa human cervical adeno-
carcinoma epithelial cell line. Confocal and brightfield images of HeLa cells incubated




Figure 2.38: Images of Au13-T20-HSH in HeLa cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-T20-HSH at a concentration of 0.25
nM in complete cell media for 24 hours before fixing. (a) HoechstSH and DRAQ5 overlay.
(b) Reflection and DRAQ5 overlay. (c) Transmission and DRAQ5 overlay. (d) “Orthogonal
View” of Reflection and DRAQ5 overlay. Reflection image λexc = 633 nm, λem = 623-643 nm.
HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red
channel), λexc = 633 nm, λem = 640-800. (Scale bar 20 µm).
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overlay of the red and blue luminescence image channels, corresponding to the DRAQ5
nuclear counterstain and the HoechstSH luminescence respectively. It is evident from
that these image slices that the most intense cyan emission is in the perinuclear region.
Figure 2.38b shows an overlay of the red channel and the reflectance channel, in which
gold nanoparticles appear as bright white spots due to their high elastic scattering cross-
section of the gold nanoparticles at 633 nm relative to biological tissue.263 This image
overlay indicates cellular uptake with localisations of the nanoparticles within the cell
periphery again localised mostly to the perinuclear region, corresponding to the areas of
cyan emission observed in Figure 2.38a.
Evidence of some nuclear uptake is also evident with nanoparticles localised within the
red area corresponding to the nucleus. Due to the nature of confocal microscopy, when
recording an image the focal plane is chosen such that the nucleus is at its largest, thus the
image slice is of a central plane in the cell and not above or below the cell. Nanoparticles
observed in the nucleus are thus in the same focal plane.
Using line-intensity profiles, where pixel intensity along a selected line of interest is
examined, it is possible to determine the size of a typical cluster and compare spatial
positions of the peak emissions from different image channels (Figure 2.40). Figure 2.40a
shows a magnification of a cell in the HoechstSH image in Figure 2.38, and Figure
2.40b the corresponding cell in the reflectance channel. In both images an identical line
of interest (yellow) is drawn for the intensity profile measurement shown in Figure 2.40c.
The intensity profiles obtained by measuring pixel intensity along the line of interest
for the HoechstSH image channel (blue-dashed line) and the reflectance (black-solid
line) exhibit peaks at approximately the same spatial localisation on the line of interest
with peaks at approximately 2860 nm and 2760 nm along the line. This suggests that
the HoechstSH is stable on the nanoparticle after a 24 hr period of exposure to a
cellular environment. The lack of an exact correlation between the peaks and indeed the
intensity of the peaks is likely due to the relatively diffuse nature of the HoechstSH




Figure 2.39: Images of Au13-T20-HSH in HeLa cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-T20-HSH at a concentration of 0.25
nM in complete cell media for 24 hours before fixing. (a) Regions of interest (ROIs) for spectral
scans. (b) Spectral scans from (ROIs). Reflection image λexc = 633 nm, λem = 623-643 nm.
HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red
channel), λexc = 633 nm, λem = 640-800. (Scale bar 20 µm).
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The size of the cluster of nanoparticles can also be estimated using the full-width at
half-maximum of the intensity profile from the reflectance channel, indicting a group of
nanoparticles comprising a cluster approximately 600 nm in diameter. This would indicate
the nanoparticles are subject to compartmentalisation once inside the cell where they are
translocated into late stage endosomes/lysosomes, as depicted in Figure 2.2d.
A further analysis performed on the cells in Figure 2.38 is imaging of multiple fo-
cal planes such that a three-dimensional image stack can be reconstructed. The nuclear
localisation is confirmed in Figure 2.38d which provides an orthogonal view of the three-
dimensional image stack. The central image square is a single image slice from the stack
as indicated by the yellow lines/cross-hairs in the coronal (YZ) and transverse (XZ) cross-
sections displayed to the right and below. The nanoparticle-nucleolus association is evi-
dent in the transverse view as indicated by the yellow arrow with nanoparticles localised
at discrete foci on the periphery of the nucleolus. This is quite significant as the nucle-
olus is a nuclear substructure responsible for assembling the cells ribosomal subunits for
protein synthesis in eukaryotic cells. It consist of chromosomes which contain the genes
for pre-ribosomal ribonucleic acid (rRNA) as well as proteins and RNAs that are not
related to ribosome assembly.265 Of particular relevance to the clusters of nanoparticles
in Figure 2.38d is the location of the centromeres which are located on the periphery of
the nucleolus.266,267 Centromeres consist of protein structures responsible for directing
the chromosomal DNA they are attached to during mitotic cell division. It is interest-
ing to note the apparent affinity of the nanoparticles to these areas of the nucleolus and
specifically the centromere/chromosomes. The presence of the surface bound Hoech-
stSH complex on the nanoparticles may indeed have a role to play in this occurrence due
to its DNA binding affinity.
Spectral emission scans of regions of interest (Figure 2.39a) can also be constructed
by plotting the intensity of the emission in those regions of interest as a function of
discrete wavelength gates. The ROIs chosen characterised the emission from the Hoech-




Figure 2.40: Images and line profiles of Au13-T20-HSH in HeLa cells monitored by confocal
luminescence and reflection microscopy. Cells were incubated with Au13-T20-HSH at a con-
centration of 0.25 nM in complete cell media for 24 hours before fixing. (a) HoechstSH and
(b) reflectance channel and line of interest (yellow) drawn for intensity profile measurement. (c)
Intensity profiles obtained by measuring pixel intensity along the line of interest for the Hoech-
stSH image channel (blue-dashed line) and the reflectance (black-solid line). Distance on x-axis
refers to distance along the yellow line of interest in (a) and (b). Reflection image λexc = 633
nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem =
410-550 nm.
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nanoparticles are observed and in the nucleus/nucleolus. The emission from these areas is
characteristic of the Hoechst with peak emission observed at approximately 490 nm. (Fig-
ure 2.39b) Upon binding to DNA the Hoechst dye exhibits a characteristic blueshift,241
and interestingly this is observed in the nucleolus which exhibits an emission maximum of
approximately 480 nm. This observation again suggests the surface-bound HoechstSH
dye is bound to DNA.
In conclusion the A549 and HeLa human adenocarcinomic cell lines were investigated
as subjects for uptake of Au13-T20-HSH. Both cell lines were observed to internalise the
nanoparticles and co-localisation of the peaks along line intensity profiles of HoechstSH
emission with the positions of nanoparticles demonstrate the stability of the dye on the
nanoparticle following exposure to a cellular environment. The majority of the nanoparti-
cles were found in the perinuclear region after 24 hours, indicative of an endocytotic uptake
mechanism which can lead to nanoparticle compartmentalisation in late-stage endosoma-
l/lysosomal structures in the perinuclear region.268,269 Line intensity profiles furthermore
indicate nanoparticle clusters several hundred nanometres in diameter, again indicative
of the endocytotic and subsequent endosomal/lysosomal processing mechanism. Spectral
emission scans compiled from confocal images obtained over a range of wavelengths also
confirm the cyan emission observed emanates from the HoechstSH.
Interestingly nuclear uptake of nanoparticles was observed and was confirmed using
three-dimensional image stacks and orthogonal views of the cells. The most striking fea-
tures were nanoparticles located on the periphery of the nucleolus. This is of great interest
considering the DNA binding ability of the HoechstSH complex on the nanoparticles.
There is thus great scope to further investigate the uptake and nuclear interactions of
these nanoparticles as imaging and indeed as potential therapeutic agents.
Confocal Microscopy of Au13-Z-HSH in Cells
Initial cell work was performed with the A549 human lung adenocarcinoma epithelial cell




Figure 2.41: Images of Au13-Z-HSH in HeLa cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration of 0.25 nM
in complete cell media for 24 hours before fixing. (a) HoechstSH and DRAQ5 overlay. (b)
Reflection and DRAQ5 overlay. (c) Transmission and HoechstSH overlay. (d) HoechstSH,
DRAQ5 overlay and reflection overlays (green false colour has been applied to reflection image).
Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel),
λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red channel), λexc = 633 nm, λem = 640-800.
(Scale bar 50 µm)
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Z-HSH in A549 cells following a 20 minute incubation are exhibited in (Figure G.3). The
dark spots evident in the transmission image are similar to observations of the Au13-T20-
HSH in A549 cells after a 20 minute exposure (Figure 2.37), with nanoparticles located
toward the periphery of the cells. The features are again very similar to observations of
lamellar bodies in a study on lipid-coated gold nanoparticle uptake in A549 cells by Wang
et al.264 The presence of these features in A549 cells exposed to the different preparations
of HoechstSH coated gold nanoparticles, namely Au13-T20-HSH and Au13-Z-HSH,
and indeed lipid coated gold nanoparticles in the study by Wang et al., suggest it is a
common mechanism of the A549 cell line for gold nanoparticles.
Subsequent imaging studies were performed with the HeLa human cervical adenocar-
cinoma epithelial cell line. (Further images are provided in Appendix G.3). Confocal and
brightfield images of HeLa cells incubated with Au13-Z-HSH for 24 hours are shown
in Figure 2.41. Figure 2.41a shows an overlay of the red and blue luminescence image
channels, corresponding to the DRAQ5 nuclear counterstain and the HoechstSH lumi-
nescence respectively. It is evident from that these image slices that the most intense
cyan emission is in the perinuclear region, exemplified by the cell in the extreme top-left
and the cell above the spherical cluster of cells in the centre of the image. Figure 2.41b
shows an overlay of the red and reflectance channels in which gold nanoparticles appear
as bright white spots. This image overlay again indicates cellular uptake with clusters of
nanoparticles within the cell periphery, localised mostly to the perinuclear region. Notably
the cells in Figure 2.41a which exhibited intense HoechstSH/cyan emission do not show
many white spots in the corresponding locations in Figure 2.41b. This can be explained
due to uneven illumination in the images, particularly in the reflection image in which a
lighter background is seen in the bottom half of the image. The visual correlation in these
images between the white spots of nanoparticles and the intense cyan emission observed
in the middle of the central spherical cluster of cells, and indeed in the cell above indicates





Figure 2.42: Images of Au13-Z-HSH in a multicellular spheroid of HeLa cells, monitored by
confocal luminescence and reflection microscopy. Cells were incubated with Au13-Z-HSH at a
concentration of 0.25 nM in complete cell media for 24 hours before fixing. (a) HoechstSH and
DRAQ5 overlay. (b) Reflection and DRAQ5 overlay. (c) Transmission and DRAQ5 overlay.
Reflection image λexc = 488 nm, λem = 478-498 nm. HoechstSH luminescence, (blue channel),
λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red channel), λexc = 633 nm, λem = 640-800.
(Scale bar 50 µm)
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The problem of uneven illumination can be an issue when recording a confocal image
but is not an issue on the brightfield transmission image in Figure 2.41d, which shows an
overlay of the brightfield image in which the nanoparticles appear as dark spots and the red
channel. In this image the perinuclear localisation of the majority of the nanoparticles is
clear in all cells. As in Figure 2.38 which presents Au13-T20-HSH in HeLa cells after 24
hours, the nanoparticles in the images are of aggregates or clusters, observed as such due
to the cells’ processing mechanism for spherical gold nanoparticles. Figure 2.41d shows an
overlay of the DRAQ5 red image, the cyan HoechstSH image and the reflection image
which has been given a green false colour for easier visualisation of the nanoparticles in
the presence of the cyan emission. It is again apparent from this image that perinuclear
localisation is dominant, however the cell on the extreme right shows some nuclear uptake
of the nanoparticles. Figure 2.38d showing uptake of the Au13-T20-HSH in HeLa cells
after 24 hours exhibits similar nuclear localisation, with nanoparticles located around the
periphery of the nucleolus.
Figure 2.42 shows magnified images of the most prominent feature in Figure 2.41,
the spherical cluster of cells known as a multicellular spheroid. Figure 2.42b exhibits the
overlay of the blue and red channel shows the intense cyan emission from the HoechstSH.
Figure 2.42c shows the overlay of the red channel with the reflection image which was
recorded with 488 nm (as opposed to 633 nm for the previous images). At this wavelength
it is possible to examine the cell membranes of the cluster of cells more clearly due to
the greater contrast they exhibit relative to the background, although The nanoparticles
scatter less at this wavelength than at 633 nm. The image overlay shows multiple clusters
of nanoparticles enclosed within a ring of cell nuclei.
The cluster of cells in the centre of the image spans 90 µm in diameter and as mentioned
is known as a multicellular spheroid. Multicellular spheroids are commonly used three-
dimensional cell culture systems for cancer research, possessing an advantage over two-
dimensional cultures due to their close resemblance of physiological tumour conditions




Figure 2.43: Images of Au13-Z-HSH in HeLa cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration of 0.25 nM
in complete cell media for 24 hours before fixing. (a) “Orthogonal View” of Reflection and
DRAQ5 overlay. (c) Regions of interest (ROI) for Spectral scans. (d) Spectral scans from
(ROI). Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue
channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red channel), λexc = 633 nm, λem =
640-800. (Scale bar 20 µm)
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spheroids, such as cell scaffolds or non-physiological matrix compounds.274 It is therefore
surprising that in this study no specific measures were taken to induce the growth of
the multicellular spheroid yet such a structure was still observed. The dense clusters of
nanoparticles in the centre spanning 20 µm in diameter is particularly striking and it would
be interesting to determine with the aid of further investigations whether longer incubation
times with the nanoparticles yield growth of more multicellular spheroids, if indeed they
are responsible for their production. It is difficult without continuous imaging of the cell
population to conclude whether the nanoparticles have caused growth of the spheroid, or
whether they were simply internalised by an existing spheroid. Although the multicellular
spheroid feature was observed only once in this microscopy sample which contains a
population of many hundreds of cells, the dense clustering of the nanoparticles within the
spheroid that closely mimics tumours in a physiological environment nevertheless holds
great theranostic potential for these nanoparticles.
Nuclear uptake was also observed in another sample of cells shown in Figure 2.43.
Examining an image slice from the three-dimensional stack in greater detail using an
orthogonal view, nuclear uptake is again obvious in both cells to the right and to the
bottom (Figure 2.43a). The yellow arrows in the image directed at transverse views of
the left cell show the location of the nanoparticles in the direct centre of the nucleus.
Performing a line intensity profile on several of these clusters indicate they range in
size from 400 - 800 nm and thus composed of several tens of nanoparticles suggesting
the nanoparticles have undergone extensive accumulation within the cell possibly in to
late stage endosomes/lysosomes. Surprisingly some particles have however still achieved
nuclear localisation.
Spectral emission scans of the same cell exhibiting nuclear uptake are shown in Figures
2.43b and 2.43c. The ROIs chosen for obtaining spectral scans characterise the emission
from the HoechstSH in the cells in the cytoplasm/perinuclear region, in the nucleus
and in the nucleolus. The emission from these areas is characteristic of the Hoechst dye
with peak emission observed at approximately 470 nm. It is notable that the emission
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spectrum from nanoparticles in the cytoplasm is notably broader that those in the nucleus.
This may due to a contribution to the emission spectrum from autofluorescence such as
mitochondria and lysosomes which are located in this cytoplasm and perinuclear region.275
Uptake of Au13-Z-HSH in a sample of the HeLa cells also afforded the opportunity
to study the dynamics of internalised nanoparticles during cell division (Figure 2.44).
Cell division was discussed in Section 2.1.4 and is an important factor in the uptake
of nanoparticles. A study by Kim et al. on the role of the cell cycle in nanoparticle
uptake and dilution concluded uptake of nanoparticles is affected by the cell cycle phase.
Furthermore nanoparticles internalized by cells are not exported from cells were found to
be split between daughter cells when the parent cell divides.276
Figures 2.44a-c show a widefield view of a selection of newly divided cells or cells just
prior to division. Magnifications of a pair of cells from this FOV that have just divided
are shown in Figures 2.44d-f. It is noticeable that the clusters of nanoparticles in these
cells are located at the terminus where the cells would have separated, suggesting that
the nanoparticles have been split between the two daughter cells. Figures 2.44g-i shows
a binuclear cell prior to separation and illustrates how the nanoparticles will be divided
into the daughter cells as they pull away from each other, thus confirming the conclusions
of Kim et al.276
Uptake of Au13-Z-HSH was also examined in live HeLa cells after a 24 hour incu-
bation allowing for the examination of cells in a natural physiological state. Widefield
confocal images are shown in Figure 2.45 and show nanoparticle uptake in all of the
cells (approximately twenty cells in the field-of-view). Magnifications of representative
cells from these images are shown in Figure 2.46. Figure 2.46a-c exhibits a pair of cells
which show significant uptake of Au13-Z-HSH. This is indicated in the HoechstSH and
DRAQ5 overlay by the bright cyan spots of luminescence within the red DRAQ stained
area which denotes the cell nucleus (Figure 2.46a). The DRAQ5 nuclear stain defines the
nuclear membrane very distinctly in live cells so it is clear that nearly all of the nanopar-





Figure 2.44: Images of Au13-Z-HSH in HeLa cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration of 0.25 nM
in complete cell media for 24 hours before fixing. (a-c) widefield view of cells: (a) HoechstSH
and DRAQ5 overlay. (b) Reflection and DRAQ5 overlay. (c) Transmission and DRAQ5 over-
lay. (d-f) magnifications of a newly divided cell: (d) HoechstSH and reflection overlay. (e)
Reflection and DRAQ5 overlay. (f) Transmission and DRAQ5 overlay. (g-i) magnifications
of a dividing cell: (g) HoechstSH and reflection overlay. (h) Reflection and DRAQ5 overlay.
(i) Transmission and DRAQ5 overlay. Reflection image λexc = 633 nm, λem = 623-643 nm.
HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red
channel), λexc = 633 nm, λem = 640-800. (Scale bar 50 µm)
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DRAQ5 overlay (Figure 2.46b). In this cell only a few clusters of nanoparticles are outside
the nucleus on the top-left edge of the cell. Another point of note is the constriction in
the nucleus observed on the left side. This “pinching” of the nucleus indicates the cell is
in the cytokinesis stage of cell division.229
Figure 2.46c-f shows another cell exhibiting nuclear uptake with clusters on nanopar-
ticles located on the periphery of the nucleolus, as indicated by the green arrows in Figure
2.46d and Figure 2.48. Performing line intensity profiles on these features indicate they
range in size from 400-600 nm in diameter, and are thus composed of several tens of
nanoparticles. A further interesting feature is the presence of nanoparticles in the direct
centre of the both the nucleoli in the nucleus, as indicated by the dashed-yellow arrows.
Performing line intensity profiles indicate they range in size from 400 to 500 nm for the
clusters designated “NP1” and “NP2” respectively (Figure 2.48), again indicating they
are composed of several tens of nanoparticles in close proximity. Figures 2.46e and 2.47
exhibit orthogonal views of the cells and also confirm this with white spots of nanoparti-
cles located in the central plane of the nucleus, as indicated by the yellow arrows and the
corresponding transverse views.
In conclusion the A549 and HeLa human adenocarcinomic cell lines were investigated
as for uptake of Au13-Z-HSH with uptake of observed in both cell lines. Nanoparticle
uptake in the A549 cell line induced the formation of lamellar bodies analogous to previous
observations of gold nanoparticle uptake in the A549 cell line.264 In the HeLa cell line
after 24 hour exposure Au13-Z-HSH were observed primarily in the perinuclear region.
Perinuclear localisation of Au13-T20-HSH was also observed suggesting the endocytotic
uptake and processing mechanism is generally preferred for gold nanoparticles in the HeLa
cell line. In confocal observations one of the most striking features was a multicellular
spheroid, a spherical mass of cells with a dense cluster of nanoparticles within its centre.
It is unclear however whether the nanoparticles induced the formation of this feature or
were internalised within an already existing spheroid. The presence of such a large cluster




Figure 2.45: Images of Au13-Z-HSH in live HeLa cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration of 0.25 nm
in complete cell media for 24 hours before (live) imaging. (a) HoechstSH and DRAQ5 overlay.
(b) Reflection and DRAQ5 overlay. (c) Transmission and DRAQ5 overlay. (d) HoechstSH
image. Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue
channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red channel), λexc = 633 nm, λem =
640-800. (Scale bar 50 µm)
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(a) Cell 1 (b) Cell 1 (c) Cell 2
(d) Cell 2 (e) Orthogonal View of Cell 1
Figure 2.46: Images of Au13-Z-HSH in live HeLa cells monitored by confocal luminescence
and reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration of 0.25
nM in complete cell media for 24 hours before (live) imaging. (a, b) image overlays of cell
1: (a) HoechstSH and DRAQ5 overlay. (b) Reflection and DRAQ5 overlay. (c, d) image
overlays of cell 2: (c) HoechstSH and DRAQ5 overlay. (d) Reflection and DRAQ5 overlay.
(e) Orthogonal view of cell 1. Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH
luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red channel), λexc
= 633 nm, λem = 640-800. (Scale bar 50 µm)
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(a) Orthogonal View of Cell 2 (b) Orthogonal View of Cell 2
Figure 2.47: Images of Au13-Z-HSH in live HeLa cells monitored by confocal luminescence
and reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration of 0.25
nM in complete cell media for 24 hours before (live) imaging. (a) and (d) Orthogonal views of
cell 2. Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue
channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red channel), λexc = 633 nm, λem =
640-800. (Scale bar 50 µm)
interactions of multicellular spheroids and nanoparticles are studied in greater detail.
Similarly to HeLa cells exposed to Au13-T20-HSH nuclear uptake of Au13-Z-HSH
was also observed in single confocal image slices and confirmed in three-dimensional image
stacks and orthogonal image views. Spectral emission measurements of HoechstSH from
areas corresponding to nanoparticle localisation yield the characteristic Hoechst emission
peak at 480 nm. Line intensity profiles of nuclear localised nanoparticles indicate they are
clusters composed of several tens of nanoparticles in close proximity, again indicative of
compartmentalisation which is a signature of the endocytotic internalisation mechanism.
Images of dividing cells also indicate how internalised nanoparticles are divided in to
daughter cells, supporting conclusions made by Kim et al.276
Uptake of Au13-Z-HSH was also observed in live cells. The three-dimensional aspect
of cellular imaging with live cells afforded clear evidence of nuclear uptake with well
defined nuclear boundaries and centralised nanoparticle localisation within. This is of
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(a) (b)
Figure 2.48: Image of Au13-Z-HSH in HeLa cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration of 0.25nM
in complete cell media for 24 hr before imaging. (a) reflection and DRAQ5 overlay. (b) Line
intensity profile measurements performed on the nanoparticle clusters designated NP1 and NP2.
Size was estimated by measuring the full-width at half-maximum of the intensity profiles. Re-
flection image λexc = 633 nm, λem = 623-643 nm. DRAQ5, (red channel), λexc = 633 nm, λem
= 640-800. (Scale bar 10 µm)
.
great interest considering the DNA binding ability of the HoechstSH complex and offers
further impetus to investigate the uptake and nuclear interactions of these nanoparticles.
The nanoparticles exhibit use as imaging and indeed as potential therapeutic agents in
light of these observations.
Preliminary Study: Confocal Microscopy of Au13-Z-HSH in Cells with Lyso-
tracker
As depicted schematically in Figure 2.2, nanoparticles can be internalised by cells in to
endosomes that ultimately fuse with late-stage acidic lysomosomes as the cell attempts
to degrade the cargo with lysosomal enzymes.277 To explore this possibility for uptake of
Au13-Z-HSH lysotracker (a red fluorescent dye) was used to stain lysosomes in HeLa
cells following 24 hour incubation with the nanoparticles. HeLa cells were subsequently
fixed and examined by confocal microscopy.




Figure 2.49: Images of Au13-Z-HSH in HeLa cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration of 0.25 nM
in complete cell media for 24 hours, incubated with Lysotracker for 30 minutes (1 µM concen-
tration) and then fixed. (a) HoechstSH, lysotracker and reflection (green false colour) image
channel overlay. Magnification of yellow inset box: (b) transmission and HoechstSH image
channel overlay, (c) reflection (green false colour) and lysotracker overlay. (d) Line intensity
profile taken in reflectance (green (false colour) channel) and lysotracker (red channel) taken at
the yellow-dashed arrow. Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH
luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm, lysotracker, (red channel),
λexc = 633 nm, λem = 640-800. (Scale bar (a) 50 µm, (b,c) 10 µm)
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HSH for 24 hours and co-stained with Lysotracker. An overlay of the transmission
and HoechstSH image channels of the area enclosed by the yellow inset box is shown
in Figure 2.49b and exhibits dark spots of nanoparticles in the cytoplasm and in the
nucleus. By performing an intensity based image segmentation on the HoechstSH image
it possible to derive an outline of the nucleus of the cell. An overlay of the nuclear
outline, the lysotracker (red) channel and the reflectance (green false colour) channel is
shown in Figure 2.49c. The yellow arrows in this magnification indicate nuclear localised
nanoparticles co-localised with diffuse red emission. Due to the diffuse nature of the
emission it is however difficult to categorically state the nanoparticles are in lysosomes.
The cluster of nanoparticles indicated by the yellow dashed arrow is on the periphery
of the nucleus indeed on the nuclear membrane itself. The cluster of nanoparticles is co-
localised with discrete spot of red emission, as indicated by line intensity profiles taken in
the lysotracker (red) and reflectance (green) channels which show peaks in the intensity at
the same location (Figure 2.49d). The full-width at half-maximum of the peak indicates
the nanoparticles are indeed in a cluster of several tens of nanoparticles. It is interesting to
observe such a large cluster of nanoparticles virtually on the nuclear membrane in addition
to nanoparticles in the nucleus. Both clusters of nanoparticles were localised to areas of red
emission suggestive of endosomal/lysosomal compartmentalisation, potentially indicating
a trafficking mechanism of these organelles into the nucleus.
Confocal Microscopy of Au100-Z-HSH in HeLa Cells
Uptake of Au100-Zonyl-HSH is investigated in HeLa cells where 100 nm gold nanopar-
ticles are large enough to be imaged as single nanoparticles as opposed to the 13 nm gold
nanoparticles which are only visible in clusters consisting of several tens of nanoparti-
cles.77 Images of HeLa cells incubated with Au100-Z-HSH nanoparticles for 90 minutes
are shown in Figure G.5 (Appendix G.3.3), representative magnified images are shown
in Figure 2.50. After 90 minutes significant nanoparticle uptake has occurred in all cells
(Figure 2.50a). Nanoparticles are dispersed throughout the whole cell (Figure 2.50b) and
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(a) (b)
Figure 2.50: Images of Au100-Z-HSH nanoparticles in HeLa cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au100-Z-HSH at a concentration
of 0.10 pM in complete cell media for 90 min before fixing. (a) widefield reflection and DRAQ5
overlay. (b) magnified inset of reflection and DRAQ5 overlay. Reflection image λexc = 633 nm,
λem = 623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550
nm, DRAQ5, (red channel), λexc = 633 nm, λem = 640-800. (Scale bar (a) 50 µm) (b) 10 µm
are not specifically localised to the perinuclear region. Figure G.6 (Appendix G.3.3) shows
a further set of images of a cell in the metaphase stage of cell division, exhibiting another
example of cytoplasmic nanoparticle localisation.278
To establish whether the Au100-Z-HSH were eventually transferred in to the perin-
uclear region HeLa cells were incubated with Au100-Z-HSH nanoparticles for 24 hours.
Images are shown in (Appendix G.3.3), images of representative cells are shown in Figure
2.51. DRAQ5 overlays with the reflectance and brightfield images are shown in Figures
2.51b and 2.51c and constitute magnifications of the yellow-boxed region in Figure 2.51a.
The amount of cellular uptake of the nanoparticles is quite striking and indeed all of the
cells in the field-of-view show evidence of nuclear uptake indicated by the white and dark
spots in the nuclei stained red with the DRAQ5 stain. To confirm these nanoparticles
were in the same plane as the nucleus three-dimensional z-stacks were again recorded.
Examining orthogonal views of each of the cells it is apparent that the nanoparticles are


































































































































































































































































































































































































To further evaluate the cytoplasmic and nuclear uptake another cell was imaged and
was subject to the segmentation protocol (ImageJ). Image segmentation uses the principle
of creating boundaries in an image based on differences in pixel intensity, thus the cell
membrane and nuclear boundary were extracted using blue and red channel images as
shown in Figure 2.52. The boundary extraction protocol was applied to the cell shown in
Figure 2.53. Nanoparticle uptake is obvious in the image overlays but the extent to which
nuclear localisation is clear in Figure 2.53d, most strikingly with a dense area in the centre
of the nucleus. By taking a ratio of the total pixel intensity of the area enclosed within the
magenta boundary and comparing it to the total pixel intensity from the area bounded by
the green and magenta boundaries, it is possible to obtain a crude comparison between
the relative amount of nanoparticles in the nucleus and the cell cytoplasm respectively.
The results of this calculation indicate that 80 % of the nanoparticles in this image slice
of the cell are in the within the nuclear boundary.
Line intensity profiles enable nanoparticle size to be estimated. Line intensities were
measured on the two of the smallest white spots and two of the larger spots to ascertain a
crude measure of the size range of the nanoparticle clusters (Appendix G). Single nanopar-
ticles can be modelled computationally and are determined to appear as spots 300 nm in
diameter, as described in Section 3.3.2.77 The measurements performed indicate that the
smaller spots measure are single nanoparticles and the larger spots clusters of two to three
nanoparticles in close proximity to each other. It is perhaps surprising to see such signif-
icant nanoparticle uptake in to the nucleus considering the size of nanoparticles. Nuclear
pore complexes traditionally govern the transfer of a variety of biomolecules between the
cytoplasm and the nucleus. Nuclear pores typically allow passage of cargo the order of a
few tens of nanometres in diameter,279 this would therefore suggest an alternative mode
of nuclear translocation of Au100-Z-HSH in to the cells.
In conclusion uptake of Au100-Z-HSH was readily observed with significant uptake
after a 90 minute exposure with nanoparticles observed dispersed throughout the cells.
After a 24 hour exposure nuclear uptake had also occurred. It is difficult to compare the
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Figure 2.52: Segmentation protocol to extract Cell (a-d) and nuclear boundary (e-h) in HeLa
cell. Cell boundary is extracted using the raw blue channel image (a) which is saturated by
brightening the pixels (b). The image in then binarised by choosing an appropriate pixel intensity
threshold and using the erode and fill functions (c). Boundaries are drawn (green) around the
binarised region using the Find Edges function (d). Nuclear boundary is extracted using the red
channel (e). The nucleus is manually cropped from the image (f) and saturated in terms of pixel
intensity/brightness (g). Boundaries are drawn (magenta) around the binarised region using the
Find Edges function (h).
extent of nuclear uptake of the Au100-Z-HSH with the Au13-Z-HSH as the 13 nm
nanoparticles are beyond the resolution limit until they form clusters composed of several
tens of nanoparticles. Line intensity profiles of Au100-Z-HSH within the nucleus indi-
cate they are composed of small clusters of two to three nanoparticles in close proximity.
Taking in to account the size of the nuclear pores, (Pante et al. state that the nuclear pore
complex is able to transport macromolecules no greater than 39 nm in size165), also sug-
gests an alternative mechanism of internalisation rather than transit through the nuclear
pores.
Transmission Electron Microscopy of Au13-Z-HSH in Cells
Transmission electron microscopy (TEM) was performed on HeLa cells incubated with
the HoechstSH functionalised nanoparticles. In TEM a beam of electrons is passed




Figure 2.53: Images of Au100-Z-HSH nanoparticles in HeLa cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au100-Z-HSH at a concentration
of 0.10 pM in complete cell media for 24 hours before fixing. (a) HoechstSH and reflection im-
age overlay. (b) reflection image and DRAQ5 overlay. (c) transmission brightfield and DRAQ5
overlay magnification. (d) cell and nuclear boundaries superimposed on reflection image. Re-
flection image λexc = 633 nm, λem = 623-643 nm. DRAQ5, (red channel), λexc = 633 nm, λem
= 640-800. (Scale bar 10 µm
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Figure 2.54: TEM images of Au13-Z-HSH in HeLa cells. Cells were incubated with Au13-Z-
HSH at a concentration of 0.25 nM in complete cell media for 2 hours before fixing. Widefield
image is shown in (a). Magnifications of insets (b - e) are in shown in (b∗ - (e∗)) respectively.
Line profiles of nanoparticles in (c∗) are exhibited in (f∗) and (f∗∗) C.M - cell membrane, N.M
- nuclear membrane, N - nucleus, N∗ - nucleolus, V - vesicle, NP - nanoparticles.
resolution the high contrast provided by electron dense materials such as gold allows for
single nanoparticle imaging in the intracellular environment. Cells were incubated with
nanoparticles at the same concentration and conditions as for confocal imaging studies
and all TEM samples were left unstained. Although this reduces contrast of cellular
organelles artefacts from the staining process are avoided.
Figure 2.54 shows HeLa cells incubated with Au13-Z-HSH for 2 hours with Figure
2.54a exhibiting a widefield view in which gold nanoparticles are observed as dark spheres
due to their high electron density. Figure 2.54b shows a magnification of the intracellular
area, depicted by the inset box (b). The magnification shows the nuclear membrane,
cytoplasm and nucleus can be observed. It is interesting to note that a cluster of electron
dense particles are seen within the nuclear membrane (Figure 2.54c∗). Line intensity
profiles indicate the cluster is approximately 13 - 15 nm in diameter (Figure 2.55f∗),
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Figure 2.55: TEM images of Au13-Z-HSH in HeLa cells. Cells were incubated with Au13-Z-
HSH at a concentration of 0.25 nM in complete cell media for 2 hours before fixing. Widefield
images are shown in top panel. Magnifications of insets (a), (b) and (c) are shown in (a∗),
(b∗) and (c∗) respectively. C.M - cell membrane, N.M - nuclear membrane, N - nucleus, N∗ -
nucleolus, V - vesicle, S.V - secretory vesicles.
corresponding well to the size of the Au13-Z-HSH.
Further magnifications are shown in Figure 2.54d∗ and 2.54e∗. Nanoparticles in these
images are observed in membrane bound vesicles approximately 200 nm in diameter with
vesicles in the respective images both containing eight nanoparticles. Referring to the
uptake mechanisms and vesicle designations described in Figure 2.2, these vesicles are
Type 2 in nature and are likely to be trafficking vesicles in the early stages of endocytosis.
Figure 2.55 shows further HeLa cells incubated with Au13-Z-HSH for 2 hours. Fig-
ures 2.55a-c show widefield views of the cells and Figures 2.55a∗-c∗ magnifications of the
respective insets. Nanoparticles in Figures 2.55a∗ and b∗ are again observed in membrane
bound vesicles approximately 200 - 300 nm in diameter. The vesicle in Figure 2.55a∗,b∗
contains three nanoparticles. The vesicles in Figure 2.55b∗ are in close proximity and
without well defined membranes may be in the process of merging together.
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Notably in Figure 2.55c nanoparticles appear to be in extracellular vesicles. Denoted
as secretory vesicles (S.V) these may be vesicles that have been ejected by cells as depicted
schematically in Figure 2.2. It is interesting to note that nanoparticles are seen on the
cell membrane in Figure 2.55c. The single nanoparticle magnified in Figure 2.55c∗ in
particular is not in an obviously apparent vesicle and as such may be entering the cell
by passive diffusion through the cell membrane. Alternatively an extracellular vesicle
containing the nanoparticle have just been re-internalised by the cell with the membrane
of the vesicle breaking down in the process. Re-uptake of exocytosed nanoparticles as
demonstrated in a study by Bartczak et al. in which re-uptake of extracellular vesicles
containing 15 nm peptide coated gold nanoparticles was observed after four hours in
HUVEC cells (human umbilical vein endothelial cells).
TEM images of HeLa cells incubated with Au13-Z-HSH for 24 hours are exhibited
in Figures 2.56-2.58. Examining the first set of images in Figure 2.56 the most prominent
feature in the widefield view of a cell (Figure 2.56a) is the presence of several densely
packed vesicles containing nanoparticles. The first of these, magnified in Figure 2.56b∗
contains approximately forty clearly defined nanoparticles with several more appearing
as dense indistinguishable flocculations, confirming the endocytotic pathway of uptake
as the primary means of nanoparticle internalisation. Quite striking with regards to its
extremely dense nanoparticle uptake is the organelle in Figure 2.56c∗, a multi-vesicular
body containing many lamellar folds. A similar feature was observed by Nativo et al. in
HeLa cells and was also observed to contain internalised nanoparticles.119 Referring to
the schematic shown in Figure 2.2, this structure can be designated as a Type 6 multi-
laminar vesicle (multivesicular body - M.L.V), defined as comprising the latter stage of the
endocytotic mechanism of uptake and serving as precursors for lysosomal degradation.280
Another possibility is that the structure is part of the endoplasmic reticulum or Golgi
network of the cell. Several studies have stated that the payloads contained in endocytotic
vesicles can be delivered to the endoplasmic reticulum or Golgi network in cells.281–283
Indeed the study by Dragoni et al. shows gold nanoparticle uptake in a similar structure
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Figure 2.56: TEM images of Au13-Z-HSH in HeLa cells. Cells were incubated with Au13-Z-
HSH at a concentration of 0.25 nM in complete cell media for 24 hours before fixing. Widefield
image is shown in (a). Magnifications of insets (b), (c) and (d) are in shown in (b∗), (c∗)
and (d∗) respectively. C.M - cell membrane, V - vesicles, M.L.V - multi-laminar vesicle, NP -
nanoparticles.
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Figure 2.57: TEM images of Au13-Z-HSH in HeLa cells. Cells were incubated with Au13-
Z-HSH at a concentration of 0.25 nM in complete cell media for 24 hours before fixing. Mag-
nifications of insets (a) and (b) are in shown in (a∗) and (b∗) respectively. Line profile of
nanoparticle cluster denoted by (c) are exhibited in (c∗). Size is approximated by the full-width
at half-maximum. C.M - cell membrane, V - vesicle, M - mitochondrion, NP - nanoparticles.
in rat liver cells which is denoted as the Golgi complex.283 A study on the exocytosis of
nanoparticles by cells by Sakhtianchi et al.284 also stated that on the pathway to late-stage
vesicles/endosomes, such as that observed in the left of Figure 2.56b∗, nanoparticles may
escape vesicular restriction and enter the cytoplasm. This is interesting with respect to
the nanoparticles denoted by the red arrows in Figure 2.56c∗ and black arrows in Figure
2.56d∗ as these nanoparticles although in close proximity to the folds are not in well-
defined membrane bound vesicles. In the same study by Sakhtianchi et al it was also
stated that nanoparticles located in the cytoplasm or confined in vesicles can enter the
nucleus, mitochondria, endoplasmic reticulum, and Golgi apparatus by hitherto unknown
mechanisms.284
Figure 2.57 shows a further set of images of HeLa cells following a 24 hour incubation
with Au13-Z-HSH. Notable features in the magnified images (Figures 2.57a∗,a∗∗) is
possible interaction of a cluster of nanoparticles with a mitochondrion. Figures 2.57b∗,
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b∗∗ also illustrate the efficiency of cells to process nanoparticles with an extremely densely
populated vesicle measuring approximately 300 nm in diameter observed (Figure 2.57c∗).
Further images exhibiting a HeLa cell following 24 hour exposure to Au13-Z-HSH are
shown in Figure 2.58 and significantly show nuclear uptake of nanoparticles, confirming
confocal imaging observations. A section of the widefield image of the cell is shown in
Figure 2.58a where nuclear uptake is seen in the bottom of the image. Outlined in red
is the nuclear membrane including a dashed section where it is not well defined and
invaginated inwards. Examining the magnified inset (b) in Figure 2.58b*, the extent of
nuclear uptake is apparent with nanoparticles observed dispersed in an area spanning over
3 µm in length. Interestingly when examined at a higher magnification (Figure 2.58c∗) the
nanoparticles are localised on the periphery of an area of condensed chromatin, possibly
the nucleolus, as outlined in blue.285 This supports the observations made with confocal
microscopy images of the nanoparticles in cells where they were also observed on the
periphery of the nucleolus (Figure 2.46).
The section of undefined nuclear membrane is shown in Figure 2.58d∗ and 2.58d∗∗ with
and without outlines depicting the nuclear membrane (red) and a vesicle (green) near to
where the nuclear membrane breaks (red dashed line). The vesicle also possesses an
internal vesicle (I.V) suggesting it is multi-vesicular and has it’s origin in the latter stages
of endocytosis in the lysosomal degradation pathway as previously discussed. Such vesicles
are known to contain nanoparticles so it is possible that the nanoparticles observed in the
nucleus may have achieved nuclear translocation via a similar vesicle based mechanism.
Eukaryotic cells predominantly undergo open mitotic cell division which is characterised
by the breakdown of the nuclear envelope prior to daughter chromosomes migrating apart,
with new nuclei assembling around them.286 Although unreported in the literature it is
possible that vesicles containing nanoparticles which are observed in close proximity to
the nucleus or indeed free nanoparticles in the cytoplasm, are enclosed by the reforming
nuclear membrane in the latter stages of cell division. Without an imaging study over
the whole cell division cycle, it is however difficult to resolutely conclude this as the
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Figure 2.58: TEM images of Au13-Z-HSH in HeLa cells. Cells were incubated with Au13-Z-
HSH at a concentration of 0.25 nM in complete cell media for 24 hours before fixing. Widefield
image is shown in (a). Magnifications of insets (a), (b) and (c) are in shown in (a∗), (b∗)
and (c∗) respectively. Magnifications of inset (c) are shown in (c∗) and (c∗) with and without
annotations. N.M - nuclear membrane (red), N∗ - nucleolus (boundary defined in blue) V -
vesicle (boundary defined in green), I.V (internal vesicle).
mechanism of nuclear uptake.
In conclusion the TEM images yield similar observations to those afforded by confocal
imaging of Au13-Z-HSH. Some nanoparticles are observed in clusters compartmen-
talised in late stage endosomes/lysosomes in the perinuclear region with nuclear uptake
is also observed. The high resolution afforded by TEM allows individual nanoparticles
to be imaged and the extent to which they are observed as large clusters illustrates how
effective the cellular machinery is in processing internalised nanoparticles.
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2.3.7 Cellular Uptake of Au13-P-HSH and Au100-P-HSH
Confocal Microscopy of Au13-P-HSH in A459 Cells
Confocal and brightfield images of A459 cells incubated with Au13-P-HSH are shown
in Figure 2.59. Figures 2.59a-b show overlays of the transmission brightfield image and
the reflection image with the DRAQ5 red channel image respectively. In these widefield
views the nanoparticles are visible as dark spots in the transmission image and white
spots in the reflection image with uptake clearly observed in all cells. Notably the cells
were incubated in complete media at neutral pH. This suggests that the majority of the
nanoparticles have achieved uptake through endocytosis and not via the pHLIP peptide’s
pH dependence mechanism which would potentially insert the nanoparticles through the
membrane at acidic pH as discussed in Section 1.2.
Magnifications of the representative cell indicated by the yellow-dashed inset are shown
in Figure 2.59c-e. These images exhibit the HoechstSH and reflection (green false colour)
image overlay, the transmission brightfield and DRAQ5 overlay and the reflection and
DRAQ5 overlay respectively. The green spots in Figure 2.59c correspond to the loca-
tions of the nanoparticles with the reflection image given a green false colour to provide
clarity with the cyan HoechstSH image overlay. The locations of the nanoparticles are
co-localised with spots of cyan emission from the HoechstSH as indicated by the overlay
of the intensity profile peaks measured in the reflection and HoechstSH images (Figure
2.60a). This confirms the stability of the HoechstSH complex on this pHLIP peptide
mediated preparation of nanoparticles after 24 hour exposure to a cellular environment.
Performing further intensity profile measurements on several of the white spots in the
reflectance image (Figure 2.60) indicates they are composed of nanoparticle clusters ap-
proximately 400 nm in size. The largest feature measured is 700 nm in diameter indicating
significant compartmentalising of the nanoparticles in the cell. Smaller clusters or indeed
single nanoparticles may also be present but not exhibit a high enough (scattering/lumi-




Figure 2.59: Images of Au13-P-HSH in A549 cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-P-HSH at a concentration of 0.25 nM
in complete cell media for 24 hours before fixing. (a) Widefield transmission brightfield and
DRAQ5 overlay. (b) Widefield reflection and DRAQ5 overlay. (c-e) Magnifications of yellow-
dashed inset. (c) reflection (green false colour has been applied) and HoeschstSH overlay. (d)
Widefield transmission brightfield. (e) Reflection and DRAQ5 overlay. Reflection image λexc =
633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem =




Figure 2.60: Image of Au13-P-HSH in an A549 cell monitored by confocal luminescence and
reflection microscopy. Cells were incubated with Au13-P-HSH at a concentration of 0.25 nM
in complete cell media for 24 hours before fixing. (a) reflection (green false colour has been
applied) and HoeschstSH overlay. (b) Line intensity profile of a nanoparticle compared in the
HoechstSH (blue solid line) and reflectance (black dashed line) images. (c) Line intensity
profiles of nanoparticles in the red-dashed inset in the reflectance (black dashed line) image.
Sizes are approximated as the full-width at half-maximum of the intensity profiles. Reflection
image λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel), λexc =
405 nm, λem = 410-550 nm.
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for them to be visible. Further images are provided in Appendix G.4.1.
Four further orthogonal are presented in Figure 2.61 which exhibits Au13-P-HSH in
fixed A549 cells after 24 hours. The orthogonal views are centred on two groups of cells in
the field-of-view with the HoechstSH blue channel and DRAQ5 red channel overlaid with
the reflectance channel. The cells in these images have been image prior to cell division
as several nuclei are grouped very closely in the top cluster of cells, and are presumably
in the process of pulling away from each other. The single cell below is slightly earlier
in the cell division cycle, with the nuclear chromatin condensing ready for duplication.
Although these are fixed cell samples the transverse views in all the orthogonal views are
not “squashed” as can be the case with fixed cell samples. As such the localisation of
the particles is much clearer in the side-views with nanoparticles (white spots) distinctly
evident in the central plane in the nucleus. This is most apparent in the single cell lower
down in the field-of-view and the corresponding orthogonal views in Figure 2.61c and
2.61d. It is interesting to note that nuclear uptake of nanoparticles in these cells coincides
with cell division, providing impetus to study this potential relationship further.
Confocal Microscopy of Au13-P-HSH in HeLa Cells
Confocal luminescence and reflection microscopy images of Au13-P-HSH in HeLa cells
following a 30 minute incubation are shown in Appendix G (Figure G.10). It is difficult
to confirm localisation of the Au13-P-HSH in the reflection image due to extensive
scattering from the cellular material. Spots of cyan emission in the HoechstSH image
channel do suggest nanoparticle uptake, however with the absence of corresponding spots
in the reflectance and indeed white light transmission image channels this cannot be
confirmed.
Confocal and brightfield images of HeLa cells incubated with Au13-P-HSH for 24
hours are shown in Figure 2.62. Figures 2.62a and 2.62b show overlays of the reflec-
tion image and the transmission brightfield image with the DRAQ5 red channel image




Figure 2.61: Orthogonal view images of Au13-P-HSH nanoparticles in A549 cells monitored
by confocal luminescence and reflection microscopy. Cells were incubated with Au13-P-HSH
at a concentration of 0.25 nm in complete cell media for 24 hours before fixing. (a, c) reflection
and HoeschstSH overlay. (b, d) reflection and DRAQ5 overlay. Reflection image λexc = 633
nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem =




Figure 2.62: Images of Au13-P-HSH nanoparticles in HeLa cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au13-P-HSH at a concentration
of 0.25 nM in complete cell media for 24 hours before fixing. (a) Widefield reflection and DRAQ5
overlay. (b) Widefield transmission brightfield and DRAQ5 overlay. Reflection image λexc =
633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem =





Figure 2.63: Images of Au13-P-HSH nanoparticles in HeLa cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au13-P-HSH at a concentration
of 0.25 nM in complete cell media for 24 hours before fixing. (a-c) Magnifications of yellow-
dashed inset (Figure 2.62). (a) Reflection and DRAQ5 overlay. (d) Transmission brightfield
and DRAQ5 overlay. (b) Orthogonal view of the reflection and DRAQ5 image stack overlay.
(c) HoechstSH image indicating ROIs for spectral scans. (d) Spectral emission scans taken
from ROIs. Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence,
(blue channel), λexc = 405 nm, λem = 410-550 nm. DRAQ5, (red channel), λexc = 633 nm,




Figure 2.64: Images of Au13-P-HSH nanoparticles in HeLa cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au13-P-HSH at a concentration
of 0.25 nm in complete cell media for 24 hours before fixing. (a) HoechstSH and reflection
image overlay. (b) DRAQ5 and reflection image overlay. (c, d) Orthogonal views of the reflec-
tion and DRAQ5 image stack overlay. Reflection image λexc = 633 nm, λem = 623-643 nm.
HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm. DRAQ5, (red
channel), λexc = 633 nm, λem = 640-800. (Scale bar (a, b) 10 µm)
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Nanoparticles have most likely accumulated or compartmentalised within the cells such
that they are now resolvable compared to the shorter 30 minute exposure. With the
limited resolution of confocal microscopy it is of course possible that nanoparticles were
internalised after 30 minutes exposure but were not in large enough accumulations to
exhibit a detectable scattering or luminescent signal. Cells were furthermore incubated
in complete media at neutral pH suggesting that the majority of the nanoparticles have
most likely been internalised by endocytosis and not via the pHLIP peptide’s pH depen-
dence mechanism. Further studies measuring the scatter due to nanoparticle uptake from
the cells via flow cytometry could be performed in future to quantitatively assess the pH
dependance of uptake of Au13-P-HSH.
Magnifications of the representative cell indicated by the yellow-dashed inset are shown
in Figure 2.63. The prominent feature of the cell shown in these magnifications is the
localisation of the nanoparticles throughout the cell cytoplasm. The uptake in the A549
cells (Figure 2.59) and indeed the majority of the HeLa cells in the widefield view show
dense nanoparticle localisation in the perinuclear region. The cell exhibited in Figure
2.63c-g is relatively squamous compared to the other cells in the widefield view indicating
it may be ready to divide having duplicated many organelles and increased in size.
The reflection/transmission and DRAQ5 overlays also show evidence of nuclear uptake
very similar to that observed in Figure 2.38d and Figure 2.46d which exhibit Au13-
T20-HSH and Au13-Z-HSH uptake in HeLa cells after 24 hours. As in these images
Au13-P-HSH are also observed in clusters around the periphery of the nucleolus (Figure
2.63b) indicating that the nuclear uptake of the nanoparticles may also be independent
of the pHLIP and surfactant coating. Spectral scans of the nuclear region exhibit the
characteristic Hoechst emission with a peak at 485 nm (Figure 2.63d). Further confocal
images are exhibited in Figure 2.64.
Two further orthogonal are presented in Figure 2.64 which exhibits Au13-P-HSH in
fixed HeLa cells after 24 hours. The orthogonal views are centred on two groups of cells
in the field-of-view with the HoechstSH blue channel and DRAQ5 red channel overlaid
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with the reflectance channel. The bottom pair of cells in this set of images is clearly in
the latter stages of cell division as both cells can be seen pulling away from each other
but still joined by a region of constricted cytoplasm. Again although these are fixed cell
samples the transverse views in all the orthogonal views are not “squashed” as can be
the case with fixed cell samples. As such the localisation of the particles is much distinct
in the side-views, this is most clear in Figure 2.64c where nanoparticles (white spots) are
located throughout the central plane in the nucleus. As with the A549 cells incubated
with Au13-P-HSH, it is interesting to note that nuclear uptake of nanoparticles in these
cells coincides with cell division, providing impetus to study this potential relationship
further.
Confocal Microscopy of Au100-P-HSH in HeLa Cells
Uptake of Au100-P-HSH was investigated in HeLa cells. Images and magnifications
of yellow-dashed insets showing HeLa cells incubated with Au100-P-HSH for 2 hours
are exhibited in Figure 2.65. The widefield images show two clusters of cells in which all
cells show nanoparticle uptake. The HoechstSH and reflectance image overlay indicate
that uptake mostly perinuclear (Figure 2.65a). Magnifications of the uppermost cluster
of cells confirm this (Figure 2.65c-d) with large clusters of nanoparticles observed on the
nuclear periphery in the cells. Line intensity profile measurements performed on a cluster
of nanoparticles towards the cell periphery in this cell are shown in Figure 2.66b.
Single 100 nm nanoparticles can be modelled computationally and are determined to
appear as spots 300 nm in diameter due to diffraction effects,77 the peak widths measured
therefore indicate the clusters spanning 500 - 600 nm in width are likely comprised of
pairs of nanoparticles. It is interesting to note that the HoechstSH image measurement
yields two clearly defined peaks, indicating a spatial separation of over 1500 nm between
the two clusters however in the reflection image the two peaks merge. This is due to
diffraction effects, specifically the wavelength dependence, due to excitation at 405 nm




Figure 2.65: Images of Au100-P-HSH nanoparticles in HeLa cells monitored by confocal lu-
minescence and reflection microscopy. Cells were incubated with Au100-P-HSH at a concen-
tration of 0.10 pM in complete cell media for 2 hours before fixing. (a,b) widefield views: (a)
reflection and HoechstSH overlay. (b) transmission and DRAQ5 overlay. (c,d) magnifications
of yellow-dashed inset: (c) HoechstSH and DRAQ5 overlay. (d) transmission and DRAQ5
overlay. (e) orthogonal view of three-dimensional z-stack of DRAQ5 and reflection overlays. (f)
line intensity profile measurements performed on the nanoparticles shown in the image insets
(HoechstSH image - blue-dashed line, reflection image - black-solid line). Sizing is estimated
using the full-width at half-maximum. Reflection image λexc = 633 nm, λem = 623-643 nm.
HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red
channel), λexc = 633 nm, λem = 640-800. (Scale bar: (a,b) 50 µm, (c, d) 10 µm).
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(a) (b)
Figure 2.66: Images of Au100-P-HSH nanoparticles in HeLa cells monitored by confocal lu-
minescence and reflection microscopy. Cells were incubated with Au100-P-HSH at a concen-
tration of 0.10 pM in complete cell media for 2 hours before fixing. (a) orthogonal view of three-
dimensional z-stack of DRAQ5 and reflection overlays. (b) line intensity profile measurements
performed on the nanoparticles shown in the image insets (HoechstSH image - blue-dashed line,
reflection image - black-solid line). Sizing is estimated using the full-width at half-maximum.
Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel),
λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red channel), λexc = 633 nm, λem = 640-800.
(Scale bar: (a,b) 50 µm, (c, d) 10 µm).
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in the peaks of the intensity profiles does also indicate the HoechstSH emission is co-
localised to the nanoparticles and is thus stable on the nanoparticles after exposure to a
cellular environment.
Uptake of Au100-P-HSH was investigated in HeLa cells following a 24 hour incu-
bation. Widefield images are shown in Appendix G.4.4. Magnifications of representative
cells are shown in Figure 2.67 and Figure 2.68. The transmission brightfield and DRAQ5
image overlay is shown in Figure 2.67a. Nanoparticle uptake is evident in all of the cells
in the FOV however the most prominent feature is the nanoparticle uptake observed in
the cell nucleus denoted by the yellow-dashed circle. The extent of the uptake is evident
in the DRAQ5 and reflectance image overlay (Figure 2.67c) where nanoparticles are seen
in the nucleus and indeed on the periphery of the nucleolus as previously observed. The
green arrows indicate such features in all three of the cells in the image indicating this is
not an isolated occurrence.
Sizing measurements performed on the several of the white spots indicated by the
arrows suggest diameters ranging from 400 - 600 nm, indicating they are composed of
one or two nanoparticles taking in to account diffraction effects.77 (Line intensity profiles
are provided in Figure G.13, Appendix G.4.4). The confocal image slice shown in Figure
2.67d corresponds to an section from a three-dimensional image stack of the cells in
which further uptake in the nucleus, particularly around the nucleolus is evident. The
nanoparticles are confirmed as being in the same central plane as the nucleus by the
transverse views as indicated by the yellow arrow.
Figure 2.68 shows the HeLa cells and spectral scans recorded from the indicated ROIs.
All three cells (1-3) in the the image were analysed with ROIs corresponding to cytoplas-
mic localised and nuclear localised nanoparticles. ROIs are provided in Figure 2.68a on
the DRAQ5, HoechstSH and reflectance (green false colour) image overlay. The emission
intensity profiles are shown in Figures 2.68b, 2.68c and 2.68d. It is evident that in both
cells 1 and 2 the emission is blueshifted in the nucleus compared to the cytoplasm. To




Figure 2.67: Images of Au100-P-HSH nanoparticles in HeLa cells monitored by confocal lu-
minescence and reflection microscopy. Cells were incubated with Au100-P-HSH at a concen-
tration of 0.10 pM in complete cell media for 24 hours before fixing. (a) transmission brightfield
and DRAQ5 overlay. (b) HoechstSH image. (c) reflection and DRAQ5 overlay. (d) orthogonal
view of three-dimensional z-stack of reflectance and DRAQ5 overlay. Reflection image λexc =
633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem




Figure 2.68: Images of Au100-P-HSH nanoparticles in HeLa cells monitored by confocal lu-
minescence and reflection microscopy. Cells were incubated with Au100-P-HSH at a concen-
tration of 0.10 pM in complete cell media for 24 hours before fixing. (a) regions used for spectral
emission scans shown on DRAQ5, HoechstSH and reflectance overlay (green false colour ap-
plied to reflectance channel). transmission and DRAQ5 overlay. (b, c, d) spectral emission scans
taken from corresponding cells and regions. Reflection image λexc = 633 nm, λem = 623-643
nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5,
(red channel), λexc = 633 nm, λem = 640-800. (Scale bar 10 µm).
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Figure 2.69: TEM images of Au13-P-HSH in HeLa cells. Cells were incubated with Au13-P-
HSH at a concentration of 0.25 nM in complete cell media for 24 hours before fixing. Widefield
images of the cytoplasm of the cell are shown in top panel. Magnifications of insets (a), (b) and
(c) are shown in (a∗), (b∗) and (c∗) respectively. C.M - cell membrane, V - vesicle, F - vesicular
folds.
maxima (data not shown). Peaks were thus observed in cell 1 at (nucleus) 485 nm and
(cytoplasm) 500 nm, in cell 2 at (nucleus) 485 nm and (cytoplasm) 510 nm and in cell 3
(nucleus) 485 nm. The blueshift observed is characteristic of the HoechstSH binding to
DNA (Appendix D).
Transmission Electron Microscopy of Au13-P-HSH in Cells
Figure 2.69 exhibits TEM images of HeLa cells incubated with Au13-P-HSH for 24
hours. (Images after 2 hour exposure are provided in Appendix G.4.3). The top panel
of images show widefield views of the cells and Figures 2.69a∗-c∗ magnifications of the
respective insets. Au13-P-HSH are observed as dark spheres due to their high electron
density. They are observed in vesicles approximately 1-2 µm from the cell membrane
inside the cells in Figure 2.69a∗ and 2.69b∗, which enclose 15-20 nanoparticles. Referring
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to the uptake mechanisms and vesicle designations described in Figure 2.2 these vesi-
cles are probably of Type 4 or 5. The vesicle observed in Figure 2.69c is much further
within the cell at a distance of approximately 6 µm away from the cell membrane plac-
ing it close to the nuclear membrane as indicated. Examining the vesicle at a higher
magnification reveals it is elliptical in shape, measures 700 x 450 nm along the major
and minor axis respectively and contains upwards of 50 nanoparticles. Multiple folds are
also evident (red-arrow) indicating the vesicle is part of the latter stages of endocytosis
(Figure 2.2). The presence of multiple membrane bound vesicles suggests endocytosis
as the predominant uptake mechanism of the Au13-P-HSH as also indicated by con-
focal imaging observations. A single nanoparticle is however observed in the cytoplasm
(red-dashed arrow) suggesting that passive uptake directly through the cell membrane or
endosomal/vesicular release may also occur on occasion.
Figure 2.70 exhibits another HeLa cell following incubation with Au13-P-HSH. Fig-
ure 2.70a shows a widefield view of the cell with the nuclear membrane and nucleolar
boundary indicated by red and blue dashed lines respectively. The most striking feature
in this image is the distribution of nanoparticles observed in the nucleus denoted by the
inset box (b) and magnified in the corresponding image comprising Figure 2.70b∗. The
distribution of nanoparticles is almost identical to that observed in Figure 2.58 which
shows nuclear localised Au13-Z-HSH in a HeLa cell after 24 hours. Interestingly a mag-
nification of this region in Figure 2.70d∗ reveals an elliptical vesicular structure containing
clusters of nanoparticles approximately 50 nm in diameter (see inset). This is typical of
some of the nanoparticles observed in the late stage endosomal/lysosomal compartments
in Figure 2.69 which measure many tens of nanometres on diameter and can contain
several tens of nanoparticles.
Unlike the vesicles in Figure 2.69 the vesicular compartment observed here in the
nucleus contains only three nanoparticles spots inside (green arrows) with two on the
periphery (red arrows). A late stage endosome/vesicle would presumably have many
more nanoparticles as previously observed. Coupled with the lack of a distinct membrane
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Figure 2.70: TEM images of Au13-P-HSH in HeLa cells. Cells were incubated with Au13-P-
HSH at a concentration of 0.25 nM in complete cell media for 24 hours before fixing. Widefield
image is shown in (a). Magnifications of insets (b), (c) and (d) are shown in (b∗), (c∗) and
(d∗) respectively. Line intensity profile of representative NP is shown in inset of (d∗). Vesicles
indicated by orange arrows, including two containing nanoparticles as indicated by blue arrows,
seem to be traversing the broken nuclear membrane. The vesicular compartment observed in
the nucleus contains three nanoparticles inside (green arrows), with two on the periphery of the
vesicle (red arrows). C.M - cell membrane, N.M - nuclear membrane (red dashed-line), N∗ -
nucleolus (outlined by blue dashed-line), NP - nanoparticles.
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in some areas and clusters of nanoparticles observed just outside the vesicle indicates the
nanoparticles have achieved release or expulsion from the compartment. It is possible that
with late stage endosomes/vesicles possessing an acidic internal environment (Figure 2.2)
the pHLIP peptide on the nanoparticles has enabled them to insert through the membrane
as previously discussed (Section 1.2). Similar uptake is observed with the Au13-Z-HSH
however indicating that this may not be the case.
Without a temporal based TEM study examining uptake over a range of time points
it is difficult to be certain of the exact mechanism of nuclear uptake. However another
feature of significance is observed in Figure 2.70d∗ which shows a magnification of an
undefined section of nuclear membrane above the nuclear localised nanoparticles. Figure
2.58 shows Au13-Z-HSH in the nucleus of a HeLa cell also in close proximity to what
appears to be a break in the nuclear membrane. Furthermore a vesicle is observed at the
location of the membrane dissolution Figure 2.58d∗∗. A similar such feature is observed
in here in Figure 2.70d∗ where multiple vesicles indicated by orange arrows, including
two containing nanoparticles indicated by blue arrows seem to be traversing the broken
nuclear membrane. The nuclear localised vesicle in this cell may thus have achieved uptake
through this pathway.
Nuclear membrane dissolution occurs when the cell divides via mitosis and it is known
that endoplasmic reticulum derived vesicles are used by the cells to reform the nuclear
membrane.287,288 With vesicles containing nanoparticles known to potentially translocate
to the endoplasmic reticulum284 it is possible that these vesicular compartments form
part of the same pathway. An alternative hypothesis is that the dense nanoparticle cargo
contained in these compartments makes them difficult for cells to translocate away from
the nuclear vicinity, and they subsequently become trapped when the nuclear envelope
reforms after cell division. Again further investigations would be required to confirm
these hypotheses. Notably nanoparticles were also observed to be associated with acidic
endosomal/lysosomal compartments in the nucleus of the HeLa cell in the preliminary
study using the Lysotracker stain (Section 2.3.6), furthermore indicating nuclear uptake
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via such vesicles is not an isolated occurrence in the cells.
Figure 2.71 shows another HeLa cell exhibiting nuclear uptake of a cluster of nanopar-
ticles. Figure 2.71 shows a widefield view of the cell where the nuclear membrane is
denoted by the red dashed line. Immediately apparent is a vesicular structure near the
centre of the nucleus which is magnified in in Figure 2.71b∗. An interesting feature is seen
to the left of the image where the nuclear membrane invaginates inwards and is apparently
broken, as indicated by the break in the red dashed line. The bold red arrow indicates the
possible path traversed by the vesicle in to the nucleus hypothesising a similar mechanism
to that proposed for nuclear localised vesicle/nanoparticles in Figure 2.70. Figure 2.71c∗
shows a magnification of the vesicle that is cylindrical in shape and over 3 µm in length
and exhibits three further internal vesicles (Figure 2.71d∗). The largest of the internal
vesicular compartments is 600 nm in diameter and contains upwards of 30 distinguishable
nanoparticles, and furthermore in the vesicle to the extreme right two further nanoparti-
cles as well as another smaller internal vesicle are observed. The collection of vesicles as
a whole are thus indicative of a Type 4 endocytotic vesicle which denotes multi-vesicular
bodies. (Figure 2.2)
In conclusion confocal microscopy of A549 and HeLa cells exposed to Au13-P-HSH
indicated cellular uptake of the nanoparticles. Cells were exposed to the nanoparticles in
complete media at neutral pH suggesting an uptake mechanism independent of the pHLIP
peptides pH dependant mechanism. Colocalisation of the nanoparticles with the Hoech-
stSH emission indicate stability of the HoechstSH complex on the nanoparticles when
prepared via pHLIP peptide mediation and following exposure to a cellular environment.
Line profiles of nanoparticles in the A549 cells indicate they are composed of clusters of
nanoparticles the majority of which are approximately 400 nm in size suggesting signifi-
cant compartmentalisation of the nanoparticles, indicative of endocytosis. Nuclear uptake
of Au13-P-HSH is also readily observed with nanoparticles localised to the periphery
of the nucleolus. Interestingly uptake of Au13-T20-HSH, Au13-Z-HSH and Au100-
Z-HSH exhibits similar nuclear translocation. TEM images of Au13-P-HSH present
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Figure 2.71: TEM images of Au13-P-HSH in HeLa cells. Cells were incubated with Au13-P-
HSH at a concentration of 0.25 nM in complete cell media for 24 hours before fixing. Widefield
image is shown in (a). Magnifications of insets (b), (c) and (d) are shown in (b∗), (c∗) and (d∗)
respectively. Yellow arrow in (d∗) denotes possible path of nanoparticle containing structure in
to the nucleus. C.M - cell membrane, N.M - nuclear membrane (red dashed-line), N∗ - nucleolus,
V - vesicles, NP - nanoparticles.
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further evidence of nuclear localised nanoparticles. Most strikingly a cluster of nanopar-
ticles seemingly achieving vesicular escape within the nucleus was observed located close
to a break in the nuclear membrane. Another example of nuclear localised nanoparticles
were also identified in a cell nucleus where a structure several micrometers in diameter
containing multiple vesicles within was observed. This is extremely interesting as such
structures are usually found in the perinuclear region and provides great impetus for fur-
ther studies monitoring uptake and nuclear translocation. Distinct attention should be
afforded to cells undergoing division when the nuclear membrane breaks down and reforms
in light of the hypotheses presented to explain the observed nuclear uptake, particularly
as it is known that endoplasmic reticulum derived vesicles are used by the cells to reform
the nuclear membrane.287,288
2.3.8 Nanoparticle Uptake - Effect on the Cell Cycle
Due to the nuclear localisation of Au13-Z-HSH and Au13-P-HSH and HoechstSH
coating on these nanoparticles, the cell cycle of populations of HeLa cells was examined for
signs of cell cycle dsyregulation. Cells were furthermore synchronised such that they could
be incubated with nanoparticles for time periods where the cell population was enriched
in the G0/G1, S and G2/M phases. As such to establish appropriate time points HeLa
cells were initially cultured to 60 % confluence and deprived of serum (0 % FBS media)
for 48 hours to induce cells in to the G0-G1 phase. Following serum deprivation cells were
stimulated back in to progression through the cell cycle in phase by the re-introduction
of serum containing media (10 % FBS media). Cells were harvested at 2 hour time points
to establish the times the cells peaked in the S and G2/M phases (Figure 2.72).
It was hypothesised that nuclear uptake of the nanoparticles observed by confocal
microscopy and TEM may be related to cell division, particularly the breakdown of the
nuclear membrane which occurs during the latter G2 phase and the early M-phase. Cells
were therefore synchronised as described and incubated with nanoparticles for 2 hour time
periods corresponding to when the largest fraction of cells were in the required phase of
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Figure 2.72: Distribution of cells in the G0/G1, S and G2/M phases of the cell cycle after serum
re-stimulation following 48 hour serum deprivation. After serum stimulation for the appropri-
ate time period cells were harvested by trypsinisation and fixed in 70 % ethanol. For analysis
cells were washed in PBS, treated with RNaseA and stained with the fluorescent nucleic acid
propidium iodide dye. Cell fluorescence was analysed using a FACS Calibur 14 flow cytometer
(BD Biosciences). G0/G1, S and G2/M proportions were calculated using FCS Express Flow 5
software (De Novo Software) with fitting performed via chi-squared minimisation. Results are
reported as the average % of cells in each phase ± 1SD.
the cell cycle. Thus the potential of the nanoparticles to dysregulate the cell cycle could
be assessed in relation to the cell cycle phase. Cells were therefore incubated with Au13-
Z-HSH and Au13-P-HSH from 11-13, 22-24 and 30-32 hours after serum-stimulation,
corresponding to peak fractions in G2/M phase, G0/G1 phase and S phase respectively
(Figure 2.72).
Following exposure to Au13-Z-HSH and Au13-P-HSH the fraction of cells in the
respective phases was determined and compared to an undosed control population of
cells at the same phase/time in the cell cycle (Figure 2.73). No significant change in the
proportions of cells in the G2/M phase, G0/G1 phase and S phase were observed relative
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to the undosed cell population (P < 0.05). This suggests that in cells with nuclear uptake
the vesicular confinement of the majority of internalised nanoparticles may prevent them
from dysregulating the cell cycle. (Data and statistical analysis are presented in Appendix
I). Exposure to Au13-Z-HSH and Au13-P-HSH in unsynchronised cell populations was































































































































































































































































































































































































































































































































































































































































































Gold nanoparticles were successfully synthesised to provide a scaffold for the thiolated
HoechstSH complex. This was achieved by addition of the Tween 20 and Zonyl
7950 surfactants, and pHLIP peptide respectively. Luminescent nanoparticles bearing
the optical signature of the HoechstSH and exhibiting the characteristic photophysical
properties of the Hoechst dye upon addition of CT-DNA were produced and characterised.
Cellular uptake of the HoechstSH nanoparticle preparations were examined in the
A549 and HeLa human cancer cell lines. Uptake of Au13-T20-HSH, Au13-Z-HSH
and Au100-Z-HSH were examined in A549 and HeLa cells by confocal microscopy with
significant nanoparticle uptake to the perinuclear regions in all cells. Analysis of the
nanoparticles in cells indicate the stability of the HoechstSH complex on nanoparti-
cles after prolonged exposure to a cellular environment. Uptake of Au13-P-HSH and
Au100-P-HSH as also examined in A549 and HeLa cells. Most striking was nuclear up-
take in some cells of all the nanoparticle preparations, with notable localisation of clusters
of nanoparticles to the periphery of the nucleoli.
Nuclear localised Au13-Z-HSH Au13-P-HSH are again observed in TEM microscopy
of HeLa cell sections. This is particularly surprising as nanoparticle uptake is believed to
occur primarily via endocytosis and would in theory result in endosomal/lysosomal restric-
tion. Large clusters of nanoparticles are indeed observed in membrane bound organelles
in TEM images and preliminary Lysotracker staining studies corroborate this observation.
Nuclear localised nanoparticles are also observed in vesicles and freely dispersed within
the nucleus, indicating a translocation mechanism for nanoparticles across the nuclear
envelope potentially related to it’s dissolution upon cell division. Furthermore a vesicular
release mechanism or indeed compromised membrane integrity of the nuclear localised
vesicles may subsequently lead to free dispersion of the nanoparticles in the intra-nuclear
space. In the context of the aforementioned nuclear uptake of nanoparticles and the DNA
binding ability of the Hoechst complex, Au13-Z-HSH and Au13-P-HSH are examined
for their ability to induce dysregulation to the HeLa cell cycle in both synchronised and
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non-synchronised cell populations. Flow cytometry analysis of the cell cycle indicates no
significant dysregulation following exposure to Au13-Z-HSH and Au-P-HSH compared
to undosed controls (P < 0.05).
In summary luminescent gold nanoparticles have been synthesised and with the use of
surfactants and a peptide as a pre-coating, the particles have been utilised as a scaffold
for the addition of the HoechstSH complex. Thus nanoprobes exhibiting the optical
signature of the HoechstSH lumiphore and it’s capability of DNA interaction were pro-
duced, as indicated by photophysics and circular dichroism studies. Cellular uptake of the
nanoparticles is readily observed in two carcinomic human cell lines with extremely inter-
esting nuclear interactions, as observed by confocal and transmission electron microscopy.
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2.6 Experimental
2.6.1 Synthesis of Au13-T20-HSH
Tween 20 (1.5 ml at 1.2 mM in dH2O) purchased from Sigma-Aldrich,was added to 13 nm
citrate-stabilised gold nanoparticles (9 nM, 1.5 ml) to give a final particle concentration of
4.5 nM, and a final surfactant concentration of 0.6 mM. The solution was stirred for 2 min-
utes. HoechstSH complex (200 -l, 0.6 mM stock) (made in situ; NH4OH (aq. 30 % w/w
sol.): HoechstSAc (1.2 mM, MeOH)) was added into the nanoparticle/surfactant solution.
The solution was stirred for 2 minutes. Final concentration of HoechstSH in nanopar-
ticles 8 µM. Nanoparticles were isolated by size-exclusion chromatography on Sephadex
G-25 Hi-trap column, eluting with water, to give a final nanoparticle concentration of
approximately 4 nM (estimated by UV-Vis absorption spectroscopy) Au13-T20-HSH.
UV-Vis (H2O) λmax = 527 nm (SPR). Diameter = 19±6 nm (DLS number distribution).
Diameter = 43±21 nm (DLS intensity distribution), zeta potential = -34±3 mV (isolated,
1 nM in deionised water diluent). Emission (H2O, λexc = 350 nm) λmax = 445 nm.
2.6.2 Synthesis of Au13-Z-HSH
Zonyl 7950 (1 µl, 1.15 g ml−1, purchased from Sigma-Aldrich and used without further
purification) was added to 13 nm citrate-stabilised gold nanoparticles (3 ml, 4.5 nM fluoro-
surfactant coated nanoparticles. The solution was stirred for 2 minutes. Fluorosurfactant
coated nanoparticles were isolated by centrifugation twice at 13,000 rpm for 30 minutes
(decanting the supernatant and re-suspension of the pellet in dH2O. HoechstSH complex
(40 µl, 0.6 mM stock) (made in situ; NH4OH (aq. 30 % w/w sol.)): HoechstSAc (1.2 mM,
MeOH) was added into the nanoparticle/surfactant solution. HoechstSH achieves 8 µM
final concentration. The particles were centrifuged twice at 13,000 rpm for 30 minutes (de-
canting the supernatant and re-suspension of the pellet in dH2O) to give Au13-Z-HSH.
UV-Vis (dH2O) λmax [nm] = 521 (SPR). Diameter = 20±6 nm (DLS number distribu-
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tion). Diameter = 41±18 nm (DLS intensity distribution), zeta potential = -45±12 mV
(isolated, 1 nM in deionised water diluent). Emission (H2O, λexc = 350 nm) λmax = 480
nm.
2.6.3 Synthesis of Au100-Z-HSH
Zonyl 7950 (1 µl, 1.15 g ml−1) was added to 100 nm citrate-stabilised gold nanoparticles (1
ml, 40 pM fluorosurfactant coated nanoparticles. The solution was stirred for 2 minutes.
Fluorosurfactant coated nanoparticles were isolated by centrifugation twice at 13,000 rpm
for 90 seconds (decanting the supernatant and re-suspension of the pellet in dH2O. Hoech-
stSHHoechstSH complex (50 µl, 0.6 mM stock) (made in situ; NH4OH (aq. 30 % w/w
sol.): HoechstSAc (1.2 mM, MeOH) was added into the nanoparticle/surfactant solution.
HoechstSH achieves 10 µM final concentration. The particles were centrifuged twice at
13,000 rpm for 90 seconds (decanting the supernatant and re-suspension of the pellet in
dH2O) to give isolated Au100-Z-HSH. UV-Vis (dH2O) λmax [nm] = 545 (SPR). Diam-
eter = 72±17 nm (DLS number distribution). Diameter = 98±37 nm (DLS intensity
distribution), zeta potential = -40±12 mV (isolated, 10 pM in dH2O).
2.6.4 Synthesis of Au13-P-HSH
Procedure was adapted from gold nanoparticle preparation by Davies et al.82 A 20 µl
solution of pHLIP (1 mM in 10 % DMSO, phosphate buffer saline (PBS) solution) was
added to 13 nm citrate-stabilised gold nanoparticles (2.5 ml, 4.5 nM), to a final peptide
concentration of 8 µM. The solution was stirred for 2 minutes. HoechstSH complex
(200 µl, 0.6 mM stock) (made in situ; NH4OH (aq. 30 % w/w sol.): HoechstSAc (1.2
mM, MeOH)) was added into the nanoparticle/surfactant solution (final concentration of
HoechstSH in nanoparticles 45 µM). Nanoparticles were isolated by size-exclusion chro-
matography on Sephadex G-25 Hi-trap column Au13-P-HSH. UV-Vis (H2O) λmax =
524 nm (SPR). Diameter = 14±4 nm (DLS number distribution). Diameter = 36±19 nm
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(DLS intensity distribution), zeta potential = -53±12 mV (isolated, 1 nM in deionised
water diluent). Emission (H2O, λexc = 350 nm) λmax = 445 nm.
2.6.5 Synthesis of Au100-P-HSH
Procedure was adapted from gold nanoparticle preparation by Davies et al.82 A 5 µl
solution of pHLIP (1 mM in 10 % DMSO, phosphate buffer saline (PSB) solution) was
added to 100 nm citrate-stabilised gold nanoparticles (2.5 ml, 40 pM), giving a final pep-
tide concentration of 2 µM. The solution was stirred for 2 minutes. HoechstSH complex
(50 µl, 0.6 mM stock) (made in situ; NH4OH (aq. 30 % w/w sol.): HoechstSAc (1.2
mM, MeOH)) was added into the nanoparticle/surfactant solution (final concentration
of HoechstSH in nanoparticles 10 µM). The particles were centrifuged twice at 13,000
rpm for 90 seconds (decanting the supernatant and re-suspension of the pellet in dH2O)
affording Au100-P-HSH. UV-Vis (dH2O) λmax [nm] = 588 (SPR). Diameter = 113±41
nm (DLS number distribution). Diameter = 154±50 nm (DLS intensity distribution),
zeta potential = -40±12 mV (isolated, 10 pM in dH2O).
2.6.6 Cell Cycle Analysis
HeLa cells were seeded in flasks or six-well plates and cultured in complete cell medium
containing 10% FBS. Upon 50% confluence cell medium was removed and cells washed
thrice with PBS. For synchronisation cells were incubated in serum-free medium (0%
FBS) for 48 hr. Control cells were incubated in 10% FBS for 48 hr. After 48 hrs elapsed
cells were gently washed in PBS thrice and incubated in complete cell medium (containing
10% FBS) with a 0.25 nM (final concentration) addition of gold nanoparticles as require.
Cells were harvested at the required time points for fixing.
For fixing cells were transferred to Falcon tubes to achieve approximately 106 cells
per tube. Cells were centrifuged 300 g for 5 min, the supernatant was discarded and the
pellet re-suspended in 2 ml PBS. The cells were again centrifuged, supernatant discarded
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followed by resuspension of the pellet in 500 µl PBS. Cells were vortexed accompanied
by the drop-wise addition of 70 % ice-cold ethanol. Tubes were transferred to the freezer
(-20C) before staining (minimum 24 hr).
For propidium iodide (PI) staining and analysis cells were centrifuged for 8 min at 300
g. The supernatant was aspirated off and the pellet washed with 3 ml PBS. Cells were
centrifuged for 5 min at 300 g, the supernatant discarded and the pellet resuspended in 500
µl PBS. To each cell sample 5 0µl RNAse A solution and 5 µl of PI (1 mg/ml) was added.
Followed by incubation at room temperature for a minimum 30 min in the dark. For each
sample, a minimum of 10,000 cells were analyzed by fluorescence activated cell sorting
(FACS) with a flow cytometer (BD FACS Calibur 14, BD Biosciences, Erembodegem-
Dorp 86, 9320 Erembodegem, Belgium). The percentage of cells in the G0/G1, S and
G2/M phases was calculated using FCS Express Flow 5 software, with fitting performed
to minimise the chi-squared value (De Novo Software, 400 N. Brand Blvd., Suite 850,
Glendale, CA 91203).
2.6.7 Circular Dichroism
Circular dichroism spectra were recorded on a JASCO J180 spectropolarimeter using
quartz emission cells with 1 cm path length. Spectra were recorded at an internal tem-
perature of 22 C. Solutions of CT-DNA were stocked at 100 µM and 800 µM in milli-Q
water. Stocks of Au13-Z-HSH and Au13-P-HSH were at 3.5 nM concentration, diluted
in Tris-HCl [10 mM], NaCl [10 mM] buffer as required from initial synthesis. Instrument
parameters were as follows: sensitivity - standard, band width 2 - µM, data pitch 0.5 nm,
scanning speed - 200 nm/min, accumulations - 12. DNA concentrations were measured
and adjusted by measuring UVV absorbance at 260 nm (ε = 6600 mol−1dm3cm−1), and
sonicated/vortexed for approximately 30 seconds before each measurement.
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Cellular Uptake of Gold Nanoparticles Labelled with a
Luminescent Ruthenium(II) Complex
3.1 Introduction
Research in to the use of metal complexes as cellular probes has attracted much inter-
est due to their distinct physico-chemical properties.289–291 Detection platforms utilising
nanoparticles that incorporate luminescent probes can offer improved sensitivity and sta-
bility in addition to the potential for multiplexing with the integration of multiple probes
on to a single nanoprobe.9–13
Luminescent nanoprobes offer scope for imaging with multiple modalities and can be
functionalised to target specific cells and/or tissues. They can therefore be designed to
interrogate a range of biomolecular processes opening new avenues in disease diagnosis
and therapy.14–17,77 Gold nanoparticles and quantum dots have attracted particular in-
terest for a wide range of applications.13,17,47,119 Functionalising gold nanoparticles with
luminescent probes enables construction of a nanoprobe that bears the distinct optical
characteristics of the lumiphore.75 Luminescent probes such as these can also exploit
the high electron density of gold and its light scattering properties to offer multimodal
imaging and furthermore do not suffer from blinking as observed in quantum dots.
One such example is the attachment of neutral lanthanide lumophores to gold nanopar-
ticles co-coated with a pH sensitive peptide. These nanoparticles have demonstrated
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Figure 3.1: Confocal microscopy and TEM of images of live HeLa cells incubated with ruthenium
polypyridyl functionalized gold nanoparticles for 4 hours. (A) brightfield image, (B) ruthenium
emission from the red channel from 600 to 700 nm, (C) overlay of the red luminescence, the
blue channel (exhibiting the DAPI nuclear costain), and the brightfield image, (D) TEM image
of internalised following incubation with HeLa cells. Figure adapted from Elmes et al.300
selective cellular uptake and have been imaged using their luminescence in the intracel-
lular environment.82 Ruthenium polypyridyl complexes are amongst the most studied
lumiphores and are particularly advantageous due to their photophysical properties292
which have seen their application for the purposes of luminescence recognition, sensing293
and as both sensitive and structurally specific DNA probes.294 In addition to excitation
and emission in visible wavelengths they also exhibit large Stoke’s shifts and relatively
long lifetimes (of the order of several hundred nanoseconds) compared to cellular autoflu-
orescence and organic dyes (≤ 50 nanoseconds) and good photostability.77,278,295,296 The
long lifetime makes the ruthenium complex particularly suited to fluorescence-lifetime
imaging microscopy (FLIM), where the lifetime of a fluorescent signal as opposed to its
intensity is used to form an image.297–299
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Figure 3.2: Top panel - confocal microscopy images of A549 cells incubated with lipid coated gold
nanoparticles (green) for 72 hours (a), with acidic compartments in the cells labelled with Lyso
Tracker Red (b) and an image overlay exhibited in (c). Images show co-localisation of nanopar-
ticles with acidic compartments (lysosomes and/or endosomes). Bottom panel - brightfield DIC
(d) and confocal microscopy image (e) of A549 cells incubated with lipid coated gold nanopar-
ticles (green) for 48 hours with an image overlay exhibited in (f). Images show formation of
lamellar bodies which have internalised the nanoparticles. (Figure adapted from Wang et al.264)
The association of luminescent ruthenium complexes to gold nanoparticles has tradi-
tionally exploited methods exploiting electrostatic interactions,191 thiol exchange,192 or by
direct reduction of Au3+.193–195 Such methods have their intrinsic limitations however, for
example nanoparticles are restricted to sizes smaller than 10 nm, are relatively polydis-
perse and control over the coating of the ruthenium probe is non-trivial. An alternative
is the use of surfactant based mediation. The interaction of the Zonyl family of fluorosur-
factants with gold surfaces has previously been investigated by Lu et al., in which gold
nanoparticles were capped with Zonyl FSN which were stable in solution even at high salt
concentrations.301 Tang et al. also used Zonyl FSN self-assembly on gold surfaces.302
Cellular uptake of gold nanoparticles functionalised with ruthenium(II) polypyridyl
complexes has previously been investigated by Elmes et al. using confocal microscopy
and TEM.300 Synthesis of the ruthenium(II) polypyridyl in the study by Elmes et al.
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used the Brust thiol exchange method which lasts 12 hours in duration followed by iso-
lation steps after synthesis.192 The ruthenium(II) polypyridyl gold nanoparticles were
internalised by HeLa cells through what was hypothesised as receptor-mediated endo-
cytosis or plasma membrane driven transport. Figure 3.1 shows a brighfield image (A)
where the gold nanoparticle clusters as dark spots which are co-localised with areas of red
ruthenium luminescence in the red channel image (B). The TEM image (D) indicates that
the nanoparticles are clustered and confined to vesicles in the intracellular environment.
Gold nanoparticle uptake is also readily observed in other cell lines. Wang et al.
explored nanoparticle uptake in the A549 human lung cancer epithelial cell line, a type II
alveoloar epithelial cell line whose most important role is the secretion of lung surfactants
which aid diffusion in the alveolar spaces.303 Gold nanoparticles (20 - 30 nm) were coated
with a phospholipid bilayer and uptake studied with flow cytometry, confocal microscopy
and TEM.264 Nanoparticle exposure in humans can occur via inhalation in which case the
lung epithelial cells will be amongst the first to be exposed. The A549 cell line, although
adenocarcinomic, does afford the opportunity to therefore explore important biological
interactions as an in vitro model for the epithelial cells of the lung.304
Although the nanoparticles in this study by Wang et al. were not coated with ruthe-
nium, interesting and notable interactions between particles and A549 cells were observed.
Microscopy revealed the lipid coated gold nanoparticles localised to acidic compartments
and lysosomes in the cells and were subsequently cleared from the cells via an exocytosis
mechanism (Figure 2.2). Exposure to the nanoparticles was also seen to induce formation
of lamellar bodies, exhibited as bright vesicular structures in the cytoplasm of exposed
cells which were absent from undosed control cells (Figure 3.2). The lamellar bodies were
also shown to contain nanoparticles by confocal microscopy and confirmed by TEM imag-
ing. It was concluded that as the nanoparticles were similarly (negatively) charged to the
lipid surfactant that the lung epithelial cells naturally internalise and secrete they were
readily internalised via the same mechanism. Furthermore the increase in the number
of lamellar bodies, which serve the purpose of exporting lipid surfactant, was explained
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as a cellular response to increase the number of compartments that were in turn able to
remove the nanoparticles. The results of the study illustrate how the physico-chemical
properties of nanoparticles can influence uptake and ejection of nanoparticles in cells.
3.2 Chapter Outline
Direct addition of the thiol derivatised ruthenium complex to gold nanoparticles leads
to irreversible aggregation of the particles due to the positive charge of the complex,
thus a novel coating strategy was adopted for gold nanoparticles. In work performed by
Dr. Nicola Rogers addition of the ruthenium complex was achieved by pre-coating the
nanoparticle with a fluorinated surfactant prior to addition of the thiolated ruthenium
complex.77,190 The large gold cores of the nanoparticles provide scaffolds for extensive
labelling with the surface active ruthenium(II) polypyridyl complex producing a lumines-
cent water soluble gold colloid. The work discussed herein presents an investigation in to
the uptake of the highly luminescent ruthenium coated nanoparticles in A549 human lung
cancer cells by the author. Confocal and transmission electron microscopies reveal signif-
icant internalisation of the particles and interestingly single nanoparticles were observed
in the intracellular environment. Furthermore significant nuclear uptake of the nanopar-
ticles occurred but was not observed to induce toxicity as assessed by mitochondrial and
cell membrane integrity assays. The work performed in this chapter contributes to the
appended publication.
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Figure 3.3: Preparation method for Au13-Z-RuSH and Au100-Z-RuSH. Nanoparticle were
pre-coated with the Zonyl 7950 surfactant prior to labelling with the luminescent ruthenium
complex, thus irreversible nanoparticle flocculation and aggregation was avoided.
3.3 Results and Discussion
3.3.1 Synthesis and Characterisation of Au13-Z-RuSH and Au100-
Z-RuSH
Preparation and characterisation of the nanoparticles was performed by Dr. Nicola
Rogers.77,190 Gold nanoparticles were synthesised as described in Chapter 2. In brief
Zonyl 7950 was employed to pre-coat the nanoparticle surface. Following isolation of
the surfactant coated particles was addition of the ruthenium complex (RuSH) as il-
lustrated in Figure 3.3. (Further details on synthesis and characterisation are provided
in Appendix K for convenience). Nanoparticles were isolated by centrifugation affording
13 Au13-Z-RuSH and 100 nm Au100-Z-RuSH gold nanoparticles coated with the
ruthenium complex.
3.3.2 Cellular Uptake of Au13-Z-RuSH and Au100-Z-RuSH
The application of Au13-Z-RuSH and Au100-Z-RuSH as cellular imaging probes
was explored by exposure to the A549 human lung cancer epithelial cell line. Uptake
of Au13-Z-RuSH was readily observed after a 24 hour incubation with uptake evident
primarily to the perinuclear region of the cells (Appendix K, Figure K.1). Qualitative
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Figure 3.4: Ruthenium luminescence and Hoechst nuclear stain overlay images of Au13-Z-
RuSH in fixed A549 cells monitored by confocal luminescence microscopy. Cells were incubated
with nanoparticles at a concentration of 0.9 nM in complete cell media for 24 hours. Cells
were imaged: (a) immediately after the 24 hr incubation, (b) 1 day, (c) 2 days and (d) 3
days post-incubation. Hoechst (blue channel), λexc = 405 nm, λem = 410-455 nm. Ruthenium
luminescence (red channel), λexc = 633 nm, λem = 640-800. (Scale bar 10 µm).
comparisons of the nanoparticle localisation from the reflection and transmission images
with the ruthenium luminescence from the red image channel also illustrates the stability
of the ruthenium coating following exposure to a cellular environment.
To evaluate nanoparticle uptake and their intracellular fate over an extended period
of time a pulse-chase experiment was performed (Figure 3.4). Following an initial expo-
sure for 24 hours cell media containing Au13-Z-RuSH was replaced with fresh media to
essentially examine a “batch” of internalised nanoparticles over time. Using the Hoechst
33258 nuclear counterstain the perinuclear localisation of the nanoparticles (red spots)
is evident in cells imaged immediately after the initial 24 hour exposure (Figure 3.4a).
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Figure 3.5: Images of Au100-Z-RuSH in A549 cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with nanoparticles at a concentration of 0.4 pM in
complete cell media for 24 hours before fixing. (a) Hoechst nuclear stain, (b) ruthenium lumines-
cence, (c) ruthenium luminescence and Hoechst overlay, (d) reflectance image, (e) transmission
image (f) transmission image and Hoechst nuclear stain overlay, (f) Hoechst nuclear stain and
reflection image overlay. Reflection image λexc = 633 nm, λem = 623-643 nm. Hoechst (blue
channel), λexc = 405 nm, λem = 410-455 nm. Ruthenium luminescence (red channel), λexc =
633 nm, λem = 640-800. (Scale bar 20 µm).
Imaging the cells after a further 24 and indeed 48 hours reveals rather more discrete perin-
uclear accumulations of nanoparticles several hundred nanometres in diameter, compared
to a more qualitatively diffuse and homogenous distribution of nanoparticles immediately
after the initial exposure (Figure 3.4b-c). It is interesting to note that even after 72 hours
after removal of the media containing the nanoparticles the cells still exhibited internalised
Au13-Z-RuSH (Figure 3.4d). Based on the number of cell nuclei in the images a 72
hour time period corresponds to approximately three cell-division cycles. The pulse-chase
study thus demonstrates not only the long-term stability of the luminescent ruthenium





Figure 3.6: Images of Au100-Z-RuSH in A549 cells monitored by confocal luminescence and
reflection microscopy, and point-spread function analysis to compare observed size and theoreti-
cally observed size of single nanoparticles. Cells were incubated with nanoparticles at a concen-
tration of 0.4 pM in complete cell media for 24 hours before fixing. (a) reflectance image, (b)
ruthenium luminescence, (c) theoretical 100 nm gold nanoparticle modelled as a section of a si-
nusoidal wave representing a simple model of the nanoparticle sphere, (d) Gaussian model of the
measured point-spread function from confocal luminescence measurements, (e) result of the con-
volution of the measured point-spread function from confocal luminescence measurements with a
simple model of the nanoparticle sphere, f) reflection microscopy image (left) and confocal lumi-
nescence image (right) indicating chosen nanoparticle (inset scale-bar 1 µm). (Computational
code provided in Appendix J.3).
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(a) (b)
Figure 3.7: (a) and (b) comparison of the result of the convolution of the measured point-spread
function with the simple model of the nanoparticle sphere (solid line) and the actual measured
intensity profile of a nanoparticle in the reflection and confocal luminescence images Au100-Z-
RuSH in A549 cells. (Cells were incubated with nanoparticles at a concentration of 0.4 pM in
complete cell media for 24 hours before fixing). (Computational code provided in Appendix J.3).
No immediate nuclear localisation of the Au13-Z-RuSH was evident. The lumi-
nescence and scattering signal does however have to be above a certain threshold to be
detected which single or small clusters of Au13-Z-RuSH may be not exhibit. The larger
size of Au100-Z-RuSH are particularly advantageous in this respect. The 100 nm gold
nanoparticles exhibit a larger scattering as discussed in Section 1.2 and a greater lumi-
nescence to due to a higher number of ruthenium complexes populating a larger surface
area on the 100 nm gold nanoparticle compared to the 13 nm nanoparticles. A549 cells
incubated with Au100-Z-RuSH for 24 hours show significant uptake of the nanoparti-
cles demonstrating the ability of the cells to internalise a range of particles ranging an
order of magnitude in size from 13 to 100 nm.
Confocal microscopy images are presented in Figure 3.5. Cells exhibit nuclear Hoechst
staining (cyan) and nanoparticles are exhibited as red spots in the ruthenium luminescence
red channels and as black and white spots in the transmission and reflection images,
exploiting the absorption and scattering of gold respectively.263 Qualitative colocalisation
of the red ruthenium luminescence and the nanoparticles again indicates the stability of
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Figure 3.8: Images of Au100-Z-RuSH in A549 cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with nanoparticles at a concentration of 0.4 pM
in complete cell media for 24 hours before fixing. (a-d) ruthenium luminescence and Hoechst
overlays, (e) Orthogonal view of image (d) Reflection image λexc = 633 nm, λem = 623-643
nm. Hoechst (blue channel), λexc = 405 nm, λem = 410-455 nm. Ruthenium luminescence (red
channel), λexc = 633 nm, λem = 640-800. (Scale bar 10 µm).
the ruthenium probe on the 100 nm gold nanoparticles after prolonged exposure to a
cellular environment.
The majority of the nanoparticles are perinuclear localised and to further characterise
the size of the nanoparticles a computational analysis was performed on particles observed
in Figure 3.6). Initially a theoretical 100 nm gold nanoparticle was created by using a
section of a sinusoidal wave, thus representing a simple model of the nanoparticle sphere
(Figure 3.6c). A theoretical point-spread function of the microscope was then created
represented as a Gaussian model, essentially describing the response of the microscope to
a point source or object (Figure 3.6d). A convolution of these two models thus represents
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Figure 3.9: Images of Au13-Z-RuSH in A549 cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with nanoparticles at a concentration of 0.9 nM
in complete cell media for 24 hours before imaging. (a) Confocal image sequence from 3D z-
stack of live cells with ruthenium luminescence and nuclear Hoechst overlay, with enlargement
of highlighted slice shown in (b). (c) orthogonal view of the central z-stack slice (xz plane below,
yz plane-right) illustrating ruthenium luminescence from within the same z-plane as the nuclear
Hoechst luminescence (arrow). Reflection image λexc = 633 nm, λem = 623-643 nm. Hoechst
(blue channel), λexc = 405 nm, λem = 410-455 nm. Ruthenium luminescence (red channel),
λexc = 633 nm, λem = 640-800. (Scale bar 50 µm).
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Figure 3.10: Transmission Electron Microscopy of Au100-Z-RuSH in A549 cells. Cells were
incubated with Au100-Z-RuSH at a concentration of 0.4 pM in complete cell media for 24
hours before fixing. Widefield image is shown in (a). Magnifications of insets (b), (c), (d) and
(e) are shown in (b∗-e ∗). C.M - cell membrane, N.M - nuclear membrane, N - nucleus, D -
deformation(s), NP - nanoparticle. (Scale bars (a,b ∗) 2 µm, (c∗, d) 500 nm, (e∗) 200 nm).
the theoretically observed image of a single 100 nm gold nanoparticle (Figure 3.6e). The
theoretical observation can then be compared with the actual observed intensity profiles of
a nanoparticle in the reflectance and ruthenium luminescence imaging channels (Figure
3.6f). Direct comparisons of the theoretical and actual observations are exhibited in
(Figures 3.7a and 3.7h) for the reflection and luminescence imaging modes respectively.
According to the computational model the observable particle width in the luminescence
channel should be approximately 250 - 300 nm. Close correlation with the actual observed
profiles indicate the Au100-Z-RuSH analysed are single nanoparticles Figure 3.6).
One of the most striking observations of the A549 cells incubated with Au100-Z-
RuSH were several cells exhibiting nuclear uptake as indicated by the arrows in Figure
3.8. The cell nucleus exhibited in Figure 3.8d was amongst those which showed the
greatest nuclear uptake of the nanoparticles with a homogenous distribution of Au100-
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Figure 3.11: Transmission Electron Microscopy of Au100-Z-RuSH in A549 cells. Cells were
incubated with Au100-Z-RuSH at a concentration of 0.4 pM in complete cell media for 24
hours before fixing. Widefield image is shown in (a). Magnifications of inset (b) is shown in
(b∗). N.M - nuclear membrane, V - vesicle, NP - nanoparticle, chromatin denoted with red
dashed-line. (Scale bars 2 µm and 100 nm).
Z-RuSH across the entire nucleus. More revealing is the orthogonal view of a three-
dimensional image stack of the cell which exhibits transverse views showing discrete red
ruthenium emission throughout the central plane of the nucleus, confirming the nanopar-
ticles imaged are in the nucleus and not above or below as indicated by the green arrows
in Figure 3.8e.
Figure 3.9 exhibits images of Au13-Z-RuSH in A549 cells. The uptake in these
images is similar to those that seen in the majority of the fixed cell specimens discussed,
with perinuclear localisation of Au13-Z-RuSH observed in both cells in the field-of-view.
No cells exhibiting nuclear uptake were observed in the live cell imaging specimen, however
as a very small sample of live cells just a single specimen were examined (compared to
several fixed cell specimens), this can not be excluded. An ideal solution would involve
several live cell imaging experiments to evaluate the proportion of cells exhibiting nuclear
localised particles, thus uptake in to the nucleus can be quantified and excluded to be as
a result of fixing artefacts.
TEM imaging of A549 cells incubated with Au100-Z-RuSH for 24 hours allows the
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intracellular localisation of the nanoparticles to be examined at high resolution (Figure
3.10). TEM images show several clusters of approximately twenty nanoparticles in close
proximity to each other. The widefield images in Figure 3.10 show the majority are lo-
cated in the perinuclear region of the cells analogous to observations by confocal imaging
microscopy. Examining the inset boxes at higher magnification a striking feature in the
cells are the nuclear deformations close to the locations of the nanoparticles (Figures
3.10c∗ and e∗). Without examining cells incubated with nanoparticles over an extended
period of time it is difficult to conclude whether the nanoparticles have induced these de-
formations. Perturbations of the intracellular environment would however be unsurprising
considering the large size of the nanoparticle clusters, indeed nuclear deformations caused
by gold nanoparticles have previously been observed. Gold nanostars functionalised with
nucleolin-specific aptamers (to achieve nuclear uptake) and a Cy5 red fluorescent marker
were shown to induce major changes to the shape of the nuclear envelope in areas where
the nanoconstructs localised (Figure 1.12). In this study by Dam et al. uptake was ex-
amined in HeLa cells and furthermore cells displaying these folds in the nuclear envelope
showed increased apoptosis and decreased cell viability, thus revealing a new correlation
between changes in nuclear phenotype.148
Nuclear uptake of Au100-Z-RuSH was also observed with single nanoparticles im-
aged within the nuclear membrane. One such example was located on the periphery of an
area of condensed chromatin indicated by the red-dashed line in Figure 3.11, again con-
firming the nuclear uptake observed in the confocal imaging observations. Interestingly
these observations are analogous to those of Au13-Z-HSH and Au13-P-HSH in HeLa
cells where nanoparticles were associated to areas of condensed chromasomal material
(Section 2.3.6 and 2.3.7).
In light of the cellular and indeed nuclear uptake of Au13-Z-RuSH and Au100-Z-
RuSH cytotoxicity assays assessing both mitochondrial function (MTT assay) and cell
membrane integrity via adenylate kinase release (AK assay) were performed. The MTT as-
say measures the cytotoxicity of gold nanoparticles based on the activity of mitochondrial
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Figure 3.12: MTT assay (a colorimetric assay performed for assessing cell metabolic activity
exhibiting percentage cell viability of A549 cells after 24 hour incubation with AuNP (hashed)
and AuNP-Z-RuSH (grey) for the 13 nm particles (a) and the 100 nm particles (b). Dosing
was performed with 0.2-4.5 nM 13 nm particles and 0.8-20 pM 100 nm nanoparticles (equating
to 2 - 50% dilutions of the media with water). The equivalent dosing with deionised water blanks
(white) are presented on each graph.
NAD(P)H-dependent cellular oxidoreductase enzymes which is directly proportional to
cell viability. The enzymes are able to reduce the trazolium MTT 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide dye in to insoluble purple formazan.305 A solution
of dimethyl sulfoxide is adde to solubilize the crystals and the absorbance of the resulting
solution is measured (between 500 and 600 nm). The higher the absorbance, the greater
the amount of formazan, the greater the enzyme activity. Comparing the absorbance to
undosed control cells thus allows percentage cell viability to be determined. The adeny-
late kinase assay to assesses membrane damage to examine whether nanoparticle uptake
causes any reduction in the cell membrane integrity. Any ruptures in the cell membrane
would cause a release of the “AK” enzyme found naturally in the cell cytoplasm. If the en-
zyme is detected in the cell media it is indicative of compromised cell membrane integrity.
Quantification of the amount present in the media is achieved by adding a reagent that
increases in luminescence intensity upon binding with the enzyme, thus the luminescence
can be compared to undosed control cells and percentage cell viability determined.
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Figure 3.13: AK Assay showing percentage cell viability of A549 cells after 24 hour incuba-
tion with Au100 (hashed) and Au100-Z-RuSH (grey), dosing with 0.8-20 pM nanoparticles
(equating to 2 - 50% dilutions of the media with water) and the equivalent dosing with deionised
water blanks (white). Viability was measured in four independent experiments; each experiment
consisted of duplicate plates with duplicate measurements at each concentration. The error bars
for each data point represents the mean 1 standard deviation (SD) of these measurements. Data
outside of 1 SD of the mean of these sixteen readings were classified as outliers and disregarded.
No statistically significant toxicity of the nanoparticles was observed by the MTT
assay. Confocal microscopy of the cells dosed with Au13-Z-RuSH correspond to a
concentration of 0.9 nM and Au100-Z-RuSH a concentration of 4 pM, as indicated
by the arrows in Figure 3.12. All nanoparticle incubations resulted ina concentration-
dependent decrease in the ability of cells to reduce MTT, a measure of mitochondrial
activity (P < 0.001), as assessed by a 1-way one-way analysis of variance (ANOVA). The
ANOVA test is an analysis technique used to compare means of three or more samples
and was performed on the data by Dr. N. Hodges, School of Biosciences. As the MTT
assay was conducted on five independent samples, each producing a mean percentage cell
viability, the ANOVA test was suitable to test statistical significance in the data.
When treatment with particles was compared to the matched water blank there was
no statistically significant difference between either the citrate-stabilised gold nanoparti-
cles, Au13-Z-RuSH and Au100-Z-RuSH with the appropriate water blank, with the
167
exception of Au100-Z-RuSH at 4 pM and 13.6 pM, as assessed by a Bonferoni corrected
t-test (P < 0.05). The Bonferoni correction was applied to take in to account the multiple
repeats (five independent experiments) and comparisons performed on the percentage cell
viability measurements from each experiment. Furthermore no statistically significant
concentration dependent release of adenylate kinase (a measure of cytoplasmicmembrane
integrity) was observed at any of the treatments investigated, as assessed by a 1-way
ANOVA. The 1-wat ANOVAh was again aplpied to the data as multiple experiments
each yielding mean percentage cell viability were conducted. (Figure 3.13).
3.4 Conclusion
In conclusion the Zonyl 7950 surfactant has enabled coating of gold nanoparticles with
the ruthenium transition metal complex. Gold nanoparticles both 13 and 100 nm in di-
ameter are thus functionalised as luminescent nanoprobes exhibiting the distinct optical
signature of the ruthenium complex. The nanoparticles are subsequently imaged in the
A549 human lung adenocarcinoma cell line via confocal and transmission electron micro-
scopies. The size of the 100 nm coated gold nanoparticles has enabled their imaging at
single nanoparticle resolution as demonstrated by comparisons of computational models
with actual observations.
Evidence of nuclear uptake is also observed in cell nuclei as well as deformations to
the nuclear envelope, potentially caused by clusters of nanoparticles in close proximity to
the nucleus. Further investigations are required to ascertain the extent to which nuclear
uptake occurs and time-resolved studies to ascertain the cause of peturbations to the
envelope. Toxicity assays evaluating mitochondrial function (MTT) and cell membrane
integrity (AK) indicate the nanoparticles do not present significant toxicity in cells. The
luminescent nanoprobes thus offer great potential in examination of cellular interactions
at a single nanoparticle level.
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3.6 Experimental
3.6.1 Synthesis and Characterisation of RuSAc
Figure 3.14: Schematic reaction scheme for the preparation of RuSH
Synthesis and characterisation of RuSAc performed by Dr. Nicola Rogers.:190 Synthe-
sis described in SI of attached publication.77
169
3.6.2 Synthesis and Characterisation of Au-Z-RuSH
Figure 3.15: DLS intensity distributions (a) and (b), and number distributions (c) and (d). In
(a) and (c): Au13-Z-RuSH (bold full line), Au13-Z (dashed line) and Au13 (full line). In
(b) and (d) Au100-Z-RuSH (bold full line), Au100-Z (dashed line) and Au100 (full line).
UV-Vis absorption spectra (solid line), excitation spectra, λem = 630 nm (dashed line), and
luminescence spectra, λexc = 450 nm (bold solid line) of 2 nM Au13-Z-RuSH (e) and 10 pM
Au100-Z-RuSH (f).
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Synthesis and Characterisation of Au13-Z-RuSH and Au100-Z-RuSH performed
by Dr. Nicola Rogers.190 Au13 synthesised according to Grabar et al.244 UV-Vis (H2O)
λmax [nm]: 520 (SPR), 260. Diameter = 13 ± 1 nm (DLS number distribution). Zeta
potential = -40 ± 5 mV (2 nM in deionised water). Method of Ziegler and Eychmller was
followed for Au100 preparation.77 UV-Vis (H2O) λmax [nm] = 566 (SPR). Diameter = 98
± 27 nm (DLS number distribution). Zeta potential = -33 ± 3 mV (4 pM in deionised
water).
Au13-Z and Au100-Z: Zonyl 7950 1 µl, (1.15 g ml−1) was added to Au13 (1 ml, 9
nM), or Au100 (1 ml, 40 pM), to give fluorosurfactant coated nanoparticles. 13 nm coated
particles were centrifuged twice at 13,000 rpm for 30 min, and the 100 nm particles at
13,000 rpm for 90 s (twice), and the supernatant was decanted from each pellet to remove
unbound material. Au13-Z, with a zeta potential of - 61 ± 4 mV (2 nM in deionised
water), a diameter of 20 ± 2 nm (DLS number distribution). Au100-Z, with a zeta
potential of - 47 ± 3 mV (4 pM in deionised water) and diameter of 92 ± 21 nm (DLS
number distribution).
Au13-Z-RuSH and Au100-Z-RuSH A solution of RuSH (20 µl, 3.5 mM) added
to Au13-Z (1 ml, 9 nM) or Au100-Z (1 ml, 40 pM), was stirred for 20 min. The Au13-
Z and Au100-Z were prepared as above and used without centrifugation. The 13 nm
coated particles were centrifuged at 13,000 rpm for 15 min, and the 100 nm particles
at 13,000 rpm for 90 s, and the supernatant was decanted from each pellet to remove
unbound material. The nanoparticles were re-suspended in deionised water (1 ml), and
the procedure was repeated twice. Au13-Z-RuSH : UV-Vis (H2O) λmax[nm] = 522
(SPR). Diameter = 18 ± 5 nm (DLS number distribution), zeta potential = -48 ± 2 mV
(2 nM in deionised water). Emission (λexc = 450 nm) λmax[nm] = 640. Au100-Z-RuSH:
UV-Vis (2) λmax[nm] = 567 (SPR). Diameter = 76 ± 22 nm (DLS number distribution),
100 nm (mean diameter by NanoSight Particle Tracking), zeta potential= -35 ± 3 mV (4
pM in deionised water). Emission (λexc = 450 nm) λmax[nm] = 640.
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3.6.3 Photophysical Measurements
All photophysical measurements of RuSAc and Au-Z-RuSH were performed by Dr.
Nicola Rogers. In brief, UV-Vis absorption spectroscopy measurements were performed
on a Varian Cary 5000 spectrometer and steady-state luminescence measurements were
performed on an Edinburgh Instruments FLS920 spectrophotometer. Emission lifetimes
were measured using a 445 nm diode LASER and the time-correlated single-photon count-
ing module integrated within the FLS920 spectrometer, and were tail-fitted with the
Edinburgh Instruments F900 software.
3.6.4 MTT Assay
Cells were seeded in a 96-well plate at a density of 8000 cells per well. Following incu-
bation for 24 hours at 37 C in 5 % CO2, removal of media and a PBS wash, particles or
water in complete media at the required concentrations were added for a further 24 hour
incubation. The media was removed (and retained for the adenylate kinase assay) and
the cells washed twice with PBS followed by incubation in 10 µl MTT (5 mg mL-1 stock
in PBS) in 100 µl per well complete media. After 3 hours incubation the supernatant was
discarded and DMSO (200 µl per well) added to dissolve the resultant formazan crystals.
Absorbance against a DMSO blank was immediately read in a microplate reader at 590
nm. Percentage cell viability was expressed relative to the untreated cells in complete
media.
3.6.5 Adenylate Kinase Release Assay
The Adenylate Kinase (AK) assay was performed using the commercially available bio-
luminescent ToxiLight kit (Lonza Ltd., Wokingham, UK). AK detection reagent (100 µl)
was added to each well of a 96-well white luminescence plate (Greiner Bio-One Ltd, UK).
Upon reaching room temperature 20 µl aliquots of the test supernatant was transferred
to each well and samples incubated for 5 min. Bioluminescence was then immediately
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measured with a microplate reader (Bio-tek Instruments Inc., Kineticalc software for
Windows). The assay was performed on duplicate plates with duplicate measurements
for each concentration tested. Percentage viability was expressed relative to 100 % lysed
cells (positive controls), using Biosoft N25-9 detergent.
3.6.6 Flow Cytometry
Cells were cultured in 6-well plates to approximately 60 % confluence before treatment
with Au100-Z-RuSH (4 pM) for 24 hours. Cells were washed in PBS, detached with
trypsin-EDTA solution (3 min, 37C), and pelleted by centrifugation. The supernatant was
removed and cell pellets re-suspended in PBS and transferred to flow cytometry tubes for
analysis (FACScalibur, BD Biosciences, USA). Forward scatter, side scatter and red fluo-
rescence (λexc = 488 nm with light collected through a 670 nm band pass filter) of 50,000
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High coating of Ru(II) complexes on gold
nanoparticles for single particle luminescence
imaging in cells†
Nicola J. Rogers,‡a Sunil Claire,‡b Robert M. Harris,c Shiva Farabi,a Gerald Zikeli,a
Iain B. Styles,d Nikolas J. Hodges*c and Zoe Pikramenou*a
Gold nanoparticles are efficiently labelled with a luminescent ruthe-
nium complex, producing 13 and 100 nm diameter, monodisperse
red-emissive imaging probes with luminescence lifetimes prolonged
over the molecular unit. Single, 100 nm particles are observed in
whole cell luminescence imaging which reveals their biomolecular
association with chromatin in the nucleus of cancer cells.
The design of coordination metal complexes as cellular probes
has attracted much research interest based on their distinctive/
unique photophysical and electrochemical properties.1–3 How-
ever, nanoscale probes are more ideal for detecting spatially
localised cellular probes in luminescence imaging. Indeed,
gold nanoparticles and quantum dots have been used for a
plethora of biochemical and therapeutic applications.4–7 We
have combined these approaches, and demonstrated labelling
gold nanoparticles (AuNPs) with luminescent metal complexes,
so that the nanoprobes bear the distinct optical signature of the
luminescent agent, independent of the particle properties.8,9
Such designed probes offer multimodal detection taking advan-
tage of gold’s high electron density, and also lack the blinking
effect observed in quantum dots. We demonstrated 13 nm
AuNP coated with neutral (uncharged) lanthanide lumo-
phores and different modalities to image them in cells.10 When
co-coated with a pH sensitive peptide, selective cell uptake
could be achieved.11
To explore metal lumophores with still more efficient light
excitation in the visible region, we have now chosen highly photo-
stable ruthenium(II) polypyridyl complexes. However, a new strategy
is required for the coating of AuNPs since the positive charge of the
ruthenium complex leads to flocculation of the AuNPs in aqueous
solutions; this challenge is addressed herein. Association of ruthe-
nium complexes with AuNPs has previously been studied using
electrostatic interactions,12 thiol exchange methods using Brust-
type13 nanoparticles,14–17 or by direct reduction of Au3+ by
NaBH4.
18–20 All of these methods lead to nanoparticles with sizes
smaller than 10 nm that are relatively polydisperse, with limited
control over the coating of the ruthenium probe. To increase
sensitivity and spatial resolution in imaging,21 nanoparticles with
large Au cores and high number of labels are desirable.
In this communication, we now report an efficient coating
method for water soluble gold nanoparticles, 13 (AuNP13) and
100 (AuNP100) nm in diameter, with a ruthenium complex that
allows luminescence imaging of non-aggregated, single nano-
particles in cells, revealing interesting biomolecular interactions.
The preparation of RuSAuNP13 and RuSAuNP100 was achieved by
controlling the coating of the nanoparticle surface with a non-ionic
fluorinated surfactant, Zonyl 7950 (Scheme 1) prior to the addition
of the surface-active ruthenium complex, RuSH (ESI†). RuSH has
two thiol groups for attachment to gold nanoparticles and a hexyl
spacer group to distance the ruthenium centre from the surface.22
Scheme 1 Controlling nanoparticle labelling with metal complexes to avoid
flocculation. Method for preparation of RuSAuNP13 and RuSAuNP100.
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Zonyls 7950 was chosen to stabilize nanoparticles and inhibit
flocculation induced from the positively charged ruthenium
complex. It bears a hydrophilic polar head group and a hydro-
phobic chain and its interaction with gold surfaces has been
demonstrated.23–25 We isolated and characterised the ZAuNP13
and ZAuNP100 and then added the RuSH complex to yield
RuSAuNP13 and RuSAuNP100 (ESI†). The surface environment
of the nanoparticle changes with the addition of the cationic
complex and partial displacement of the surfactant as confirmed
using zeta potential studies and X-ray photoelectron spectroscopy
analysis of the Au 4f region. Analysis of the inductively-coupled
plasma optical emission spectroscopy (ICP-OES) results, based on
the Au : Ru ratio, gives 103 ruthenium complexes per AuNP13
(ESI†). For the case of RuSAuNP100, the number of RuS com-
plexes per AuNP, was estimated to be 105 based on calculations
from the 1MLCT UV-Vis absorption of the supernatant from
centrifugation due to their insufficient digestion for ICP-OES.
The Zonyl enables a very high loading on the nanoparticles and
the extent of loading per surface area is similar in both sizes,
allowing for an estimated surface area of B0.5  0.5 nm per
ruthenium complex. The TEM images and dynamic light scatter-
ing studies confirm the uniformity of the nanoparticles. The
RuSAuNP100 can also be tracked as single particles by NanoSight
analysis (ESI†).
It is striking that isolated RuSAuNP13 and RuSAuNP100 display
luminescence lifetimes of 340 ns and 360 ns (10%), indicating not
only no quenching from the gold surface but indeed an enhance-
ment compared to the free molecular RuSH complex 260  6% ns
in water with 1% CH3CN. The larger particles can also be imaged as
a single RuSAuNP100 in flow in a microchannel using lumines-
cence microscopy (Fig. 1a). A luminescence spectrum, collected
from the image, confirms the characteristic 3MLCT profile centred
at 640 nm with a blue shift from the free RuSH complex emission
(650 nm), attributed to the influence of the Zonyl hydrophobic
environment. To further examine the effect of the addition of
ZAuNP to RuSH, the luminescence lifetime of RuSH was monitored
during addition of a solution of ZAuNP to RuSH (Fig. 1b). A 50%
increase of the luminescence lifetime is observed upon binding of
RuSH to ZAuNP100 or ZAuNP13 (Fig. 1b and ESI†). These titra-
tion results are consistent with the isolated RuSAuNP13 and
RuSAuNP100 lifetimes. The saturation point in Fig. 1b is consistent
with the 105 loading estimated above from UV-Vis absorption. The
luminescence lifetime of RuSH mixed with Zonyl 7950 is 400 ns
(3%), indicating that the effect of the Zonyl is the dominant cause
of the extended lifetime of the nanoparticles.
To study the potential of RuSAuNP13 and RuSAuNP100 in
cellular imaging, they were incubated with A549 human lung cancer
cells. Cytotoxicity assays using both MTT (mitochondrial function)
and adenylate kinase release (cell membrane integrity) showed that
there was no statistically significant toxicity of the nanoparticles when
compared to a water matched control, at concentrations of up to
5 times the concentration used for imaging studies (ESI†). To
monitor the uptake and accumulation of particles in cells over
time we performed a pulse-chase experiment (ESI†) using con-
focal fluorescence microscopy for detection. Interestingly, even
after 3 days of the chase experiment, which we estimate as
representing approximately three cell divisions based on the
number of nuclei per field of view, many cells still contained
labelled RuSAuNP13 particles, demonstrating the stability, long
half-life and poor clearance of RuSAuNP13 particles. Although
nuclear localisation could not be excluded, there was little or no
evidence of RuSAuNP13 within the nucleus at any of the time
points investigated. However, when the larger nanoparticles
were used, more detailed information could be extracted. Cells
incubated with RuSAuNP100 displayed clear visualisation of
individual RuSAuNP100 nanoparticles as evidenced by both con-
focal luminescence and confocal reflection microscopy (Fig. 2).
Fig. 1 (a) Luminescence image and spectrum (inset) of a solution of
RuSAuNP100 in flow within a 100 mm deep, 1 mm wide ibidi micro-
channel, using epiluminescence microscopy. lexc = 450 nm, lem > 510 nm.
The emission spectrum (inset) is taken from the field of view in the image.
(b) Effect of nanoparticle addition to the lifetime of RuSH (0.17 mM, 1%
CH3CN in H2O) by monitoring the luminescence at 630 nm upon titration
of ZAuNP100 0–400 ml (40 pM), lexc = 450 nm.
Fig. 2 Confocal images of single RuSAuNP100 nanoparticles in A549
cells. (a) Reflection microscopy image lexc = 488 nm, lem = 478–498 nm and
(b) ruthenium luminescence image lexc = 453 nm, lem = 555–800 nm.
Respective comparisons of the measured point-spread function of the micro-
scope convolved with a model of the nanoparticle sphere (solid-line), and the
experimental intensity profile of a nanoparticle from the inset (dashed-line) are
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Gold nanoparticles appear as bright spots in the confocal
reflection images based on the strong scattering signal of the gold.
The confocal luminescence signal confirms the ruthenium red
luminescence of the particles (Fig. 2). Co-localisation of signals in
the red and the reflection images confirm the stability of the
nanoprobe after 24 h incubation. To further analyse the results,
we used a convolution of the measured point-spread function from
the confocal luminescence measurements using a simple model of
the nanoparticle sphere (Fig. 2). The model predicts the estimated
observable particle width in the luminescence images to be
250–300 nm (due to light diffraction effects) and is consistent with
actual measurements performed. In complementary cell studies, the
RuSAuNP13 are observed only as accumulations of nanoparticles,
due to their smaller diameter and limited resolution (ESI†).
Analysis of the confocal luminescence images of the cells
treated with RuSAuNP100 reveal co-localisation of red particles
and Hoechst 33258 emission in some cells, confirming that few of
these nanoparticles can localise in the nucleus (Fig. 3). This is in
contrast to RuSAuNP13 which were absent from the nucleus,
although this could be attributed to low spatial resolution as
accumulations of the 13 nm AuNPs are required for their visua-
lisation. Still more revealing is that some of the single nano-
particles appear to be localized to a condensed area of Hoechst
staining, indicative of nuclear chromatin material containing
genomic DNA (Fig. 3). The confocal luminescence images are
further supported by TEM studies (Fig. 3). In the TEM images of
the A549 cells treated with RuSAuNP100, particles can be seen in
close proximity to optically dense regions of the nucleus, which
are attributed to condensed chromatin. These results indicate an
interaction of the nanoparticles with chromatin that is visualised
using the aforementioned microscopy techniques.
In conclusion, by employing the Zonyl 7950 surfactant we have
achieved a very high loading of a luminescent transition metal
complex on AuNPs of different sizes. This has enabled the design
of nanoprobes that can be imaged at single nanoparticle resolu-
tion in cells by conventional and widely available optical micro-
scopy methods. These nanoparticles do not present any
significant cytotoxicity in cells and are stable in cells without
losing their coating. Their strong luminescence allows imaging of
particle association with DNA condensed material in the nucleus.
These nanoprobes therefore present great potential in the detec-
tion and monitoring of biomolecular interactions at the level of a
single nanoprobe. Applications may also be envisaged in the
development of new nanomaterials with properties encoded by
the grafted transition metal complex.
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University of Birmingham for funding and support. Some instru-
ments used in this study were supplied through Birmingham
Science City: Innovative Uses for Advanced Materials in the Modern
World (West Midlands Centre for Advanced Materials Project 2)
with support from Advantage West Midlands (AWM) and partial
funding from the European Regional Development Fund (ERDF).
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2006, 4183–4185.
21 W. S. Chang, B. Willingham, L. S. Slaughter, S. Dominguez-Medina,
P. Swanglap and S. Link, Acc. Chem. Res., 2012, 45, 1936–1945.
22 P. Bertoncello, E. T. Kefalas, Z. Pikramenou, P. R. Unwin and
R. J. Forster, J. Phys. Chem. B, 2006, 110, 10063–10069.
23 C. Lu, Y. Zu and V. W.-W. Yam, Anal. Chem., 2007, 79, 666–672.
24 Y. Tang, J. Yan, X. Zhou, Y. Fu and B. Mao, Langmuir, 2008, 24,
13245–13249.
25 F. Li and Y. B. Zu, Anal. Chem., 2004, 76, 1768–1772.
Fig. 3 Imaging nuclear localisation of RuSAuNP100 in A549 cells.
(a) Orthogonal view of the central z-stack slice (xz plane below, yz
plane-right) from a single cell, illustrating ruthenium luminescence from
within the central z-planes containing the Hoechst luminescence. (Scale
bar 10 mm; acquisition time 75 s). (b) Ruthenium luminescence image and
(c) corresponding overlay with Hoechst nuclear stain; acquisition time =
60 s, showing association of chromatin with RuSAuNP100 particles inside
the nucleus (Scale bar 1 mm; acquisition time = 60 s). (d) Transmission
electron micrographs (70–90 nm slice width) of A549 cell dosed with
RuSAuNP100; magnified inset shows interaction of nanoparticles with





















































Deposition and Imaging of Silica particles in Dentine
4.1 Introduction
The use of artificially engineered nanoparticles in dentistry is attracting much research
interest due to the many clinical applications nanotechnology can be used for.306 One
such example is the use of nanofillers to aid in the restorative aspect of dentistry to repair
the physiological and mechanical functions of the tooth. Such treatments are of great
relevance for nanoparticle applications involving dentinal tubules where they can be used
to help strengthen the dentine, reduce hypersensitivity by tubule occlusion or exhibit an
antibacterial efficacy.
The dentine itself is composed of hydrated mineralised tissue that underlies the enamel
surface layer and constitutes much of the bulk of the tooth (Figure 4.1). The dentine
composition by weight is 70% inorganic, 20% organic and 10% water with hydroxyapatite
and collagen constituting much of the inorganic and organic phases. The characteristic
channels which permeate the dentine are called dentinal tubules and range in diameter
from 2.5 µm in the vicinity of the pulp, 1.2 µm in the middle of the dentine and 0.9 µm
at the dentino-enamel junction.307 Interestingly tubule density also varies. Tubules cover
45,000 mm2 near the pulp, 29,000 mm2 in the middle of the dentine and 20,000 mm2 at
the dentino-enamel junction.181,182,307–309
The porous nature of the dentine due to it’s organic components and high water
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Figure 4.1: Schematic of human tooth anatomy showing the four main components of the tooth,
namely enamel, dentine, cementum, and pulp. Characteristic microscopic channels that perme-
ate the dentine are known as dentinal tubules. Dental research studies have investigated the use
of nanomaterials in different clinical applications including enamel remineralization, antibacte-
rial applications, caries management, dentine hypersensitivity and root canal therapy. Figure
adapted from Besinis et al.306
concentration, in addition to the presence of the dentinal tubules, can make them prone
to causing dentine hypersensitivity. The main causes of hypersensitivity are gingival
recession (receding gums) leading to exposure of root surfaces, loss of the surface layers
and tooth wear.310
Nanomaterials can aid in the treatment of dentine hypersensitivity by the occlusion
of the dentinal tubules.311,312 Earl et al. investigates tubule occlusion with nanoscale
hydroxyapatite particles and found that shape and size of the particles used was of great
importance.313 Hydroxyapatite particles 100 nm in size were found to be optimal in
achieving tubule occlusion whilst larger 600 nm needle like particles showed very limited
infiltration. Demineralisation of the dentine surface also enhanced tubule infiltration and
occlusion thus demonstrating the complexities of achieving tubule occlusion with regards
to particle shape, size and indeed chemistry with the surface environment of the dentine
itself.
Besinis et al. further illustrated the dependence of particle size on occlusion ability
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with extensive infiltration achieved with spherical hydroxyapatite and silica nanoparti-
cles below 15 nm in size.188 Interestingly in a follow-up study the hydroxyapatite and
silica nanoparticles were also found to enhance remineralisation of the dentine.314 Silica
nanoparticles have also found application in tubule occlusion with 40 nm silica particles
shown to prevent the movement of fluid with the tubules, thus addressing one of the
primary causes of hypersensitivity.313
A further notable point of relevance regards a number of investigations addressing the
use of toothpastes specifically designed for sensitive teeth that have indicated they do
in fact have an adverse effect, causing dentine erosion and exacerbating dentinal tubule
exposure.315 These studies using nanoparticles thus offer great potential as more viable
solutions in dental healthcare. Optimisation of the nanotechnology and monitoring its
applications with imaging is thus of great importance.
In the context of the aforementioned studies using silica nanoparticles to aid tubule
occlusion, silica nanomaterials engineered to encapsulate luminescent agents are of partic-
ular interest. Imaging applications of these materials range from use as optical sensors in
vitro to the use of silica nanoparticles in cells and tissues for biological applications.167,168
Silica nanoparticles are particularly advantageous due to their robustness, mechanical
stability and ability to protect the encapsulated or embedded lumiphores in imaging ap-
plications. The synthesis of monodisperse nanoparticles with encapsulated lumiphores is
also relatively trivial with further potential for functionalisation via surface conjugation.23
These properties have allowed for use of silica nanoparticles used in variety of applica-
tions. Wang et al. incorporated quantum dots in a silica based nanosphere which was able
to measure local pH in a ratiometric fashion.167 Sung et al. also incorporated quantum
dots within porous silica nanoparticles which were able to sense for Cu2+ ions.168 Zhang
et al. demonstrated surface functionalisation of silica nanoparticles with pairs of DNA
strands that “uncap” in the presence of Hg2+ ions, releasing a fluorescent dye resulting in
a measurable increase in fluorescence signal Encapsulation of multiple lumiphores within
a single nanoparticles also affords a much higher signal intensity compared to single lu-
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miphores. Encapsulation of luminescent ruthenium(II) tris-bipyridyl complexes within
500 nm diameter colloidal silica nanoparticles demonstrated this in a study by Lewis et
al where the luminescence from the encapsulated lumiphore was used to analyse fluid
flow in microchannels.170 A subsequent study established a method of immobilizing a
cyclometalated iridium(III) complex on to the surface of silica nanoparticle using a fluori-
nated polymer.169 These particles exhibited better stability than those prepared without
the polymer along with a seven-fold increase in the luminescence intensity and lumines-
cence lifetime. The surfactant prepared particles were also successfully used in fluid flows
for microparticle imaging velocimetry, exploiting the enhanced particle brightness and
demonstrating the potential for using the nanoparticles as nanotracers in microchannels.
Nano- and sub-micron particles offer the potential for use as multi-functional den-
tal agents by exhibiting the ability to deliver anti-pathogenic or analgesic drugs into the
tubules, in addition to being able to occlude the internal space and aid in the prevention of
infection and pulp infiltration.313,316,317 Tubule occlusion can be achieved with a variety
of different types of particles including calcium fluoride,318 combinations of carbonate-
hydroxyapatite nanocrystals319–321 and bioactive glass.188,314 The aforementioned strate-
gies aim to increase the mineral content of enamel and dentine where the particles are
employed as protagonists for further growth of the crystalline structure of the dentine via
seed mediation, eventually leading to dentinal tubule closure. The stability and ability
of the silica nanoparticle to adhere to the dentinal surface has seen their application for
occlusion of dentinal tubules.185 Their water solubility allows them to be easily deposited
into the irregular spaces composing the dentine surface186 and their large surface area also
allows for further functionalisation.169
4.2 Chapter Outline
Successful tubule occlusion has been demonstrated using silica nanoparticles. A common
problem with the use of such particles however is their liability to aggregate which can
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prevent them from entering a dentinal tubule prior to inducing seed based remineralisa-
tion.322 A possible method to help prevent this occurrence is the addition of surfactant
coatings to the particles, however the interaction of surfactant coated particles with den-
tine is an unexplored avenue of research. In this context the aim of the following research
is to investigate the interaction of silica particles with human molar teeth sections with
particular emphasis on examining how the particles interact with the tubule openings
via scanning electron and confocal microscopy imaging modalities. The use of different
surfactants as coatings for the particles is also explored in the context of their ability to
influence surface interactions with the dentine. The work performed in this chapter forms
the appended publication.
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4.3 Results and Discussion
Figure 4.2: Schematic diagram of silica particles with encapsulated luminescent ruthenium probe
(SiO2-Ru) and surfactants used for coating.
The particles investigated in this study for their interaction with dentine consisted
of spherical silica particles 640 nm in diameter encapsulating a luminescent ruthenium
complex (tris-(2,2’-bipyridyl) ruthenium(II) dichloride). These were denoted as (SiO2-
Ru-640) with surfactant coated particles were also prepared as follows (Figure 4.2):
1. SiO2-Ru-640: control sample (no surfactant).
2. Zonyl-SiO2-Ru-640: (a) 10 ml SiO2-Ru + 10 µl Zonyl FSA (1.3 g/ml), (b) 10 ml
SiO2-Ru + 100 µl Zonyl FSA (1.3 g/ml).
3. Tween20-SiO2-Ru-640: 10 ml SiO2-Ru + 10 µl Tween 20 (1.095 g/ml).
4. Triton-SiO2-Ru-640: 10 ml SiO2-Ru + 10 µl Triton X-100 (1.7 M).
In brief for surfactant coated nanoparticle preparations Zonyl FSA, Triton X-100 or
Tween20 were added to solutions of the SiO2-Ru-640 followed by ultrasonication and
centrifugation/resuspension to remove excess surfactant. The surfactant coatings did
not change the size within the error limit of the particle size analysed. For confocal
fluorescence imaging studies three different sized particles were prepared: SiO2-Ru-130
(130 ± 50 nm), SiO2-Ru-430 (430 ± 50 nm), SiO2-Ru-810 (810 ± 160 nm). Dentine
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surfaces used to examine interaction with the aforementioned particles were acid etched
with 10 % citric acid for 60 seconds to simulate hypersensitive dentine. Particles were
pipetted on to the tooth surface with no mechanical agitation. For the SiO2-Ru-640,
Zonyl-SiO2-Ru-640, Tween20-SiO2-Ru-640 and the Triton-SiO2-Ru-640 applications 10
µl of the solutions detailed above were uniformly pipetted on to the dentine surface. The
surface was left to air-dry completely and washed three-times with 10 µl of de-ionised
water. Particle application was performed by Hayley Floyd (PSIBS Doctoral Training
Centre, School of Chemistry, University of Birmingham).
Scanning electron microscopy (SEM) examination revealed unique interactions of the
particles with the dentine surface. After application to the surface SiO2-Ru-640 parti-
cles formed large aggregates several micrometers in diameter the majority of which were
clustered together (Figure 4.3A). Although these clusters are large enough to potentially
occlude tubule openings it seemed that the majority of SiO2-Ru-640 attached to the area
surrounding the tubule periphery (Figure 4.3A*). Partial occlusion is thus only achieved
in a small minority of the tubules where small clusters or single particles have been able
to enter.
The Triton X-100 coated particles (Triton-SiO2-Ru-640) show similar interactions
with the dentine surface section as the SiO2-Ru-640. Particle aggregation has however
qualitatively occurred to a lesser degree (Figure 4.3B). Nevertheless, the particle clusters
that formed were still too large to occlude the tubule openings and as such again seemed
restricted to the periphery of the tubule opening. The few tubules that were partially
occluded were blocked with small clusters or single particles (Figures 4.3B* and 4.3B**)
The Tween20-SiO2-Ru-640 preparation of particles were markedly less aggregated
on the acid etched dentine surface. Clusters were qualitatively smaller in size than the
SiO2-Ru-640 or the Triton 100-SiO2-Ru-640 preparations (Figure 4.3C). With the
smaller cluster size it is perhaps easier for the particles/clusters to at least partially occlude
the tubules (Figure 4.3C*). The difference with Tween20-SiO2-Ru-640 preparation is
particularly apparent when compared to the SiO2-Ru-640 particles (Figure 4.3A), where
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Figure 4.3: SEM images of acid etched molar root surface sections treated with (A) SiO2-
Ru-640, Triton-SiO2-Ru-640(B) and Tween20-SiO2-Ru-640 (C). Magnifications of insets
provided in ”*” images. (Scale bar 10 µm).
large clusters are seemingly preventing tubule occlusion due to particles/small clusters
attaching to and blocking the area surrounding the tubule periphery.
The Zonyl-SiO2-Ru-640 particles were observed as fairly large aggregated clusters
that seem to have an affinity for the tubule openings (Figure 4.4). This may be due to
the hydrophobic nature of the Zonyl surfactant which bears polar fluorine groups. The
physico-chemical properties of the particles in this instance may be such that the clusters
of particles prefer attachment within the tubule as opposed to the tubule periphery, as in
the case of the SiO2-Ru-640 and the Triton-SiO2-Ru-640. Furthermore clusters seem
to be of a suitable size to occlude the majority of the tubule openings (Figure 4.4A-C).
For the purposes of luminescence imaging of the particles further particle characterisa-
tion was performed. The silica particles exhibit red luminescence due to the encapsulated
ruthenium bipyridyl complex. Spectroscopic studies to quantify the effects of the sur-
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Figure 4.4: SEM images of acid etched molar root surface sections treated with Zonyl-SiO2-
Ru-640. Magnifications of insets provided in (A-C). (Scale bar 20 µm).
factants on the luminescence were performed by taking emission scans before and after
the addition of the surfactants (Appendix L). Upon excitation with visible light at 450
nm, where the characteristic absorption of the ruthenium complex occurs, the particles
luminesce in the red region of the spectrum with a peak around 615 nm.
Confocal luminescence microscopy of dentine sections exposed to SiO2-Ru-130, SiO2-
Ru-430 and SiO2-Ru-810 was performed, exploiting the luminescence of the encapsulated
ruthenium. Overlays of the red luminescence channel and the reflectance channel which
affords the dentine surface demonstrate nanoparticle association for all size preparations
(Figure 4.5). Due to the diffraction limit of confocal microscopy only the larger SiO2-
Ru-430 and SiO2-Ru-810 were individually resolved and were readily observed as clusters
occluding multiple tubules (Figure 4.5B-C).
4.4 Conclusion
There is increasing interest in the use of sub-micron particles in dentistry for applications
in the remineralisation of dentine and for the treatment of hypersensitivity by tubule
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Figure 4.5: Confocal luminescence and reflection microscopy image overlays (and corresponding
magnifications) of molar root surfaces treated with SiO2-Ru-130 (A), SiO2-Ru-640 (B) and
SiO2-Ru-810 (C). (Magnified image, scale bar 2 µm).
occlusion. Various nanosized particles of different materials have been introduced into
the dentinal tubules to this effect including calcium fluoride, hydroxyapatite and bioactive
glass.318,319,323 These approaches use particles to occlude the tubules or furthermore to
initiate a scaffold for the remineralisation of the dentine. The silica particles used in this
project have a porous structure and therefore have the potential to be a carrier for a
range of molecules including calcium based compounds. It is thus of great encouragement
that tubule occlusion is evident in both the SEM (Figure 4.3, 4.4) and confocal imaging
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observations (Figure 4.5).
These particles may also serve as a carrier for antimicrobial compounds and therefore
offer an approach to treating contaminated hard tissues,324,325 indeed preliminary studies
of SiO2-Ru-640 with a surfactant and silver coating have been shown to reduce bacterial
growth in solution (Appendix L).
Previous studies have shown the ability of particles to infiltrate dentinal tubules al-
though the difficulty of such applications in practice is preventing the particles from
aggregating due to physico-chemical interactions.188 In this study when the particles
with surfactant coatings were applied to the dentine surfaces qualitative differences in
the aggregation characteristics were observed with SEM observations. The absence of a
surfactant and Triton X-100 treated preparations resulted in the greatest aggregation of
the particles with little surface spread or tubule occlusion. Dentinal tubule occlusion was
greater with the Tween20 coated particles but was most readily observed with the Zonyl
preparation, most likely due to the physico-chemical properties of the sub-micron particles
when coated with the hydrophobic Zonyl surfactant. The properties of this Zonyl coating
are such that the particles seem to achieve an interaction with the surface and cluster
such that optimal tubule occlusion is achieved. Indications that the surfactant coating
influence surface interactions in such a manner, coupled with the encapsulation of lumi-
nescent complex in the particles to enable luminescence imaging, provides great impetus
for further investigations studying particle/dentine interactions. There is also great scope
for further analysis on the images to assess tubule occlusion and particle kinematics on
the dentine surface in greater detail.
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Human decay-free lower first permanent molar teeth, which were covered by the United
Kingdom Human Tissue Act (HTA), were chosen for the purpose of assessing the entry
of sub-micron particles into the tubules. The crown removed and the root sliced in half
along the vertical axis using the bone saw. The sectioned roots were ground down using a
grinder/polisher with 400/800 papers, to approximately 0.1 mm thick sections measured
by a micrometer. This method was used to produce sections with perpendicular tubule
openings. Before imaging/nanoparticle application, the sections were etched by a 60
second immersion in a 10% citric acid solution. The sections were then ultrasonicated
for 180 seconds. The sections were dehydrated using successive ethanol baths for ten-
minute periods of 50 %, 75 % then 100 % before drying for 1 hour in a 60 C oven. Tooth
preparation was performed by Dr. Phillip Tomson, School of Dentistry, University of
Birmingham.
4.6.2 Particle Preparation
The particles used in this investigation consisted of spherical silica encapsulated with a
luminescent complex, tris-(2,2’-bipyridyl)ruthenium(II) dichloride, represented as SiO2-
Ru,170 with a size of 640 nm were designated as SiO2-Ru-640 (640 ± 90 nm). The
effect of polymer coating did not change the size within the error limit of the particle
size analysed. The sizes were determined by Dynamic Light Scattering measurement us-
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ing a Zetasizer Nano ZS, (Malvern Instruments Ltd., Malvern, UK). Visualization of the
particles was performed using Nanosight tracking Analysis instrument (Malvern Instru-
ments Ltd., Malvern, UK). For confocal fluorescence imaging studies, three different sizes
were used (particle concentration 0.004% w/v). SiO2-Ru-130 (130 ± 50 nm), SiO2-Ru-
430 (430 ± 50 nm), SiO2-Ru-810 (810 ± 160 nm) estimated by the confocal reflectance
images. They were prepared as 0.004% w/v solutions by addition of 50 ml deionised
water to 2 mg particles (dry weight), followed by ultrasonication for 5 min. For surfac-
tant coated nanoparticle preparations Zonyl FSA, Triton X-100 or Tween20 (purchased
by Sigma-Aldrich) were added to 0.04% w/v solutions of the SiO2-Ru-640. The 0.04%
w/v solution required addition of 10 ml deionized water to 4 mg particles (dry weight),
followed by ultrasonication for 5 min. Additions of the various surfactants were done on
10 ml aliquots of the 0.04% w/v SiO2-Ru-640. Preparations are therefore as follows:
1. SiO2-Ru-640: control sample (no surfactant).
2. Zonyl-SiO2-Ru-640: (a) 10 ml SiO2-Ru + 10 µl Zonyl FSA (1.3 g/ml) (b) 10 ml
SiO2-Ru + 100 µl Zonyl FSA (1.3 g/ml). The excess of Zonyl FSA in (b) was used
to examine if this affected the particle interaction with dentine.
3. Tween20-SiO2-Ru-640: 10 ml SiO2-Ru + 10 µl Tween 20 (1.095 g/ml).
4. Triton-SiO2-Ru-640: 10 ml SiO2-Ru + 10 µl Triton X-100 (1.7 M).
After addition of the surfactants, 1 ml aliquots were transferred to eppendorf tubes
and centrifuged at 6000 rpm for 6 min, the supernatant discarded and the particles re-
suspended in deionized water. This wash step was done to remove excess surfactant.
The photophysical properties of the luminescent particles were analyzed using Edinburgh
Instruments FLS920 Series fluorescence spectrometer.
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4.6.3 Particle Application
The particles were dropped on to the tooth surface with no mechanical agitation. For the
SiO2-Ru-640, Zonyl-SiO2-Ru-640, Tween20-SiO2-Ru-640 and the Triton-SiO2-
Ru-640 10 µL of the supplied solution, was pipetted on to the dentine surface and
uniformly spread using the pipette tip. The surface was left to dry completely and sub-
sequently washed three-times with 10 µL of de-ionised water by pipetting it on to the
surface and aspirating it off. Dentine samples were then prepared for imaging. Particle
Application was performed by Hayley Floyd, PSIBS Doctoral Training Centre, School of
Chemistry, University of Birmingham.
4.6.4 Particle Imaging
All of the samples were prepared by mounting onto a carbon coated aluminium stub before
splutter coating with gold using a Quorum Emitech K550X splutter coater. A scanning
electron microscope, SEM (Zeiss EVO MA 10) was used under high vacuum and at a range
of electron acceleration voltages between 5 and 15 eV. The confocal microscopy studies
were performed using a Leica confocal microscope in reflectance and fluorescence modes.
Excitation was at 488 nm at approximately 20% power and at 458, 476 and 488 nm at
100% power, with emission collection at 478 - 498 nm and 580 - 800 nm, respectively.
The samples were mounted on 12 mm diameter carbon stubs (used in SEM) and were
attached to a glass slide.
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A B S T R A C T
Objectives: Sub-micron particles may assist in the delivery of compounds into dentine tubules. The
surface interactions of the particles with dentine may prevent them from entering the tubules. The aim of
this study is to investigate whether silica particles, treated with surfactants improves dentine tubules
occlusion using both artificial and human tooth models
Methods: Spherical silica particles (size 130–810 nm) bearing an encapsulated ruthenium luminescent
complex were coated with the following surfactants: Zonyl1 FSA, Triton1 X-100 and Tween201. The
particles were prepared as 0.004% w/v and 0.04% w/v solutions with deionized water and were applied to
the surface of; (1) in vitro model of PET ThinCertTM cell culture inserts; (2) 0.1 mm thick sections of
human molar teeth.
Results: Scanning electron and confocal fluorescence microscopy images show that particles without any
coating and with TritonX-100 coating had the highest aggregation. Particles with Tween-20 are less
aggregated on the surface and show inclusion in the tubules. Particles coated with fluorosurfactant Zonyl
show a preference for aggregation at the tubule. With the ThinCertTM membranes high aggregation
within the artificial tubules was increased by particle concentration.
Conclusions: The use of silica sub-micron particles on hard dental tissues is dependent on the
modification of the surface chemistry of both the particle and the dentine and the employment of the
fluorosurfactant may improve tubule occlusion. The use of ThinCertsTM membrane is useful in vitro
model to mimic dentinal tubules and observe the ability of particles to occlude small channels.
Clinical significance: The use of silica sub-micron particles on hard dentine tissues is dependent on the
modification of the surface coating of the particles. This may influence how particles are incorporated in
potential delivery vehicles applied to the dentine surface with the employment of a fluorosurfactant
showing promise.
ã 2015 Elsevier Ltd. All rights reserved.
1. Introduction
Dentinal tubules are microscopic channels within the denti-
nestructure, which traverse from the junction of the protective
outer enamel to the internal pulp containing the soft tissues [1].
They are around 1–4 microns in width and formed via the
odontoblast cells [2]. There is variation in both arrangement and
width of the tubules depending on their position within the tooth
[3]. Once the outer enamel structure is breached, exposure of
dentine occurs and allows communication through the tubular
space to the pulp underneath. This can lead to irreversible damage
to the soft tissues of the tooth. Nano- and sub-micron sized
particles offer the possibility of a multi-functional dental agent, by
both delivering anti-pathogenic or analgesic drugs into the tubules
combined with the ability to occlude of the internal space,thus
helping to prevent infection or infiltration into the pulp [4–6].
Their size makes them an attractive vehicle for entering into the
dentinal tubule and investigators have looked to different types of
particles to undertake such a task. These include calcium fluoride
[7], combinations of carbonate-hydroxyapatite nanocrystals [8–
10] as well as bioactive glass [11,12]. The general aim of these
studies is to increase mineral content of enamel and dentine,
where the particle acts as a seed for further growth of crystalline
structure leading to the closure of the tubules. One approach is that
the sub-micron particles may be introduced into a scaffold of
collagen and provide a structure for this growth and subsequent
mineralisation [13]. Furthermore, antibacterial actives or com-
pounds may be attached to the particles to inhibit or break up
bacterial growth.* *Corresponding author.
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A problem with the use of such particles is that they are liable to
aggregate [14], thus preventing them from entering a dentinal
tubule. Methods of preventing this from occurring include adding
surfactants to the particles. However, it is not known how the
addition of surfactants influences the movement of particles on the
dentine surface and into the tubules. Researchers have used
mechanical forces such as cavitation form imploding bubbles to
push particles into the dentinal tubules [15]. Observing such
activity of the sub-micron particles may be problematical due to
the complex surface of dentine and a simple in vitro model system
may assist in observing how particles behave on a dentine like
surface.
We have chosen silica particles for their distinct advantages:
availability in sizes ranging for nanometer to submicron without
altering the particle surface and their porous structure, which can
act as a container for molecules. Most studies involving silica
particles in dental applications have concentrated in their property
as a composite in biomaterials. We have previously introduced the
influence of surfactants of metal complexes attached on the
outside of the silica surface [16].
The aim of this research is to investigate the interaction of silica
particles with human molar teeth sections, with a particular focus
on entering the opening of dentine tubules. We have also used
different surfactants as coatings for the particles to address their
influence upon the surface interactions of the particle with the
dentine surfaces. An alternative in vitro models has also been
evaluated against dentine slices of human teeth to determine its
suitability as a research tool.
2. Materials and methods
2.1. Tooth preparation
Human decay-free lower first permanent molar teeth, which
were covered by the United Kingdom Human Tissue Act (HTA),
were chosen for the purpose of assessing the entry of sub-micron
particles into the tubules. The crown removed and the root sliced in
half along the vertical axis using the bone saw. The sectioned roots
were ground down using a grinder/polisher with 400/800 papers,
to approximately 0.1 mm thick sections measured by a micrometer.
This method was used to produce sections with perpendicular
tubule openings. Before imaging/nanoparticle application, the
sections were etched by a 60 s immersion in a 10% citric acid
solution. The sections were then ultrasonicated for 180 s. The
sections were dehydrated using successive ethanol baths for ten-
minute periods of 50%, 75% then 100% before drying for 1 h in a 60
oven.
2.2. Particle preparation
The particles used in this investigation consisted of spherical
silica encapsulated with a luminescent complex, tris-(2,20-bipyr-
idyl)ruthenium(II) dichloride, represented as SiO2–Ru [17], with a
size of 640 nm were designated as SiO2–Ru-640 (640  90 nm). The
effect of polymer coating did not change the size within the error
limit of the particle size analysed. The sizes were determined by
Dynamic Light Scattering measurement using a Zetasizer Nano ZS,
(Malvern Instruments Ltd., Malvern, UK). Visualization of the
particles was performed using Nanosight tracking Analysis
instrument (Malvern Instruments Ltd., Malvern, UK). For confocal
fluorescence imaging studies, three different sizes were used
(particle concentration 0.004% w/v). SiO2–Ru-130 (130  50 nm),
SiO2–Ru-430 (430  50 nm), SiO2–Ru-810 (810  160 nm) estimat-
ed by the confocal reflectance images. They were prepared as
0.004% w/v solutions by addition of 50 ml deionised water to 2 mg
particles (dry weight), followed by ultrasonication for 5 min. For
surfactant coated nanoparticle preparations Zonyl1 FSA, Triton1
X-100 or Tween201 (purchased by Sigma–Aldrich) were added to
0.04% w/v solutions of the SiO2–Ru-640. The 0.04% w/v solution
required addition of 10 ml deionized water to 4 mg particles (dry
weight), followed by ultrasonication for 5 min. Additions of the
various surfactants were done on 10 ml aliquots of the 0.04% w/v
SiO2–Ru-640. Preparations are therefore as follows:
1. SiO2–Ru-640: control sample—(no surfactant).
2. Zonyl-SiO2–Ru-640: (a) 10 ml—SiO2–Ru + 10 ml Zonyl FSA (1.3 g/
mL) (b) 10 ml—SiO2–Ru + 100 ml Zonyl FSA (1.3 g/mL). The excess
of Zonyl FSA in (b) was used to examine if this affected the
particle interaction with dentine.
3. Tween20–SiO2–Ru-640:10 ml—SiO2–Ru + 10ml Tween20 (1.095 g/
mL).
4. Triton–SiO2–Ru-640:10 ml—SiO2–Ru + 10ml TritonX—100 (1.7 M).
After addition of the surfactants, 1 ml aliquots were transferred
to Eppendorfs centrifuge tubes and centrifuged at 6000 rpm for
6 min, the supernatant discarded and the particles re-suspended in
deionized water. This wash step was done to remove excess
surfactant.
The photophysical properties of the luminescent particles were
analyzed using Edinburgh Instruments FLS920 Series fluorescence
spectrometer.
2.3. Application of particles to dentine
The particles were dropped on to the tooth surface with no
mechanical agitation taking place. For the SiO2–Ru-640, Zonyl–
SiO2–Ru-640, Tween20–SiO2–Ru-640 and the Triton–SiO2–Ru-640
10 mL of the supplied NP solution, was pipetted on to the dentine
surface and uniformly spread using the pipette tip. The surface was
left to dry completely and then subsequently washed three-times
with 10 mL of de-ionised water by pipetting it on to the surface and
aspirating it off. Dentine samples were then prepared for imaging.
2.4. Imaging of particles
All of the samples were prepared by mounting onto a carbon
coated aluminium stub before splutter coating with gold using a
Quorum Emitech K550X splutter coater. A scanning electron
microscope, SEM (Zeiss EVO MA 10) was used under high vacuum
and at a range of electron acceleration voltages between 5 and
15 eV.
The confocal microscopy studies were performed using a Leica
confocalmicroscopeinreflectanceandfluorescencemodes.Excitation
was at 488 nm at approximately 20% power and at 458, 476 and
488 nm at 100% power, with emission collection at 478–498 nm and
580–800 nm, respectively. The samples were mounted on 12 mm
diametercarbon stubs(usedin SEM)andwereattachedtoaglass slide.
2.5. ThinsertTM preparation and imaging
Polyethylene terephthalate (PET) ThinCertTM cell culture
inserts, normally used for cell tissue work, were selected with a
pore size of approximately 3 mm in diameter. They consisted of a
polystyrene housing containing a PET membrane. Prior to
application of the particles, one batch of control membranes
was not splutter coated; the second batch had one coat of gold
applied and the third batch had two coats of gold applied. The gold
splutter coating deposition was for 2 min delivering a thickness of
15 nm. Sub-micron particles were applied to the surface of each
batch of membranes with no mechanical agitation taking place.
The membranes and particles were splutter coated before SEM
imaging in a similar manner to the dentine surfaces.
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When applied directly to the molar root dentine surfaces that
had been acid etched with 10% citric acid for 60 s to simulate
hypersensitive dentine, SEM examination revealed unique inter-
actions of the particles with the dentine surface. The 0.04% w/v
SiO2–Ru-640particles formed large aggregates of several micro-
meters in diameter clustered on top of each other (Fig. 1A).
Although these clusters are large enough to potentially occlude a
tubule opening it seemed that most of the particles attached to the
area surrounding the tubule periphery (Fig. 1A*). Partial occlusion
is thus only achieved in a small minority of the tubules where small
clusters or single particles have been able to enter.
The Triton1 X-100 coated particles, Triton–SiO2–Ru-640, show
similar interactions with the dentine surface section as the SiO2–
Ru-640 (no surfactant); however, particle aggregation occurred to
a lesser degree (Fig. 1B). Nevertheless, the particle clusters that
formed were still too large to occlude the tubule openings and
instead were restricted to the periphery of the tubule opening. The
few tubules that were partially occluded to a small degree, were
blocked with small clusters or single particles (Fig. 1B* and B**).
Tween20–SiO2–Ru-640particles were markedly less aggregated
on the acid etched dentine surface with clusters qualitatively
smaller than the SiO2–Ru-640 or the Triton100–SiO2–Ru-640
preparations (Fig. 1C). With these smaller clusters it is perhaps
easier for the particles/clusters to at least partially occlude the
tubules (Fig. 1C*). This is particular relevant when compared to the
SiO2–Ru-640 particles (Fig.1A), where large clusters are potentially
preventing tubule occlusion by particles/small clusters by attach-
ing to and blocking the area surrounding the tubule periphery.
With regards to the Zonyl–SiO2–Ru-640 preparation, Zonyl is a
relatively hydrophobic surfactant, bearing polar fluorine groups.
This may explain why Zonyl–SiO2–Ru-640 particles were observed
as fairly large aggregated clusters that seem to have an affinity for
the tubule openings (Fig. 2). The particles were placed on dry
dentine and further research on how moisture affects the
Fig. 1. SEM images of SiO2–Ru-640 (A) particles suspended in: Triton–SiO2–Ru-640 (B), Tween20–SiO2–Ru-640 (C) applied to acid etched root surface sections. (Scale bar
10 mM). Concentrations: Triton–SiO2–Ru-640:10 ml – SiO2–Ru + 10 ml TritonX – 100 (1.7 M), Tween20–SiO2–Ru-640:10 ml – SiO2–Ru + 10 ml Tween20 (1.095 g/mL)
Fig. 2. SEM image of Zonyl–SiO2–Ru-640 (and corresponding magnifications) applied to molar root surface sections. (Scale bar 20 mM). Concentration: Zonyl–SiO2–Ru-640:
10 ml – SiO2–Ru + 100 ml Zonyl FSA (1.3 g/mL).
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clustering is required. The physico-chemical properties of the
particles, in this instance, may be such that these clusters of
particles prefer attachment within the tubule as opposed to the
tubule periphery, as in the case of the SiO2–Ru–640 and the Triton–
SiO2–Ru-600. Furthermore, the clusters seem to be of a suitable
size to occlude the majority of the tubule openings.
The silica particles exhibited red luminescence based on the
properties of the encapsulated ruthenium bipyridyl complex
(Fig. 3). We carried out spectroscopic studies to quantify the
effects of the surfactants on the luminescence signal. The
experiment was carried out by aliquoting silica particles into
1 ml samples, followed by taking emission scans before and after
the addition of the surfactants. This approach accounts for any
small but significant variations in the concentration of the particles
in the stock solution. The luminescence spectra are accompanied
by excitation spectra (Fig. 3).
The samples were excited with visible light at 450 nm, where
the characteristic absorption of the ruthenium complex occurs
based on a metal to ligand charge transfer transition. They
luminesce in the red region of the spectrum with a peak around
615 nm. The luminescence is sensitive to the environment, and it
clearly showed a blue shift upon coating of the particles with the
Zonyl surfactant. The emission studies showed that for all samples
of SiO2–Ru particles, the effect of the surfactant was most
pronounced for the Zonyl coating leading to particles with the
highest luminescence and a 5 nm blue shift on the emission
maximum. The effect of Zonyl is highest when excess of Zonyl was
added (sample 2b). The excitation spectra confirmed that the
emission originates from the ruthenium core.
The red luminescent particles SiO2–Ru-130, SiO2–Ru-430 and
SiO2–Ru-810 (0.004% w/v) can also be observed interacting with
molar root sections with confocal luminescence microscopy,
utilizing the luminescence of the encapsulated ruthenium. Overlays
Fig. 3. (a) Schematic diagram of silica particles with encapsulated luminescent ruthenium probe SiO2–Ru and surfactant coating. (b) Excitation (left) and emission (right)
spectra of the silica particles coated with different surfactants, lexc = 450 nm, lem = 620 nm.
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of the red luminescence channel and the reflectance channel (lexc/
em = 488 nm) of the dentine surface, demonstrated nanoparticle
association with the surface (Fig. 4). However, due to the resolution
limit of confocal microscopy, only the larger SiO2–Ru-810 were
clearly resolved, and were readily observed as clusters occluding
multiple tubules (Fig. 4).
To further characterize the particle–surface interactions, Zonyl
coated particles were applied to plain and gold splutter-coated
polyethylene terephthalate (PET) micropore sheets (Fig. 5).
A sample of Zonyl–SiO2–Ru (sample 2b) was applied to the
ThinCertsTM in a similar manner. Three ThinCertsTM samples were
used. The control sample was an unaltered PET ThinCertsTM, the
second sample had one splutter coating of gold, and the third
sample had two consecutive splutter-coatings of gold before the
particles were applied. The most interesting and noticeable result
of this experiment is that nanoparticle aggregation is clearly
surface-dependent. Aggregation between particles is a well-
documented phenomenon that is thought to be mainly driven
by Van der Waals forces, and exaggerated by a large surface-to-
volume ratio. The repulsive forces between polar surfactant-coated
particles and charged ions are overcome in favour of the attractive
Van der Waals forces on the PET surface, resulting in obvious
aggregation. It is also possible, given the chemical structure of PET,
that delta negative charges on the surface repel the delta negative
oxygen atoms of the silica shell. On the gold coated polymer
surface, surfactant-coated particles adsorb more evenly onto the
surface, presumably driven by electrostatic forces. The same
particles used in all three gold coated PET samples, were also used
on dentine. It is notable that the gold-coated PET membranes
bound the particles similar to how the particles bound to dentine.
This could be useful for future experiments, but could also be an
indicator that similar strength forces are involved. Overall, the
particles showed distinct aggregation on the plain PET micropores,
and strong surface interaction on the gold-coated version.
4. Discussion
There is much interest in the use of sub-micron particles in
dentistry and generally these particles may be used as a method to
remineralise dentine. There have been nanosized particles of
different materials introduced into the dentinal tubules and these
include calcium fluoride, hydroxyapatite and bioactive glass
[8,20,21]. All these approaches use the particles to initiate a
scaffold for the remineralisaiton of the dentine. The silica particles
used in this project have a porous structure and therefore have the
potential to be a carrier for a range of molecules including calcium
based compounds. These particles may also serve as a carrier for
antimicrobial compounds and therefore offer a novel approach to
treating contaminated hard tissues [16,17].
Previous work has shown the ability of particles to infiltrate
dentinal tubules although the difficulty of preventing the particles
from aggregating due to interaction with each other is a challenge
[11]. Previous work has suggested that surfactants may prevent
this from occurring [16] although this was not conducted in a
biological situation.
In this study, when the particles with surfactant coatings were
applied to the flat dentine surfaces, differences in the aggregation
were observed with SEM. The no surfactant and Triton X-100 treated
preparations resulted in the greatest aggregation of the particles
with little surface spread or occlusion of the tubules. The dentinal
tubule occlusion was greater in the Tween20 preparation, but was
mostreadilyobservedwith theZonyl preparation,possiblyduetothe
physico-chemical properties of the sub-micron particles when
coated with the relatively hydrophobic surfactant containing polar
fluorine groups. The properties of this preparation are such that the
particles achieve suitable interaction with the surface and clustered
to achieve optimum tubule occlusion, compared to the other
preparations investigated. The use of luminescent particles also
provides an avenue for the use of luminescence imaging to
investigate their use on dental surfaces [17].
There may be other factors involved in nanoparticle aggregation,
mainly local concentration and surface morphology. However, these
observations merit further research to establish the extent of
influence the surfactant has with respect to the chemistry, bonding
and other interactions. More research should be directed at
optimizing the entry of these particles for occluding dentine tubules.
If these particles are able to occlude the tubule opening, their novel
structure will allow active compounds to be bound onto the particle.
Such an approach may be useful in the topical treatment of dentine
sensitivity or the treatment of carious dentine.
The particles also showed distinct aggregation on the plain PET
micropores and strong surface interaction on the gold-coated PET
membranes, again revealing the importance of the surface
chemistry of both the nanoparticle, and the surface to which they
are binding. Therefore, the occlusion of the dentinal tubules may
be assisted by the use of surface chemistry modification prior to
delivery of the sub-micron particles.
For the use of particles to occlude, for example, hypersensitive
dentine, the interactions of the particles with the dentine surface
present a paradox. Electrostatic interactions of the particles with
dentine surfaces are a requirement to keep the particles on the
tooth surface, but they may prove an obstacle when attempting to
deliver the particles deeper into the tubules. It may be that other
techniques are required to overcome the surface attractive forces
and move the particles to a deeper position in the tubules.
These studies also demonstrated the use of PET ThinCertsTM as
potential in vitro dentine models for observing the activity of sub-
micron particles. Human teeth are difficult to procure and require a
Human Tissue Act (HTA) license for handling, as well as inherent
variations between individuals. Part of this project involved
preliminary examinations of PET ThinCertsTM as a possible model
for dentine. The ThinCertsTM are semi-transparent capillary pore
membranes produced from polyethylene terephthalate (PET) from
which they derive their name. The average tubule diameter for the
openings of the dentinal tubules was measured as 2.3 mm
(standard deviation: 0.50 mm). For the ThinCertsTM the average
diameter of the pore was calculated at 2.17 mm (standard
deviation: 0.23 mm), and the percentage of the total area covered
by the pores was 3.0% which is similar to that of superficial dentine
[18]. In Pashley (1996), the area of dentine occupied by the tubules
is 2.85–3.96% in mid-coronal dentine [18]. It is only 0.96% in
superficial dentine. So the tubules, which are in dentine vs. PET
membrane,are similar. These values are unsurprising, given the
gross appearance of the dentinein comparison to the ThinCertsTM.
Summing up the similarities and differences, the channel openings
are very similar in diameter although the ThinCertsTM are less
variable as shown by the standard deviations. The area in the
ThinCertsTM occupied by pores is similar to the area of superficial
dentine occupied by the dentinal tubules [8]. The other difference
is the pattern of arrangement of the pores which is more random
than the dentine. However, these images do suggest that the
ThinCertsTM may be useful as a dentine model.
This study showed distinct aggregation of the sub-micron
particles on plain PET micropore membranes and strong surface
interaction on the gold-coated version, revealing the importance of
the surface chemistry of both the nanoparticle and the surface to
which they are binding. Silica particles offer the possibility of
different sizes, coating and inclusion of therapeutic agents and their
use on hard dental tissues will be dependent on the modification of
the surface chemistry of the dentine prior to drug delivery.
The current study focused on silica particles binding to dentine
whilst future work will be directed at how they bind to mineralized
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dentine surfaces that better simulate clinical dentine hypersensi-
tivity [19].
There are several limitations with this work. The deposition of the
submicron particles may affect subsequent bonding systems ability
to attach to the dentine. The potential effect on bond strength to
dentine is an area of future investigation. Furthermore silica absorbs
water from the dentine and this in itself could potential cause post-
operative discomfort if the particles are to be used as an anti-
hypersensitivity agent. Again this will be investigated in further
studies.
5. Conclusion
The use of silica sub-micron particles on hard dentine tissues is
dependent on the modification of the surface coating of the
particles. The hydrophobic Zonyl surfactant coating appeared to
allow the most penetration of particles into the tubules. The use of
a ThinCertsTM membrane provides a useful in vitro model to mimic
dentinal tubules and observe the ability of particles to occlude
small channels.
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Fig. 4. Confocal luminescence and reflection microscopy image overlays (and corresponding magnifications) of SiO2–Ru-130 (A), SiO2–Ru-640 (B) and SiO2–Ru-810 (C) on the
molar root surface. (Magnified image, scale bar 2 mM).
Fig. 5. SEM images of Zonyl–SiO2–Ru-640 applied to PET ThinCertsTM (A) uncoated, (B) with a single gold splutter coat, (C) with two gold splutter coats. (Scale bar 20 mM).
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General Conclusions and Future Work
Nanoparticles have attracted considerable recent research interest for a variety of appli-
cations. The incorporation of luminescent moieties on to or within a nanoparticle can
produce an extremely useful imaging agent, that can offer several advantages over the
luminescent moiety alone. This thesis presented the development of functionalised gold
and silica nanoparticles for use as imaging probes.
Following an introduction on the relevant literature and the instrumentation used
for nanoparticle characterisation in the first chapter, the second chapter in this thesis
presents the use of two surfactants and a peptide to modify gold nanoparticles. Surface
modification using this methodology allows nanoparticle conjugation with the Hoech-
stSH complex synthesised by the author. The Tween 20 and Zonyl 7950 surfactants,
and the pHLIP peptide were utilised to overcome the issue of the aggregation upon direct
addition of HoechstSH complex to gold nanoparticles. The surfactants and peptides
were successfully used to modify 13 and 100 nm gold nanoparticles to produce fully char-
acterised and stable gold colloids.
The HoechstSH complex was synthesised from the Hoechst 33258 organic dye with
the incorporation of a thiol link, thereby allowing conjugation to gold nanoparticles. The
HoechstSH was characterised and photophysical studies revealed the complex exhibited
similar properties to the Hoechst family of dyes, with an increase in intensity and blueshift
in emission upon binding with DNA.
Gold nanoparticles both 13 nm and 100 nm in diameter were then functionalised
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with the Hoechst SH complex using prior modification with surfactant or peptide pre-
coatings. The resulting gold colloids were fully characterised and stable against aggre-
gation. Upon photophysical characterisation the colloids exhibited the emission charac-
teristics of the HoechstSH complex alone and upon addition of DNA, indicating the
luminescent nanoparticles are able to interact and bind with DNA through the surface
bound HoechstSH complex. This was corroborated by preliminary circular dichroism
studies that indicated stiffening of the DNA due to binding with the HoechstSH. These
results illustrate how an organic dye can by successfully functionalised for conjugation with
gold nanoparticles whilst retaining its characteristic physical properties. The successful
demonstration of surfactants and peptides to produce these organic dye functionalised
nanoparticles provide impetus for future development of other organic dyes for their use
with nanoprobes. With further functionality with a drug, targeting agent or indeed fur-
ther imaging moieties, there is great scope for the production a multi-modal theranostic
agent.
The cellular interactions of 13 nm and 100 nm HoechstSH functionalised gold nanopar-
ticles were studied in the A549 lung cancer and HeLa cervical cancer human cell lines.
Confocal microscopy studies of both cell lines show showed particle uptake in all cells
incubated with the all the nanoparticle preparations. The characteristic emission of the
HoechstSH is also observed on the particles inside the cells, illustrating the stability of
the nanoparticle-dye conjugate in an intracellular/biological environment. Nuclear up-
take of all the nanoparticle preparations was also observed in some cells. Localisation
of particles to the nucleus was seemingly related to cell division, with all cells exhibiting
nuclear uptake in the cell division stage of the cell cycle as according to their morphology.
A future study that could address this is an experiment where cell division is stopped
using mitotic inhibitor. These cells could be treated with nanoparticles with the amount
of nuclear uptake then compared to an untreated control, thus the proposed relationship
with cell division and nuclear uptake could be further scrutinized.
These interesting observations require future studies aimed at quantifying the amount
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of nuclear uptake observed in a particular cell. This can be done by developing an image
segmentation protocol such as that described in the second chapter, where the pixel
intensity due to the DRAQ5 nuclear stain was used to derive the location of the cell
nucleus. The co-localisation with nanoparticles can, be examined by extracting their
location by means of an intensity threshold algorithm on the reflectance image, exploiting
the light scattering properties of the gold nanoparticles. Performed only on a single cell
by the author in this thesis, this methodology requires development for high throughput,
such that many images/cells can be processed to provide statistical quantification of the
percentage of nuclear uptake in a particular cell population. An image analysis algorithm
can also thus provide a percentage of the total number of cells in a sample that exhibit
nuclear uptake. Confocal imaging fields-of-view were chosen on the basis of the number of
cells visible and although the percentage of cells with nuclear uptake in each field-of-view
was not recorded, if a crude approximation were provided approximately 10 % of cells
imaged exhibited nuclear uptake.
The aforementioned confocal microscopy studies were complemented with transmission
electron microscopy to provide intracellular resolution on the uptake of Au13-Z-HSH
and Au13-P-HSH in HeLa cells. A single electron microscopy sample grid contained
approximately twenty cells of which half exhibited particle uptake compared to virtually
all cells in a confocal sample exhibiting uptake. This would however be expected as
the cells on the grid have been prepared as ultra-thin samples of the order of several
tens of nanometres in height. Confocal imaging samples are of whole cells of the order of
several microns in height. It is therefore difficult to directly compare confocal and electron
microscopy and corroborate the number of cells with nuclear uptake, particularly when
the sensitivity of the confocal microscope and its ability to image single 13 nm particles is
considered. It is however promising that several cells with nuclear uptake, approximately
two to three cells out of twenty on the grid, were observed by electron microscopy.
The electron microscopy images themselves were extremely interesting. All cells that
exhibited uptake had nanoparticles located in densely packed vesicles in the perinuclear
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regions. This is analagous to the majority of confocal imaging observations. The presence
of nanoparticles in vesicles of various morphologies was related to observations made in the
literature of nanoparticles internalised by cells. Although requiring an extensive review of
the literature this examination of nanoparticle uptake provided an important perspective
on their cellular interactions, and is furthermore regarding as one of the most important
accomplishments of this research.
The most remarkable observations in cells showing nuclear uptake of Au13-Z-HSH
and Au13-P-HSH were apparent breaks in the nuclear membrane in the vicinity of the
particles and vesicles containing nanoparticles present in some cell nuclei. Such observa-
tions are remarkable particularly as no mechanism for vesicle mediated nuclear uptake of
nanoparticles such as this has been presented in the literature to the authors knowledge.
Examining this in greater detail in the future would therefore be of great interest. Such
studies could examine uptake in a time course experiment to evaluate particle localisation
over a period of minutes to hours after initial cellular internalisation.
Cells with nuclear uptake of particles all exhibited morphological indications they were
in the cell division stage of the cell cycle. The breaks in the nuclear membrane accom-
panying localisation of particles to the nucleus also occur during cell/nuclear division.
These observations prompted a study in to cell cycle dysregulation due to nanoparticles.
HeLa cells were synchronised and treated with Au13-Z-HSH and Au13-P-HSH in the
G0/1, S and G2/M phases of the cell division and examined for signs of dysregulation
against undosed controls. Although no significant effects were observed this does provide
scope for the use of these nanoparticles as non-toxic nuclear imaging probes, particularly
as particles were often localised to the periphery of the nucleoli in the cells. The cell cycle
experiments were extremely time consuming and extensive due to the requirement for ex-
perimental repeats, and although no significant effects were observed, the author considers
these challenging experiments important accomplishments in the research presented.
A further point of consideration when evaluating images of cells with nanoparticle
uptake is the comparison between the fixed and live cell specimens. As discussed in
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the introduction the fixation protocol for confocal microscopy can produce artefacts in
the specimen. Of great relevance for studying nanoparticle uptake is permeabilization
of the cell membrane and damage to the DNA structure that can occur with the use of
formaldehyde/paraformaldehyde for fixing. It is therefore reassuring that the fixed and
live cell specimens exhibit identical uptake with nanoparticles localised to the perinuclear
region of cells in both fixed and live cell specimens.
Further aspects of the research presented that would benefit from future studies in-
clude the pHLIP peptide coated particles. An investigation on to the pH dependence of
uptake in cells would be of great interest. Nanoparticle uptake can be quantified by flow
cytometry and confocal imaging after incubation in acidic and neutral buffer, potentially
exploiting the ability of the pHLIP peptide-nanoparticle conjugate to “insert” across the
cell membrane at acidic pH. Uptake methods could be further studied by incubating cells
with particles at 4 C and 37 C or in the presence of chemical endocytosis inhibitors to
establish whether passive cellular uptake of particles is significant.
Further accomplishments in the second chapter are the production of stable and lu-
minescent HoechstSH coated gold nanoparticles. The work required to produce these
particles was very arduous, to study these successfully produced nanoparticles in cells and
observe interesting cellular interactions was therefore very rewarding.
The work presented in chapter 3 was also similar in this respect. The Zonyl 7950 sur-
factant enabled coating of gold nanoparticles with a luminescent ruthenium polypyridyl
transition metal complex. Gold nanoparticles both 13 and 100 nm in diameter were func-
tionalised to produce luminescent nanoprobes exhibiting the distinct optical signature of
the ruthenium complex. The nanoparticles were imaged in the A549 human lung ade-
nocarcinoma cell line via confocal and transmission electron microscopies, and toxicity
assessed by the MTT and AK assay. The results showed the particles possessed high
luminescence in a cellular environment coupled with low cytotoxicity. Although initial
particle preparations proved troublesome with regards to achieving optimal coatings on
nanoparticles, both in terms of their stability and luminescence, successful production
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proved very fruitful in terms of the interesting cellular interactions observed with high
quality microscopic observations. Performing confocal and electron microscopy was fur-
thermore novel to the author at the outset of these studies, thus the development of these
techniques to obtain the images presented was extremely rewarding.
With regards to further work the ruthenium coated particles could be investigated in
the HeLa cell line and cellular uptake in general scrutinized with image analysis based
techniques aimed at quantification, both of particle uptake over time and the percentage
of nuclear uptake. There is great scope for the use of organelle stains that could be used
co-localisation studies with the nanoparticles to ascertain cellular fate. An example is the
Lysotracker stain used with the HoechstSH gold nanoparticles in chapter 2. Although
these were preliminary studies the results were very encouraging as the confocal imag-
ing observations indicated particles in acidic vesicles in the process of achieving nuclear
uptake. These results corroborate the observations made with electron microscopy that
indicated vesicle mediated nuclear delivery of particles was occurring.
Another aspect of the research presented that would benefit from further study is
the nuclear uptake of the ruthenium coated particles. Ideally the amount of nuclear
uptake of these particles could be examined and compared with the HoechstSH coated
nanoparticles and the relevant uncoated controls. Nuclear uptake could also be examined
in a more simplified scenario. The majority of nanoparticles in the cellular uptake studies
presented in this thesis are observed in the perinuclear region and are found restricted in
vesicles, indicative of the endocytotic mechanism of particle uptake. It would therefore
be beneficial if nuclear uptake could be examined with “non-restricted” nanoparticles.
This could be achieved by isolating cell nuclei from a population of cells and subsequently
“reseeding” them. A commonly used protocol in biosciences this technique would provide
the opportunity for the investigation of direct interaction between nanoparticles and a
cell nuclei in essentially a simplified biological scenario.
Chapter 4 describes an investigation on to the deposition and imaging of silica nanopar-
ticles encapsulating a luminescence probe on citric acid treated dentine surfaces. These
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studied were performed with the aim of evaluating the ability of particles to occlude
dentinal tubules in the context of providing a clinical treatment for dental hypersensitiv-
ity. Using scanning electron and fluorescence microscopy the interaction of the particles
with the dentine was examined. The images indicated that both the absence of a surfac-
tant and incubating the particles with the Triton X-100 resulted in the greatest particle
aggregation once they were applied to the dentine, with little tubule occlusion achieved.
Dentinal tubule occlusion was greater with Tween 20 coated particles but was most read-
ily observed with the Zonyl preparation. This was attributed to the physico-chemical
properties of the sub-micron particles when coated with the hydrophobic Zonyl surfac-
tant. The properties of the Zonyl are such that the particles exhibit physico-chemical
interactions that allow them to cluster such that optimal tubule occlusion is achieved.
Indications that surfactant coating influences surface interactions in such a manner,
coupled with the encapsulation of luminescent complex in the particles allowing for lumi-
nescence imaging, provides great impetus for further investigations studying particle/den-
tine interactions. Although particle preparation was relatively trivial it was rewarding to
work with silica nanoparticles in addition to gold nanoparticles and furthermore evaluate
them in a completely different biological context. With regards to future work there is
a requirement to quantify tubule occlusion which the author envisages can be achieved
through the development of computation image analysis. The effect of multiple parti-
cle treatments is also of interest, as is assessing tubule occlusion on the short, medium
and long time scale after treatment. This would be of particular relevance for clinical
applications of nanoparticle treatments aimed at relieving dentinal hypersensitivity.
The greatest accomplishment the author hopes to achieve is the eventual clinical ap-





6.0.1 Materials for Synthesis
Solvents were purchased from Fisher or Sigma Aldrich and anhydrous solvents were dried
over 3 molecular sieves under N2(g) for 1 hr. Deuterated solvents for NMR were also
purchased from Sigma Aldrich. HPLC grade solvents were used in photophysical studies
and water was deionised using an Elga Option 3 water purifier. All compounds were
synthesised under N2(g) unless otherwise indicated, using standard Schlenk techniques.
6.0.2 Experimental Details for Synthesis
1H and 13C spectra were recorded using a Bruker AC 300, AV 300, AMX 400 or AV 400
spectrometer. Electrospray mass spectra were recorded on a Waters Micromass LCT time
of flight mass spectrometer, using a nitrogen laser. Elemental analysis was performed on
either a Carlo Erba EA1110 Simultaneous CHN elemental analyser (University of Birm-
ingham), or at the London School of Pharmacy, UCL, on an Elemental Analyser, Model
1108 (Carlo-Erba, Milan, Italy) with PC based data system, Eager 200 for WindowsTM
and a Sartorious Ultra Micro Balance, 4504MP8.
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6.0.3 Synthesis of 13 nm Gold Nanoparticles
13 nm citrate-stabilised gold nanoparticles were synthesised according to Grabar et al.244
All glassware was washed with aqua regia (HCl:HNO3, 3:1), rinsed with deionised water
and dried in an oven for 24 hours. HAuCl4.3H2O (49.85 % Au) (0.0988 g, 0.2501 mmol)
was dissolved in deionised water (250 ml) with vigorous stirring and the solution was
heated to reflux. A solution of trisodium citrate (0.2858 g, 0.9718 mmol) in deionised
water (25 ml, 38.87 mM) was rapidly added to the centre of the vortex. The yellow
solution slowly darkened to a deep burgundy colour, and was kept at reflux for a further 10
min. The solution was cooled to room temperature with continuous stirring for a further
15 minutes to yield 13 nm gold nanoparticles. Colloids were stored at room temperature,
in the dark in airtight flasks. UV-Vis (H2O) λmax = 520 nm (SPR). Diameter = 12±4 nm
(DLS number distribution). Diameter = 28±14 nm, (DLS intensity distribution). Zeta
potential = -34±2 mV (1 nM in deionised water).
6.0.4 Synthesis of 100 nm Gold Nanoparticles
The procedure for synthesis of 100 nm gold nanoparticles was an adapted synthesis by
Ziegler and Eychmüller.259 Stock solutions of ascorbic acid (aq) (502 mg, 2.85 mmol, 1%
w/v), trisodium citrate dehydrate (aq) (500 mg, 1.70 mmol, 1% w/v) and AuCl4.3H2O
(aq) (49.85 % Au) (0.0988 g, 0.2501 mmol). Prepared as previously described HAuCl4.3H2O
(49.85 % Au) (0.0988 g, 0.2501 mmol) were 13 nm citrate-stabilised gold nanoparticle
seeds (9 nM). 13 nm citrate gold nanoparticles (6 ml, 9 nM) were diluted in dH2O to
40 ml under stirring. The Au3+ stock solution(4 ml, 0.2% w/v ) was diluted to 20 ml
in deionised water and added dropwise to the 13 nm citrate-stabilised gold nanoparticle
seeds. Ascorbic acid stock solution (1 ml, 1% w/v) was combined with trisodium citrate
stock solution (0.5 ml, 1% w/v), diluted to 20 ml in dH2O and added dropwise over 15
minutes to give a dark red solution. The mixture was refluxed for 30 minutes at 100
C. A 9 ml aliquot of the reaction mixture was diluted to 40 ml. Au3+ stock solution (4
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ml, 0.2% w/v) diluted to 20 ml was added dropwise to the diluted aliquot over 15 min.
Ascorbic acid stock solution (1 ml, 1% w/v) and trisodium citrate stock solution (0.5 ml,
1% w/v) were diluted to 20 ml, and added dropwise. The mixture was refluxed for 30
minutes at 100 C for 30 min to afford a red/purple solution. Au3+ stock solution (16 ml,
0.2% w/v) was diluted to 20 ml and added dropwise to a 40 ml aliquot of the reaction
mixture. Ascorbic acid stock (4 ml, 1% w/v) and trisodium citrate stock (2 ml, 1% w/v)
was diluted to 20 ml and added dropwise to the mixture affording a dark brown colloid.
The mixture was refluxed at 100 C for 30 minutes and allowed to cool, yielding 100 nm
gold nanoparticles as an orange/light brown colloid in water (40 pM). UV-Vis (H2O) λmax
(SPR) = 567 nm. Zeta potential (10 pM in dH2O) = -30±15 mV.
6.0.5 Photophysical Characterisation
UV-Vis absorption spectroscopy measurements used a Varian Cary 5000 spectrometer
at a 300 nm min−1 acquisition rate. Samples were prepared in either 1 cm or 0.4 cm
path length low volume quartz cuvettes. Steady-state and time-resolved luminescence
measurements were executed on an Edinburgh Instruments FLS920 spectrometer, with
a 450 W xenon arc lamp illumination source. The detection system uses a Hamamatsu
R928 photomultiplier tube (PMT), and an emission monochromator blazed at 500 nm.
Samples were prepared in quartz cuvettes with four transparent faces, and appropriate
long-pass filters were employed to eliminate second-order photon scattering. 77 K studies
were measured in an in-house built sample holder within a nitrogen cryostat (Oxford
Instruments), using the Edinburgh Instruments FLS920 spectrophotometer. All spectra
were corrected using a correction file provided by Edinburgh Instruments FLS920 for
the Xenon lamp light source, accounting for non-uniform intensity across the output
wavelength range.
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6.0.6 Dynamic Light Scattering and Zeta Potential
Dynamic light scattering (DLS) measurements were performed using a calibrated Zetasizer
Nano ZS (Malvern Instruments). DLS sizing used a standard operating procedure with
settings as follows; refractive index 0.47, water dispersant, temperature 25C, equilibration
time 120 seconds, disposable DTS0012 cuvettes, automated measurement duration with
five runs and no pause between runs. Zeta potentials were also measured using a cali-
brated Zetasizer Nano ZS (Malvern Instruments) with analagous settings using a standard
operating procedure adopting the Smoluchowski model and the DTS1060 cuvettes.
6.0.7 Materials for Cell Culture
Phosphate buffered saline (Dulbecco A) tablets were purchased from Fisher Scientific
UK Ltd, Loughborough, UK. Foetal bovine serum (FBS) was purchased from Invitro-
gen Ltd, Paisley, UK. All other materials were purchased from Sigma-Aldrich Company
Ltd, Dorset, UK. Complete cell media was made using 50ml Dulbecco’s modified Eagle’s
medium (DMEM) to which was added 50ml 10% v/v FBS, 5ml 100 µg ml−1 penicillin,
5ml 2mM L-glutamine and 5ml 100 µg ml−1 streptomycin. Phosphate buffered saline
solution (PBS) was made by dissolving 4 Phosphate buffered saline (Dulbecco A) tablets
in 400ml distilled water. When not in use all solutions were refrigerated at 4◦C.
HeLa Cell Culture
HeLa cells were cultured in 20 ml complete media in T75 flasks with vented caps at 37
◦C
containing 5% CO2. Complete media, PBS and all other solutions used for cell culture
maintenance were warmed to 37◦C prior to use. All cell maintenance was conducted in a
class II laminar flow cell culture cabinet. Cell media was changed every day according to
standard protocol. Cell viability was checked using a Nikon TMS light microscope before
and after media change to check confluence and general cell viability.
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A549 Cell Culture
The human alveolar adenocarcinoma A549 cell line (line 86012804, HPA) was maintained
in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), penicillin (100 µg ml−1), streptomycin (100 µg ml−1) L-glutamine (100 µg
ml−1), hereafter called complete media. Cells were cultured in 20 ml of complete media
in vented T75 flasks at 37C in 5 % CO2.
For both HeLa and A549 cells, cell passage was performed when confluence reached
60-70%. Media was removed and 10 ml PBS was used to wash away cell debris. 3 ml 0.1%
v/v trypsin-EDTA solution was added and then incubated in the flask for approximately
3 minutes at 37◦C. Cell detachment was monitored under a Nikon TMS light microscope.
Upon detachment 8 ml fresh complete media was added. The solution was transferred to
a 15 ml Falcon tube and centrifuged at 1500 rpm for 5 minutes. The supernatant was
then removed and the cell pellet resuspended in 1 ml fresh cell media. Cells were then
diluted in to a sterile T75 flask.
Confocal Microscopy Preparation and Treatment of Cells with Nanoparticles
Glass coverslips were sterilised in 100% ethanol and rinsed in phosphate buffered saline
solution pH 7.4 (PBS) before being transferred to a six-well plate. Cell passage was
performed as described above with 3 ml of the final cell suspension added to each well.
Cells were grown in the six-well plate as described above for at least 24 hours until
approximately 60-70% cell confluence was attained.
Prior to addition of the nanoparticles, cell media was removed from the six-well plate
and each well was washed thoroughly with PBS. 2.7 ml of media was then added to each
well with 0.3 ml nanoparticle solution to give a 1 in 10 dilution to prevent osmotic dam-
age. After the required incubation time points coverslips were extensively rinsed with
phosphate-buffered saline (PBS) twice. Cells were then were fixed with 4% paraformalde-
hyde in PBS for 10 min at room temperature and then rinsed and rehydrated in PBS.
Glass slides sterilised with a rinse in 100% ethanol and then allowed to dry were used to
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mount the coverslips which were placed on a droplet of non-fluorescent aqueous Hydro-
mount media. Fixed coverslips were then sealed with clear nail varnish applied copiously
around the rim to help prevent contamination and decay. The coverslips were then allowed
to dry for a minimum of 24 hours in the dark at 4◦C before microscopy analysis.
6.0.8 Confocal Microscopy
All samples were analysed using a Leica SP2 confocal system with inverted microscope
Leica DMIRE2 making use of the 63x/1.4 oil lens. For DAPI and Hoechst fluorescence
imaging of cells, samples were excited at 405nm with a beam intensity of 25%, and
emission detected between 410-550nm with default standard PMT gain. Transmission
images were acquired with the transmission microscopy setting on the microscope with
beam intensity 1-3%. For Hoechst-AuNPs, emission was collected with samples excited
at 405nm with a beam intensity of 25%, 476nm (75% intensity), 488nm (75% intensity)
and 496nm (75% intensity) with fluorescence emission was detected at 410-550nm with
default standard PMT gain.
Image processing was conducted using Macbiophotonics ImageJ Version 1.43M. For
the batch addition of scale bars a macro was written for conversion of the image parameters
from the Leica TCS SP2 microscope image data file, as illustrated in Appendix J.2.
6.0.9 Transmission Electron Microscopy
Cells were treated as described in the protocol above for fluorescence microscopy prepara-
tion. Analogously wells were dosed with Ru coated and non-coated gold nanoparticles for
24 hours. Coverslips were then washed with PBS and fixed in 2.5% gluteraldehyde for a
further 24 hours at 4◦C. Ultrathin sections were cut parallel to the coverslips by P. Stanley
and colleagues at the Centre for Electron Microscopy and mounted onto Formvar-coated
200 mesh copper grids. Transmission electron micrographs slice widths are 70-90 nm .
Sections were examined using a Jeol 1200 EX Transition Electron Micrograph (Jeol UK
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Ltd., Welwyn Garden City, UK) operated at 80kV in the imaging mode. Images were
acquired using Digital Micrograph Version 1.83.842 (Gatan Inc., Pleasanton California,





Characterisation of Hoechst 33258
A.1 NMR Spectra of Hoechst 33258
1H NMR δH (300 MHz, MeOD) 3.04(3H, s, H-1), 3.15-3.50(4H, m, H-3’,4’), 3.72(2H, d,
J 12.1, H-3,4), 4.04(3H, d, J 13.8, H-4), 7.13-7.18(2H, m, H-21), 7.41(1H, d, J 2.1, H-6),
7.50(1H, dd, J 2.2 9.1, H-10), 7.81(1H, d, J 9.09, H-9), 8.08-8.17(3H, m, H-14,20), 8.30(1H,
dd, J 1.7 8.7, H-13), 8.6(1H, J 1.2, H-17).
13C NMR δC (100 MHz, MeOD) 228.0, 222.7, 165.2, 151.1, 136.5 (C-16) 134.5, 131.7
(C-20), 127.8, 126.4 (C-13), 121.7, 120.0 (C-10), 118.1 (C-21), 116.3 (C-14), 115.7 (C-9),
114.7 (C-17), 114.1 (C-12), 112.1 (C-22) 100.9, 54.6 (C-2/3), 48.4 (C-3/2), 43.6 (C-1).
Figure A.1: 1H NMR designations of Hoechst 33258 in MeOD
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Figure A.2: 1H NMR designations of Hoechst 33258 in MeOD (aromatic)
Figure A.3: 1H NMR designations of Hoechst 33258 in spectrum (aliphatic)
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Figure A.4: 1H, 13C COSY NMR spectrum of Hoechst 33258, MeOD
Figure A.5: 1H, 13C HSQC NMR spectrum of Hoechst 33258, MeOD
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Figure A.6: (a) UV-Vis absorption spectrum of Hoechst 33258 in water (solid line) and steady-
state luminescence emission spectrum (dashed line). (λexc = 350 nm). (b) Excitation spectrum
of Hoechst 33258 in water (λem = 500 nm). Spectra corrected for instrument response. All
solutions measured at 1.3 µM concentration.
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B
Synthesis and Characterisation of HoechstSS
The first derivatisation of the Hoechst 33258 incorporates a disulphide group attached
to the OH terminal of the Hoechst 33258 molecule for binding to the gold surface (Fig-
ure B.1). Referred to as HoechstSS (HSS), this derivative was synthesised by the ester
coupling reaction of Hoechst 33258 with α-lipoic acid (Figure B.1). In brief a solu-
tion of α-lipoic acid (0.155 mg, 0.75 mmol) and 1-Hydroxybenzotriazole hydrate (0.57
mg, 0.37 mmol) in dry DMF (40 ml) was cooled to 0-5 ◦C, upon which 1-ethyl-3-(3-
(dimethylaminopropyl)carbodiimide (EDC) (116 mg, 0.75 mmol) was added and stirred,
(ca. 20 min). A solution of triethylamine (0.420 µL, 3 mmol) was added to Hoechst 33258
Pentahydrate bis-benzimide (400 mg, 0.75 mmol) in dry DMF (20ml) cooled to 0-5 ◦C
and stirred (ca. 20 min) was added to the reaction mixture. The solution was allowed
to warm to room temperature and stirred overnight. The solvent was removed in vacuo
to afford HoechstSS was filtered and dried, and used in the next step without further
purification (62 mg, 21 % yield). Production of the HoechstSS was confirmed by 1H and
13C(1H) NMR spectroscopy (Figure B.1) and mass spectrometry.
The HoechstSS complex was subject to decomposition after it was purified on a silica
column, with the product fraction indicating the presence of the Hoechst 33258 starting
material after a few hours (NMR and mass spectrometry). This is possibly due to pH sen-
sitivity and hydrolysis of the ester bond and although column purification was attempted
on an alumina column, the issue was not rectified. The HoechstSS was therefore not
purified further and as such NMR characterisation indicates the presence impurities in-
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Figure B.1: Synthesis of the surface-binding HoechstSS (HSS) complex.
cluding HOBT remaining from its synthesis and the Hoechst 33258 starting material. An
alternative derivative (HoechstSAc) was therefore synthesised.
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Figure B.2: 1H NMR designations of HoechstSS in spectrum
B.1 NMR Spectra of HoechstSS
Production of the HoechstSS was confirmed by 1H and 13C(1H) NMR spectroscopy (Figure
B.1). 1H NMR δH (300 MHz, MeOD) 1.40-1.66 (m, H-25,27), 1.68-1.81 (m, H-26,29), 2.17
(2H, t, J= 7.3, H-24), 2.27-2.36 (m, H-29), 2.87(3H, s, H-1), 2.93-3.08 (m, H-3/4,19), 3.14-
3.30 (m, H-3/4), 3.38-3.49 (m, H-28), 6.84 (2H, J= 8.8, H-21), 7.15-7.26 (m, H-6,10), 7.53
(1H, J= 8.6, H-14), 7.55-7.65 (m, H-9), 7.80 (1H, dd, J= 1.4, 8.6), 7.83-7.90 (m, H-20),
8.10 (1H, s, H-17). 13C NMR δC(100 MHz, MeOD) 25.6, 28.6, 30.3, 33.4, 34.5, 35.6,
35.9, 37.9, 39.9, 41.9, 42.6, 53.7, 55.0, 56.2, 101.5, 110.9, 112.5, 112.9, 114.8, 115.1, 115.3,
115.6, 117.4, 120.1, 121.1, 121.4, 122.2, 123.3, 124.2, 124.2, 127.6, 127.8, 128.4, 138.4,
140.6, 142.9, 147.0, 152.4, 154.4, 160.1, 163.5, 176.9.
H-14, H-17 integrate for 1 proton and H-24 for 2 protons, thus the relative number
of hydrogens suggest HoechstOH and α-lipoic acid have bonded together. H-24 is also
shifted with respect to the α-lipoic acid starting material, indicating a different chemical
environment i.e. due to the Hoechst 33258 (Figure A.1)
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Figure B.3: 1H NMR spectrum of HoechstSS in MeOD (aromatic)
Figure B.4: 1H NMR spectrum of HoechstSS in MeOD (aliphatic)
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Figure B.5: 1H, 13C COSY NMR spectrum of HoechstSS, MeOD
Figure B.6: 1H, 13C HSQC NMR spectrum of HoechstSS, MeOD
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C
Synthesis and Characterisation of HoechstSH
HoechstSAc incorporates a surface-binding thiol group to the OH terminal of the Hoechst
33258 for binding to the gold surface. The ancillary ligand was synthesised by the
Williamson reaction of 6-bromohexene with thioacetic acid (bromoSAc) complexed to
Hoechst 33258 by refluxing in DMF. (Figure C.1).
In brief, thioacetic acid (1.86 g, 24.6 mmol, 2 eq.) was added to a solution of 6-bromo-
1-hexene (2.00 g, 12.3 mmol, 1 eq.) in dry toluene (15 ml) with a catalytic amount of
1,1-azobis(cyclohexanecarbonitrile) (0.025 g). The solution was heated to reflux (130 ◦C)
under N2 for 30 minutes. The reaction was cooled to room temperature and quenched
with NaHCO3(aq) (60 ml, 1 M). The organic layer was extracted in ethyl acetate (120 ml),
washed with aqueous sodium bicarbonate (60 ml, 1 M), dried over Na2SO4 and filtered.
Solvent was removed in vacu to afford S-(5-bromopentyl)-ethanethioate, a yellow oil (2.64
g, 90 % yield).
A solution of Hoechst 33258, pentahydrate(bis-benzamide) (0.150 g, 0.282 mmol, 1
eq. in dry DMF (20 ml) was heated to 60 ◦C under N2 for 30 minutes. The reaction
was cooled to room temperature and sodium hydride was added (0.135 g, 5.64 mmol, 20
eq.). The mixture was heated to 130 ◦C under N2 for 30 minutes. A solution of S-(5-
bromopentyl)-ethanethioate (0.190 g, 0.846 mmol, 3 eq.) in dry DMF (5 ml) was added
dropwise and the mixture was stirred at 60 ◦C under N2 overnight. The solvent was
removed in vacuo. The crude product was purified by column chromatography (Silica,
methanol: dichloromethane, 1:10) to afford the HoechstSAc as a dark yellow oil (0.035 g,
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Figure C.1: Synthesis of the surface-binding HoechstSH (HSH) complex.
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23 % yield, Rf = 0.28). The thiol group was finally unmasked in situ by thioester hydroly-
sis with aqueous ammonia (1:1) to afford HoechstSH for addition to gold nanoparticles.
ε = 46,000 M−1 cm−1. Successful production of HoechstSH was confirmed by con-
firmed by 1H and 13 C1H pendant NMR spectroscopy and mass spectrometry. HRMS
for HoechstSAc [M+H] (583.2855), found 583.2858 (0.5 ppm). HRMS for HoechstSH
[M+H] (540.2740), found 541.2750 (0.5 ppm)
C.1 NMR Spectra of HoechstSAc
Production of the HoechstSAc was confirmed by 1H and 13C(1H) NMR spectroscopy
(Figure C.1). 1H NMR δH (300 MHz, MeOD)1.11-1.80 (8H, m, H-23, H-24, H-25, H-26),
2.19 (1H, s, SAc methyl), 2.62 (3H, s, H-1), 2.77 (2H, t, J= 6.3, H-22/27), 2.95 - 3.05
(4H, m, H-2/3), 3.19 - 3.28 (4H, m, H-2/3), 3.88 (2H, t, J=6.4, H-22/27), 6.93 (2H,
d, J=8.7, H-20), 6.96 (1H, dd, J=2.3, H-9), 7.06 (1H, d, J=2.3, H-5), 7.42 (1H, d, J=
8.7, H-8), 7.57 (1H, d, J=8.7, H-13), 7.83 (1H, d, J=8.7, H-12), 7.91 (2H, d, J= 8.7, H-
19), 8.13 (1H, s, H-16). 13C NMR δC(100 MHz, MeOD) 25.3 (C-23/24/25/26), 27.6-29.8
(C-23/24/25/26), 28.3 (C-22/27) 28.9 (C-SAc methyl), 43.3 (C-H-1), 50.1 (C-2/3), 54.4
(C-2/3), 67.4 (C-22/27), 101.4 (C-5), 112.6 (C-16), 114.8 (C-20), 115.5 (C-8,9,13), 121.5
(C-12), 128.3 (C-19).
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Figure C.2: 1H NMR spectrum of HoechstSS in MeOD (aromatic)
Figure C.3: 1H NMR spectrum of HoechstSAc in MeOD (aliphatic)
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Figure C.4: 1H, 13C COSY NMR (aromatic) spectrum of HoechstSAc, MeOD
Figure C.5: 1H, 13C COSY NMR (aliphatic) spectrum of HoechstSAc, MeOD
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Figure C.6: 1H, 13C HSQC NMR (aromatic) spectrum of HoechstSAc, MeOD
Figure C.7: 1H, 13C HSQC NMR (aliphatic) spectrum of BpyHex ligand, in CDCl3.
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D
Photophysical Characterisation of HoechstSS and
HoechstSH
(a) HoechstSS (b) HoechstSAc
Figure D.1: UV-Vis absorption spectra (solid line) and steady-state luminescence excitation
(dashed line) and emission spectra (bold dashed line) of HoechstSS (a) and HoechstSAc (b) in




E.1 Calculating Concentration of 13 nm Gold Nanopar-
ticles
Mass of HAuCl4 (49 % by assay) = 0.09889 g
Mass of Au = 0.49 x 0.09889 = 0.04846 g
No. moles of Au 0.04846 / 197 = 2.4597 x 10-4 moles
Concentration of Au = 2.4597 x 10-4 moles / 0.275 dm3 8.944 x -4 M
Estimated atomic radius of gold =140 pm









π (6.5 x 10−9)3 / 4
3
π (140 x 10−12)3
Concentration of 13 nm gold nanoparticles = 8.944 / 100,000 = 9 nM
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E.2 Characterisation of 13 nm Gold Nanoparticles
(a) UV-Vis absorption spectrum (b) Transmission Electron Micrograph
(c) DLS intensity distribution (d) DLS number distribution
(e) Zeta potential distribution
Figure E.1: Characterisation of 13 nm citrate-stabilised gold nanoparticles: (a) UV-Vis absorp-
tion spectrum measured at 4.5 nM particle concentration, (b) TEM sample of nanoparticles at
1 nM particle concentration dried on to formvar-coated copper grids, (c) DLS intensity and (d)























































































































































































































































































































E.3 Calculating Concentration of 100 nm Gold Nanopar-
ticles
During growth step one, 6 mL of the 13 nm gold nanoparticle seeds (9 nM) are diluted
in 80 mL. Assuming no new seeds are formed, the concentration of the 25 nm particles
formed = 0.7 nM.
In the second growth step 9 mL of the 25 nm gold nanoparticle seeds (0.7 nM) are diluted
to 80 mL. Again, assuming no new seeds are formed, the concentration of the 50 nm
particles formed = 80 pM.
In the final growth step, 40 mL of the 50 nm gold nanoparticles (80 pM) are diluted to
80 mL, rendering 100 nm gold nanoparticles at 40 pM.
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F
UV-Vis Absorption Spectra of Gold Nanoparticles in
Cell Media
Figure F.1: Normalised UV-Vis Absorption Spectra of (3 ml, 2.5 nM) Au13-T20-HSH (dashed
line), and following the addition of phenol red free cell media (solid line). Addition was done to
achieve a 1 in 10 dilution (300 µl Au13-T20-HSH: 2700 µl cell media), analogous to concentra-
tions/quantities used for cellular uptake studies.
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Figure F.2: Normalised UV-Vis Absorption Spectra of (3 ml, 2.5 nM) Au13-Z-HSH (dashed
line), and following the addition of phenol red free cell media (solid line). Addition was done
to achieve a 1 in 10 dilution (300 µl Au13-Z-HSH: 2700 µl cell media), analogous to concentra-
tions/quantities used for cellular uptake studies.
Figure F.3: Normalised UV-Vis Absorption Spectra of (3 ml, 2.5 nM) Au13-P-HSH (dashed
line), and following the addition of phenol red free cell media (solid line). Addition was done to
achieve a 1 in 10 dilution (300 µl Au13-P-HSH: 2700 µl cell media), analogous to concentra-
tions/quantities used for cellular uptake studies.
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G
Cellular Uptake of Au-T20-HSH, Au-Z-HSH and
Au-P-HSH
G.1 Confocal Microscopy of Au13 in Cells
G.1.1 Confocal Microscopy of Au13 in A549 Cells - 24 Hour
Incubation
(a) (b) (c)
Figure G.1: Images of 13 nm citrate-stabilised gold nanoparticles in A549 cells monitored by
confocal luminescence and reflection microscopy. Cells were incubated with nanoparticles at a
concentration of 0.25 nm in complete cell media for 24 hours before fixing. (a) HoechstSH and
DRAQ5 overlay. (b) Reflection and DRAQ5 overlay. (c) Transmission and DRAQ5 overlay.
Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel),
λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red channel), λexc = 633 nm, λem = 640-800.
(Scale bar 50 µm).
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Figure G.2: Images of 13 nm citrate-stabilised gold nanoparticles in HeLa cells monitored by
confocal luminescence and reflection microscopy. Cells were incubated with nanoparticles at a
concentration of 0.25 nm in complete cell media for 24 hours before fixing. (a) HoechstSH
image. (b) DRAQ5 image. (c) Reflection image. (d) Transmission image. (e) Transmission
and DRAQ5 overlay. (f) Reflection and DRAQ5 overlay. Reflection image λexc = 633 nm, λem
= 623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm,
DRAQ5, (red channel), λexc = 633 nm, λem = 640-800. (Scale bar 50 µm).
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G.2 Confocal Microscopy of Au13-T20-HSH in Cells
G.2.1 Confocal Microscopy of Au13-T20-HSH in A549 Cells -
20 Minute Incubation
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G.3 Confocal Microscopy of Au13-Z-HSH in Cells




Figure G.3: Images of Au13-Zonyl-HSH nanoparticles in A549 cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration
of 0.25 nm in complete cell media for 20 minutes before fixing. (a), (b) and (c) - widefield views
of cells with white light transmission, blue HoechstSH luminescence and reflection images re-
spectively. (d), (e) and (f) - magnifications of more cells with white light transmission, blue
HoechstSH luminescence and reflection images respectively. Nanoparticles are observed as dark
spots, cyan (from the HoechstSH surface coating) spots and white spots respectively in these im-
ages. Reflection image λexc = 633 nm, λem = 623-643 nm, (c, f) HoechstSH luminescence, blue
channel, λexc = 405 nm, λem = 405-550 nm. (Scale bar (a, b, c) = 50 µm, (d, e, f) = 10 µm)
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Figure G.4: Images of Au13-Z-HSH nanoparticles in A549 cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au13-Z-HSH at a concentration
of 0.25 nm in complete cell media for 24 hours before fixing. (a - c) widefield, (d - f) magni-
fications. (a, d) HoechstSH and DRAQ5 overlay. (b, e) Reflection and DRAQ5 overlay. (c,
f) Transmission and DRAQ5 overlay. Reflection image λexc = 633 nm, λem = 623-643 nm.
HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red
channel), λexc = 633 nm, λem = 640-800. (Scale bar 50 µm)
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Figure G.5: Images of Au100-Z-HSH nanoparticles in HeLa cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au100-Z-HSH at a concentration
of 0.10 pM in complete cell media for 90 min before fixing. (a-c) field-of-view 1. (d-f) field-
of-view 2: (a, d) HoechstSH and DRAQ5 overlay. (b, e) Reflection and DRAQ5 overlay. (c,
f) Transmission and DRAQ5 overlay. Reflection image λexc = 633 nm, λem = 623-643 nm.
HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red




Figure G.6: Images of Au100-Z-HSH nanoparticles in metaphasic HeLa cells monitored by
confocal luminescence and reflection microscopy. Cells were incubated with Au100-Z-HSH at
a concentration of 0.10 pM in complete cell media for 90 min before fixing. (a) reflection and
DRAQ5 overlay. (b) reflection and HoechstSH overlay. (c) orthogonal view of reflection and
DRAQ5 overlay. (d) Image montage of three-dimensional z-stack image slices. Reflection image,
λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm,




Figure G.7: Images of Au100-Z-HSH nanoparticles in HeLa cells monitored by confocal lu-
minescence and reflection microscopy. Cells were incubated with Au100-Z-HSH at a con-
centration of 0.10 pM in complete cell media for 24 hr before fixing. (a) DRAQ5 image. (b)
HoechstSH image. (c) reflection image. (d) transmission brightfield image. (e) reflection and
DRAQ5 overlay. (f) transmission and DRAQ5 overlay. Reflection image λexc = 633 nm, λem
= 623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm,
DRAQ5, (red channel), λexc = 633 nm, λem = 640-800. (Scale bar (a) 50 µm) (b) 10 µm




G.4 Microscopy of Au-P-HSH in Cells
G.4.1 Confocal Microscopy of Au13-P-HSH in A549 Cells - 24
Hour Incubation
(a) (b)
Figure G.9: Images of Au13-P-HSH nanoparticles in A549 cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au13-P-HSH at a concentration
of 0.25 nm in complete cell media for 24 hours before fixing. (a) Transmission brightfield and
DRAQ5 overlay. (b) Reflection and DRAQ5 overlay. Reflection image λexc = 633 nm, λem =
623-643 nm. DRAQ5, (red channel), λexc = 633 nm, λem = 640-800. (Scale bar 50 µm)
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G.4.2 Confocal Microscopy of Au13-P-HSH in A549 Cells - 30
Minute incubation
Figure G.10: Images of Au13-P-HSH nanoparticles in HeLa cells monitored by confocal lumi-
nescence and reflection microscopy. Cells were incubated with Au13-P-HSH at a concentration
of 0.25 nm in complete cell media for 30 hours before fixing. (a) HoechstSH channel image,
(b) reflection channel image overlay, (c) HoechstSH and reflectance channel image overlay, (d)
HoechstSH and transmission channel image overlay. Reflection image λexc = 633 nm, λem =
623-643 nm. HoechstSH luminescence, (blue channel), λexc = 405 nm, λem = 410-550 nm.
(Scale bar 20 µm)
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G.4.3 Transmission Electron Microscopy of Au13-P-HSH in A549
Cells - 2 Hour Incubation
Figure G.11: TEM images of Au13-P-HSH nanoparticles in HeLa cells. Cells were incubated
with Au13-P-HSH at a concentration of 0.25 nm in complete cell media for 2 hours before
fixing. Widefield images are shown in top-left image with magnification of insets (a*) and (a**)
shown as labelled. A further cell is shown in (b). and (c) are shown in (a∗), (b∗) and (c∗)
respectively. C.M - cell membrane, N - nuclear membrane, N - nucleus, V - vesicle, S.V -
secreted vesicle.
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G.4.4 Confocal Microscopy of Au100-P-HSH in HeLa Cells - 24
Hour Incubation
(a) (b) (c)
Figure G.12: Images of Au100-P-HSH nanoparticles in HeLa cells monitored by confocal lu-
minescence and reflection microscopy. Cells were incubated with Au100-P-HSH at a concen-
tration of 0.10 pM in complete cell media for 24 hours before fixing. (a) widefield transmission
brightfield and DRAQ5 overlay. (b) widefield HoechstSH image. (c) widefield reflection and
DRAQ5 overlay. Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH lumines-
cence, (blue channel), λexc = 405 nm, λem = 410-550 nm, DRAQ5, (red channel), λexc = 633
nm, λem = 640-800. (Scale bar (a) 50 µm) (b) 10 µm
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Figure G.13: DRAQ5 and reflection image overlay of Au100-P-HSH nanoparticles in HeLa
cells monitored by confocal luminescence and reflection microscopy. Cells were incubated with
Au100-P-HSH at a concentration of 0.10 pM in complete cell media for 24 hours before fix-
ing. Line intensity profiles were performed on nucleolus associate nanoparticles. Profiles were
measured on the reflection and DRAQ5 overlay with nanoparticle diameter estimated as the
full-width at half-maximum of the intensity profiles. Reflection image λexc = 633 nm, λem =
623-643 nm. DRAQ5, (red channel), λexc = 633 nm, λem = 640-800. (Scale bar 10 µm
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H
Imaging Controls of Counterstains
H.1 Hoechst 33258 Nuclear Stain
(a) (b) (c)
Figure H.1: Images of A549 cells monitored by confocal luminescence and reflection microscopy.
Cells were incubated with Hoechst 33258 at a concentration of 1 µM in complete cell media
for 30 minutes before fixing. (a) HoechstSH image. (b) Reflection image. (c) Transmission
image. Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH luminescence, (blue
channel), λexc = 405 nm, λem = 410-550 nm. (Scale bar 50 µm).
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H.2 DRAQ 5 Nuclear Stain
(a) (b)
(c) (d)
Figure H.2: Images of HeLa cells monitored by confocal luminescence and reflection microscopy.
Cells were incubated with DRAQ5 at a concentration of 1 µM in complete cell media for 30
minutes before fixing. (a) DRAQ5 image. (b) HoechstSH image. (c) Reflection image. (d)
Transmission image. Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH lumi-
nescence, (blue channel), λexc = 405 nm, λem = 410-550 nm. (Scale bar 50 µm).
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H.3 Lysotracker Lysosome Stain
(a) (b)
(c) (d)
Figure H.3: Images of HeLa cells monitored by confocal luminescence and reflection microscopy.
Cells were incubated with Lysotracker Deep Red at a concentration of 1 µM in complete cell media
for 30 minutes before fixing. (a) DRAQ5 image. (b) HoechstSH image. (c) Reflection image.
(d) Transmission image. Reflection image λexc = 633 nm, λem = 623-643 nm. HoechstSH




(a) 2hr Incubation (b) 24hr Incubation (c) 48hr Incubation
Figure I.1: Distribution of cells in the G0/G1, S and G2/M phases of the cell cycle after incuba-
tion with Au13-Z-HSH and Au13-P-HSH for the times indicated (0.25 nM concentration).
Cells were subsequently harvested by trypsinisation and centrifugation and fixed in 70 % ethanol.
For analysis cells were washed in PBS, treated with RNaseA and stained with the fluorescent
nucleic acid propidium iodide dye. Cell fluorescence was analysed using a FACS Calibur 14
flow cytometer (BD Biosciences). G0/G1, S and G2/M proportions were calculated using FCS
Express Flow 5 software (De Novo Software), with fitting performed to minimise the chi-squared
value. Results are reported as the average % of cells in each phase ± 1SD. Statistical significance
was tested with an independent t-test. P < 0.05, significant differences compared with undosed
control cells harvested at identical time points.
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Figure I.2: Statistical data - independent t-test for cell cycle analysis following incubation with










































MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=40.6, %G2=19.5




Number of cells: 4469.00
Number of cycles: 1.00









































MultiCycle suggestions (a guideline only):
No abnormal DNA content is observed.
The diploid %S=37.8, %G2=15.6




Number of cells: 2957.00
Number of cycles: 1.00
Cycle fit model: 1 Cycle





Absorption of the surfactant molecules to the gold surface also modifies the surface di-
electric constant of the particles.68,75 The change in SPR can furthermore be potentially
quite small in magnitude (¡0.5 nm), therefore a computational Matlab algorithm was
created to automate precise calculation of the SPR (J.1). A summary of the algorithm
is shown in Figure J.1. In brief, the gradient between UV-Vis absorption data points
is determined (Figure J.1b) and the data points fitted with a high-degree polynomial.
The roots of the fitted curve i.e. where the gradient equals zero are determined (Figure
J.1c). These roots correspond to the SPR and can be plotted in conjunction with the
full-width at half-maximum (FWHM) of the SPR band (Figure J.1d) to precisely mon-
itor gold nanoparticles by analysis of their UV-Vis absorption spectra. The FWHM of
the SPR band was determined using a computational Matlab algorithm developed by Mr
Chris Stepanek (EPSRC Doctoral Training Centre in Physical Science for Imaging in the
Biomedical Sciences, The University of Birmingham). Figure J.1e) shows the result of
this algorithm which essentially fits a Gaussian curve (red) to the SPR band of the gold
nanoparticles (blue). Extracting the FWHM of the Gaussian thus enables the extent of

























































1 %% UV-VIS Analysis: Version 1.0 (18-7-12) -
2 % Sunil Claire [sxc656@bham.ac.uk]
3 %% Importing Data...
4 %% Step 1: delete 'wavelength, abs' row (2nd row) in csv data file.
5 %% Recommended 'Baseline' columns (columns 1 and 2) are also deleted
6 %% Step 2: Save csv file with a different file name] and LOAD DATA
7 %% into Matlab via 'import' option under 'File'
8 %% Also included with this 'm' file is some UV-Vis data for which
9 %% the current code works.
10 %% SPR maxima are output in: TURNING PT RESULTS
11









21 headings(cellfun(@isempty,headings))=[]; % delete empty entries
22
23 %%
24 close all; clc;
25
26 %% NB. If you have a lot of data columns and line colours start...
27 %%... repeating, 'uncomment' the following line ...
28 %ColorSet = varycolor(15); %set number of lines
29
30 % ... and in the next 'for loop'
31 % ... 'COMMENT' "set(gca, 'XTick', 0:50:800,'FontSize',12);
32 % ... 'UNCOMMENT' "set(gca, 'XTick', 0:50:800,'ColorOrder',
33 ColorSet,'FontSize',12);
34 % [NB. Comment and uncomment lines by inserting
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35 % and removing a '%' symbol respectively at the start of the line]
36
37
38 %% Plot Data
39 for i=2:2:imax
40 hold all;
41 axis([250 800 0 5]) % Axis Lengths
42 plot(double(data(1:1201,1)),double(data(1:1201,i)),'linewidth',2);
43 grid on
44 set(gca, 'XTick', 0:50:800, 'FontSize',12);
45 %set(gca, 'XTick', 0:50:800,'ColorOrder', ColorSet, 'FontSize',12);
46 legend(headings,'FontSize',14);
47 title('TITLE', 'FontSize',18);




52 %% USER INPUT: Wavelength range within which to calculate
53 % turning point (SPR)







61 %% Precautionary Variable Clearance
62 clearvars turning point;
63 clearvars turning point nm;
64
65 %% Calculate derivative and turning points via curve fitting




69 %% USER INPUT: SELECT data columns to find turning points in
70 %% and enter column numbers in 'for loop' arguement
71 %% NB. See CSV file to get column numbers
72 % Guidelines for entering 'for loop' arguement:
73 % To choose columns 3 to 29 enter "for i=3:29" ....
74 % .... or to choose individual columns eg. 3, 5 and 9,
75 % enter "for i=[3,5,9]"
76
77 clearvars headings legend;
78 for i=3:29
79 headings legend(i)=[textdata(1,i)];
80 headings legend(cellfun(@isempty,headings legend))=[];
81 % delete empty entries
82 end
83
84 %% USER INPUT: SELECT data columns to plot and
85 %% enter column numbers in 'for loop' arguement
86 % Guidelines for entering 'for loop' arguement:
87 % To choose columns 3 to 29 enter "for i=3:2:29"
88 %....NB. ENSURE the '2' is included
89 % .... or to choose individual columns eg. 3, 5 and 9,
90 % enter "for i=[3,5,9]" ...
91 % ... NB. in this case ensure the Absorption values




















111 set(gca, 'XTick', 0:10:800);











123 % Root finding
124 roots1=roots(p);
125 roots1=roots1(find(roots1>=wavelength range(1,1)
126 & roots1<=wavelength range(1,2)));
127 turning point(i)=roots1(roots1 == real(roots1));
128 %turning point(cellfun(@isempty,turning point))=[];
129 end
130
131 %% display results
132 [r,c,v]=find(turning point');
133 % get SPR wavelengths together into vector 'v'
134 v
135
136 % add appropriate labels and OUTPUT data
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137 TURNING PT RESULTS=[headings legend' num2cell(v)]
138
139 %% Plotting concentrations vs. SPR








148 %% add SPR wavelengths to appropriate concentration labels
149 results=[TURNING PT RESULTS num2cell(concs)]




154 xlabel('[conc]/ {\mu}M perhaps');
155 ylabel('\lambda {SPR} /nm');
156 grid on
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J.2 ImageJ Batch Image Processing Macro
Image processing was conducted using Macbiophotonics ImageJ Version 1.43M. For the
addition of scale bars to batches of confocal images acquired with the Leica TCS SP2
Confocal Microscope, a macro requiring minimal user-input was created:
1 Dialog.create("Scale Bars");
2 Dialog.addMessage("Please ensure you have duplicates of all images saved
3 and you have produced all required overlays.");
4 Dialog.addMessage("Please choose the Source and Save




9 dir = getDirectory("Choose a Source Directory ");
10 list = getFileList(dir);
11 dirs = getDirectory("Choose a Save Directory ");
12
13 Dialog.create("Scale Bar Settings");
14 Dialog.addMessage("Please enter the scale bar parameters you require.");
15 Dialog.addMessage("(The 'Physical Length' parameter can be found in
16 the 'txt' file saved with the images by the Leica software).");
17
18 Dialog.create("Scale bar settings");
19 Dialog.addMessage("Set Scale");
20 Dialog.addNumber("Distance in Pixels",512);
21 Dialog.addNumber("Physical Length (metres)",0);
22 Dialog.addNumber("Scalebar Width Required (microns)",50);
23 Dialog.addNumber("Scalebar Thickness (pixels)",4);
24 Dialog.addString("Scalebar Color", "White");




28 DistanceinPixels = Dialog.getNumber();
29 PhysicalLength = Dialog.getNumber();
30 PhysicalLengthum = PhysicalLength*(1E6);
31
32 width = Dialog.getNumber();
33 widthum = width*(1E6);
34
35 height = Dialog.getNumber();
36 color = Dialog.getString();
37 font = Dialog.getNumber();
38
39 for (i=0; i<list.length; i++) {
40 path = dir+list[i];
41 //print(i+" "+path);
42 showProgress(i, list.length);
43 if (endsWith(list[i], "/") == 0) {
44 open(path);
45 title = getTitle();
46 run("RGB Color");
47 run("Set Scale...", "distance=" + DistanceinPixels+
48 " known=" + PhysicalLengthum + " pixel=1 unit=um global");
49 run("Scale Bar...", "width=" + width+ " height=" + height
50 + " font=" + font + " color=" + color + "






J.3 Computational PSF Analysis








9 figure; plot(x,normalised y,'k','LineWidth',2);
10 title('Model 100nm Gold Nanoparticle','FontSize',12);
11 xlabel('diameter/ m ', 'FontSize',12);




16 % gaussian approximation of PSF - approx 300nm FWHM
17 %(created from estimate obtained from microscope software).
18
19 x gaus=0:1e-10:1e-6;
20 y gaus PSF=gaussmf(x gaus,[1.2e-7 0.5e-6]);
21 normalised yg=(y gaus PSF-min(y gaus PSF))
22 ./(max(y gaus PSF)-min(y gaus PSF));
23 %normalised yg=y gaus PSF/norm(y gaus PSF);
24 figure; plot(x gaus,normalised yg,'k','LineWidth',2);
25 title('Theoretical PSF from Luminescence Mode','FontSize',12);
26 xlabel('diameter/ {\mu}m ', 'FontSize',12);





31 % plot convolution
32






39 title('Convolution of Theoretical Nanoparticle & PSF','FontSize',12);
40 xlabel('diameter/ m ', 'FontSize',12);
41 ylabel('Normalised Intensity', 'FontSize',12);
42 grid off;
43 box off;







51 xlabel('diameter/ m ', 'FontSize',12);





Cellular Uptake of Au13-Z-RuSH and Au100-Z-RuSH
Figure K.1: Images of Au13-Z-RuSH in A549 cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with nanoparticles at a concentration of 0.9 nM
in complete cell media for 24 hours before fixing. (a) reflectance image, (b) ruthenium lumi-
nescence, (c) transmission image, (d) Hoechst nuclear stain,(e) ruthenium luminescence and
Hoechst overlay, (f) transmission image and Hoechst nuclear stain overlay. Reflection image
λexc = 633 nm, λem = 623-643 nm. Hoechst (blue channel), λexc = 405 nm, λem = 410-455
nm. Ruthenium luminescence (red channel), λexc = 633 nm, λem = 640-800. (Scale bar 50
µm).
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Figure K.2: Images of Au13-Z-RuSH in A549 cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with nanoparticles at a concentration of 0.9 nM in
complete cell media for 24 hours before fixing. (a) transmission image, (b) reflectance image,
(c) ruthenium luminescence, (d) Hoechst nuclear stain, (e) transmission image and Hoechst
nuclear stain overlay, (f) Hoechst nuclear stain and reflection image overlay, (g) ruthenium
luminescence and reflection image overlay, (h) ruthenium luminescence and Hoechst overlay,
Reflection image λexc = 633 nm, λem = 623-643 nm. Hoechst (blue channel), λexc = 405 nm,
λem = 410-455 nm. Ruthenium luminescence (red channel), λexc = 633 nm, λem = 640-800.
(Scale bar 20 µm).
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Figure K.3: Images of A549 cells monitored by confocal luminescence and reflection microscopy.
Cells were cultured in complete cell media for 24 hours before fixing. (a) Hoechst nuclear stain
image, (b) ruthenium luminescence image (c) ruthenium luminescence and Hoechst overlay, (f)
transmission image and Hoechst nuclear stain overlay. Hoechst (blue channel), λexc = 405 nm,
λem = 410-455 nm. Ruthenium luminescence (red channel), λexc = 633 nm, λem = 640-800.
(Scale bar 50 µm).
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Figure K.4: Images of Au100-Z-RuSH in A549 cells monitored by confocal luminescence and
reflection microscopy. Cells were incubated with nanoparticles at a concentration of 0.4 pM in
complete cell media for 24 hours before imaging. (a) Confocal image slice sequence from 3D
z-stack of cells with ruthenium luminescence and nuclear Hoechst overlay, with enlargement of
highlighted slice shown in (b) and orthogonal view of the central z-stack slice (xz plane below,
yz plane-right) in (c) illustrating ruthenium luminescence from within the same central z-plane
as the nuclear Hoechst luminescence (arrow). Reflection image λexc = 633 nm, λem = 623-643
nm. Hoechst (blue channel), λexc = 405 nm, λem = 410-455 nm. Ruthenium luminescence (red
channel), λexc = 633 nm, λem = 640-800. (Scale bar 10 µm).
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Figure K.5: Images of Au100-Z-RuSH in close to proximity to condensed chromatin in the
nucleus of an A549 cell. Cells were incubated with nanoparticles at a concentration of 0.4 pM
in complete cell media for 24 hours before imaging. (a) Reflection image, (b) ruthenium lumi-
nescence image, (c) Hoechst blue channel image and (d) ruthenium luminescence and Hoechst
overlay. Reflection image λexc = 633 nm, λem = 623-643 nm. Hoechst (blue channel), λexc =
405 nm, λem = 410-455 nm. Ruthenium luminescence (red channel), λexc = 633 nm, λem =
640-800. (Scale bar 1 µm).
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Figure K.6: Images and spectral scans of Au100-Z-RuSH in close to proximity to condensed
chromatin in the nucleus of an A549 cell. Spectral data is measured and fitted as described in
image descriptions.
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Figure K.7: Flow Cytometry Analysis of A549 Incubated with Au100-Z-RuSH for 24 hours.
Cells were cultured in 6-well plates to approximately 60 % confluence before treatment with
Au100-Z-RuSH (4 pM) for 24 hours. Cells were washed in PBS, detached with trypsin-EDTA
solution (3 min, 37C), and pelleted by centrifugation. The supernatant was removed and cell
pellets re-suspended in PBS and transferred to flow cytometry tubes for analysis (FACScalibur,
BD Biosciences, USA). Forward scatter, side scatter and red fluorescence (λexc = 488 nm, with
emission collected with a 670 nm band pass filter) of 50,000 cells were measured. Weasel freeware
software was used for data analysis: Weasel Software
Figure K.8: FACS forward and side scatter data of (a) control (undosed) A549 cells and (b) cells
incubated with Au100-Z-RuSH (4 pM) for 24 hours (b). (middle and solid line in graph on
right). Median side scatter intensity exhibited in (c) - undosed control cells (dashed) and cells
incubated with Au100-Z-RuSH (4 pM) for 24 hours (solid line). An increase in the median
side scatter, from 273.8 to 361.9 is indicative of increased scattering from the dosed cells, over





Figure L.1: Excitation (dashed line) and emission (solid line) spectra of the silica particles coated
with different surfactants. λexc = 450 nm, λem = 620 nm.
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L.2 Preliminary Antibacterial Response Studies of
SiO2Ru-640
Figure L.2: Growth inhibition effect over time (hours) on Streptococcus Mutans bacteria of func-
tionalised sub-micron silica particles: plain - uncoated particles, P + Z - zonyl coated particles,
P + Z + Ag - zonyl and silver coated particles, P + Z + Zn - zonyl and zinc coated particles, P
+ PEG - PEG coated particles, P + PEG + Ag - PEG and silver coated particles, P + Z + Zn
- PEG and zinc coated particles, and S. mutans - undosed control.
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135 Raphaël Lévy, Nguyen TK Thanh, R Christopher Doty, Irshad Hussain, Richard J
Nichols, David J Schiffrin, Mathias Brust, and David G Fernig. Rational and com-
binatorial design of peptide capping ligands for gold nanoparticles. Journal of the
American Chemical Society, 126(32):10076–10084, 2004.
136 Linlin Sun, Dianjun Liu, and Zhenxin Wang. Functional gold nanoparticle- peptide
complexes as cell-targeting agents. Langmuir, 24(18):10293–10297, 2008.
137 Robert A Gatenby, Edward T Gawlinski, Arthur F Gmitro, Brant Kaylor, and Robert J
Gillies. Acid-mediated tumor invasion: a multidisciplinary study. Cancer research,
66(10):5216–5223, 2006.
138 Yana K Reshetnyak, Oleg A Andreev, Ursula Lehnert, and Donald M Engelman.
Translocation of molecules into cells by ph-dependent insertion of a transmembrane
helix. Proceedings of the National Academy of Sciences, 103(17):6460–6465, 2006.
139 Eugene A Sosunov, Evgeny P Anyukhovsky, Alexander A Sosunov, Anna Moshnikova,
Dayanjali Wijesinghe, Donald M Engelman, Yana K Reshetnyak, and Oleg A Andreev.
ph (low) insertion peptide (phlip) targets ischemic myocardium. Proceedings of the
National Academy of Sciences, 110(1):82–86, 2013.
287
140 John F Hunt, Parshuram Rath, Kenneth J Rothschild, and Donald M Engelman.
Spontaneous, ph-dependent membrane insertion of a transbilayer α-helix. Biochem-
istry, 36(49):15177–15192, 1997.
141 Dhammika Weerakkody, Anna Moshnikova, Mak S Thakur, Valentina Moshnikova,
Jennifer Daniels, Donald M Engelman, Oleg A Andreev, and Yana K Reshetnyak.
Family of ph (low) insertion peptides for tumor targeting. Proceedings of the National
Academy of Sciences, 110(15):5834–5839, 2013.
142 Lan Yao, Jennifer Daniels, Anna Moshnikova, Sergey Kuznetsov, Aftab Ahmed, Don-
ald M Engelman, Yana K Reshetnyak, and Oleg A Andreev. phlip peptide tar-
gets nanogold particles to tumors. Proceedings of the National Academy of Sciences,
110(2):465–470, 2013.
143 Monika Musial-Siwek, Alexander Karabadzhak, Oleg A Andreev, Yana K Reshetnyak,
and Donald M Engelman. Tuning the insertion properties of phlip. Biochimica et
Biophysica Acta (BBA)-Biomembranes, 1798(6):1041–1046, 2010.
144 Oleg A Andreev, Donald M Engelman, and Yana K Reshetnyak. Targeting acidic
diseased tissue: New technology based on use of the ph (low) insertion peptide (phlip).
Chimica oggi, 27(2):34, 2009.
145 Zilong Zhao, Hongmin Meng, Nannan Wang, Michael J Donovan, Ting Fu, Mingxu
You, Zhuo Chen, Xiaobing Zhang, and Weihong Tan. A controlled-release nanocarrier
with extracellular ph value driven tumor targeting and translocation for drug delivery.
Angewandte Chemie International Edition, 52(29):7487–7491, 2013.
146 Gang Han, Chang-Cheng You, Byoung-jin Kim, Rosemary S Turingan, Neil S Forbes,
Craig T Martin, and Vincent M Rotello. Light-regulated release of dna and its de-
livery to nuclei by means of photolabile gold nanoparticles. Angewandte Chemie,
118(19):3237–3241, 2006.
147 Alexander G Tkachenko, Huan Xie, Donna Coleman, Wilhelm Glomm, Joseph Ryan,
Miles F Anderson, Stefan Franzen, and Daniel L Feldheim. Multifunctional gold
nanoparticle-peptide complexes for nuclear targeting. Journal of the American Chem-
ical Society, 125(16):4700–4701, 2003.
148 Duncan Hieu M Dam, Jung Heon Lee, Patrick N Sisco, Dick T Co, Ming Zhang,
Michael R Wasielewski, and Teri W Odom. Direct observation of nanoparticle–cancer
cell nucleus interactions. ACS nano, 6(4):3318–3326, 2012.
288
149 Adegboyega K Oyelere, Po C Chen, Xiaohua Huang, Ivan H El-Sayed, and Mostafa A
El-Sayed. Peptide-conjugated gold nanorods for nuclear targeting. Bioconjugate chem-
istry, 18(5):1490–1497, 2007.
150 Bin Kang, Megan A Mackey, and Mostafa A El-Sayed. Nuclear targeting of gold
nanoparticles in cancer cells induces dna damage, causing cytokinesis arrest and apop-
tosis. Journal of the American Chemical Society, 132(5):1517–1519, 2010.
151 Sridharan Soundararajan, Li Wang, Vijayalakshmi Sridharan, Weiwei Chen, Nigel
Courtenay-Luck, David Jones, Eleanor K Spicer, and Daniel J Fernandes. Plasma
membrane nucleolin is a receptor for the anticancer aptamer as1411 in mv4-11 leukemia
cells. Molecular pharmacology, 76(5):984–991, 2009.
152 Mohamed Kodiha, Yi Meng Wang, Eliza Hutter, Dusica Maysinger, and Ursula
Stochaj. Off to the organelles-killing cancer cells with targeted gold nanoparticles.
Theranostics, 5(4):357, 2015.
153 Jennifer P Leung, Sherry Wu, Keng C Chou, and Ruth Signorell. Investigation of sub-
100 nm gold nanoparticles for laser-induced thermotherapy of cancer. Nanomaterials,
3(1):86–106, 2013.
154 Steven K Libutti, Giulio F Paciotti, Adriana A Byrnes, H Richard Alexander,
William E Gannon, Melissa Walker, Geoffrey D Seidel, Nargiza Yuldasheva, and
Lawrence Tamarkin. Phase i and pharmacokinetic studies of cyt-6091, a novel pegy-
lated colloidal gold-rhtnf nanomedicine. Clinical Cancer Research, 16(24):6139–6149,
2010.
155 Colleen M Alexander, Kristen L Hamner, Mathew M Maye, and James C Dabrowiak.
Multifunctional dna-gold nanoparticles for targeted doxorubicin delivery. Bioconjugate
chemistry, 25(7):1261–1271, 2014.
156 S Jain, DG Hirst, and JM O’sullivan. Gold nanoparticles as novel agents for cancer
therapy. The British journal of radiology, 2014.
157 I Jose, Dzmitry G Batrakou, and Eric C Schirmer. Cancer biology and the nuclear
envelope: a convoluted relationship. In Seminars in cancer biology, volume 23, pages
125–137. Elsevier, 2013.
158 Kyle B Matchett, Suzanne McFarlane, Sophie E Hamilton, Yousef SA Eltuhamy,
Matthew A Davidson, James T Murray, Ahmed M Faheem, and Mohamed El-Tanani.
289
Ran gtpase in nuclear envelope formation and cancer metastasis. In Cancer Biology
and the Nuclear Envelope, pages 323–351. Springer, 2014.
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